ID,Imprinted Gene,Gene,Paternal/Maternal,Variant and risk allele,P-value,P-value annotation,RAF,OR,Beta,CI,Mapped gene,Reported trait,Trait(s),Study accession,Location,Grouping
1562,KCNQ1,KCNQ1,Maternal,rs2237898-<b>C</b>,7 x 10-6,,NR,'-,0.0475146 unit decrease,[0.027-0.068],"KCNQ1, KCNQ1-AS1",Mosquito bite size,mosquito bite reaction size measurement,GCST004863,11:2842590,Allergy
1908,KCNQ1,KCNQ1-AS1,Maternal,rs2237898-<b>C</b>,7 x 10-6,,NR,'-,0.0475146 unit decrease,[0.027-0.068],"KCNQ1, KCNQ1-AS1",Mosquito bite size,mosquito bite reaction size measurement,GCST004863,11:2842590,Allergy
2267,MAGI2,MAGI2,Maternal,rs1829991-<b>T</b>,3 x 10-6,,NR,'-,0.0375389 unit decrease,[0.022-0.053],MAGI2,Itch intensity from mosquito bite adjusted by bite size,"mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement",GCST004862,7:78195621,Allergy
2386,NTM,NTM,Maternal,rs693249-<b>G</b>,5 x 10-6,,NR,'-,0.0180037 unit increase,[0.01-0.026],NTM,Itch intensity from mosquito bite adjusted by bite size,"mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement",GCST004862,11:131877289,Allergy
2387,NTM,NTM,Maternal,rs56184986-<b>T</b>,2 x 10-6,,NR,'-,0.0318671 unit increase,[0.019-0.045],"AP000844.2, NTM",Itch intensity from mosquito bite adjusted by bite size,"mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement",GCST004865,11:131888276,Allergy
19,ANO1,ANO1,Maternal,rs1876-<b>?</b>,5 x 10-14,,NR,'-,'-,'-,ANO1,Height,body height,GCST007841,11:70174662,Anthropometric
263,DLX5,DLX5,Maternal,rs1724298-<b>T</b>,3 x 10-29,,0.891048,'-,0.0332063 unit decrease,[0.027-0.039],"DLX5, DLX6-AS1",Heel bone mineral density,heel bone mineral density,GCST006979,7:97017872,Anthropometric
264,DLX5,DLX5,Maternal,rs1724298-<b>T</b>,7 x 10-10,,0.890544,'-,0.0328463 unit decrease,[0.022-0.043],"DLX5, DLX6-AS1",Heel bone mineral density,heel bone mineral density,GCST006288,7:97017872,Anthropometric
265,DLX5,DLX5,Maternal,rs1724298-<b>T</b>,2 x 10-6,(women),0.89082,'-,0.0350508 unit decrease,[0.021-0.05],"DLX5, DLX6-AS1",Heel bone mineral density,heel bone mineral density,GCST006288,7:97017872,Anthropometric
266,DLX5,DLX5,Maternal,rs1724298-<b>?</b>,5 x 10-27,,NR,'-,'-,'-,"DLX5, DLX6-AS1",Heel bone mineral density,heel bone mineral density,GCST007066,7:97017872,Anthropometric
267,DLX5,DLX5,Maternal,rs1724298-<b>?</b>,1 x 10-25,,NR,'-,0.0342394 unit decrease,[0.028-0.041],"DLX5, DLX6-AS1",Heel bone mineral density,heel bone mineral density,GCST006433,7:97017872,Anthropometric
268,DLX5,DLX5,Maternal,rs3757493-<b>T</b>,1 x 10-8,(European),0.424,'-,0.0359 unit decrease,'-,"SDHAF3, DLX5",Total body bone mineral density,bone density,GCST005348,7:97027260,Anthropometric
269,DLX5,DLX5,Maternal,rs6960249-<b>T</b>,1 x 10-8,,0.5909,'-,0.0325 unit increase,'-,"DLX5, SDHAF3",Total body bone mineral density,bone density,GCST005348,7:97030820,Anthropometric
270,DLX5,DLX5,Maternal,rs78456152-<b>?</b>,8 x 10-24,,NR,'-,0.0217886 unit increase,[0.018-0.026],"DLX5, SDHAF3",Heel bone mineral density,heel bone mineral density,GCST006433,7:97089060,Anthropometric
271,DLX5,DLX5,Maternal,rs7811543-<b>?</b>,1 x 10-15,,NR,'-,'-,'-,"SDHAF3, DLX5",Heel bone mineral density,heel bone mineral density,GCST007066,7:97089586,Anthropometric
272,DLX5,DLX5,Maternal,rs6958059-<b>A</b>,8 x 10-20,,0.634932,'-,0.0175454 unit increase,[0.014-0.021],"DLX5, SDHAF3",Heel bone mineral density,heel bone mineral density,GCST006979,7:97092729,Anthropometric
857,H19,H19,Maternal,rs6578985-<b>?</b>,6 x 10-6,"(AAM-CT, EA)",NR,'-,'-,'-,"H19, IGF2",Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,11:2116909,Anthropometric
858,H19,H19,Maternal,rs6578987-<b>?</b>,3 x 10-6,"(AAM-CT, Chinese)",NR,'-,'-,'-,"H19, IGF2",Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,11:2116909,Anthropometric
1533,KCNK9,KCNK9,Maternal,rs2014712-<b>?</b>,5 x 10-9,,NR,'-,'-,'-,KCNK9,Height,body height,GCST007841,8:139628391,Anthropometric
1563,KCNQ1,KCNQ1,Maternal,rs116895106-<b>A</b>,2 x 10-6,,0.0104,'-,0.2653 unit increase,[0.16-0.37],KCNQ1,Waist-to-hip ratio adjusted for BMI,BMI-adjusted waist-hip ratio,GCST008159,11:2469330,Anthropometric
1564,KCNQ1,KCNQ1,Maternal,rs2283163-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,KCNQ1,Height,body height,GCST007841,11:2555665,Anthropometric
1565,KCNQ1,KCNQ1,Maternal,rs7128926-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,"KCNQ1OT1, KCNQ1",Height,body height,GCST007841,11:2675514,Anthropometric
1566,KCNQ1,KCNQ1,Maternal,rs3216306-<b>?</b>,3 x 10-14,,NR,'-,0.03431111 unit decrease,[0.025-0.043],KCNQ1,Height,body height,GCST008839,11:2705478,Anthropometric
1567,KCNQ1,KCNQ1,Maternal,rs67886747-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,KCNQ1,Waist circumference adjusted for body mass index,BMI-adjusted waist circumference,GCST009867,11:2719704,Anthropometric
1568,KCNQ1,KCNQ1,Maternal,rs2283208-<b>?</b>,2 x 10-6,,NR,4.0412416,'-,'-,KCNQ1,Obesity without metabolic disease,metabolically healthy obesity,GCST006492,11:2722629,Anthropometric
1569,KCNQ1,KCNQ1,Maternal,rs231906-<b>?</b>,5 x 10-7,(men),0.4329,'-,'-,'-,KCNQ1,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),"BMI-adjusted waist circumference, physical activity measurement",GCST004563,11:2731379,Anthropometric
1570,KCNQ1,KCNQ1,Maternal,rs231906-<b>G</b>,4 x 10-7,(men),0.4329,'-,0.0284 cm increase,[0.017-0.039],KCNQ1,Waist circumference adjusted for body mass index,"BMI-adjusted waist circumference, physical activity measurement",GCST004562,11:2731379,Anthropometric
1571,KCNQ1,KCNQ1,Maternal,rs231906-<b>G</b>,2 x 10-8,(women),0.4329,'-,0.0315 cm increase,[0.021-0.042],KCNQ1,Waist circumference adjusted for body mass index,"BMI-adjusted waist circumference, physical activity measurement",GCST004562,11:2731379,Anthropometric
1572,KCNQ1,KCNQ1,Maternal,rs231906-<b>G</b>,1 x 10-7,(men),0.4403,'-,0.0343 cm increase,[0.022-0.047],KCNQ1,Waist circumference adjusted for BMI in active individuals,"BMI-adjusted waist circumference, physical activity measurement",GCST004564,11:2731379,Anthropometric
1573,KCNQ1,KCNQ1,Maternal,rs231906-<b>G</b>,2 x 10-7,(women),0.4326,'-,0.0332 cm increase,[0.021-0.046],KCNQ1,Waist circumference adjusted for BMI in active individuals,"BMI-adjusted waist circumference, physical activity measurement",GCST004564,11:2731379,Anthropometric
1574,KCNQ1,KCNQ1,Maternal,rs231906-<b>?</b>,5 x 10-8,(women),0.4329,'-,'-,'-,KCNQ1,Waist circumference adjusted for BMI (joint analysis main effects and physical activity interaction),"BMI-adjusted waist circumference, physical activity measurement",GCST004563,11:2731379,Anthropometric
1575,KCNQ1,KCNQ1,Maternal,rs231878-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,KCNQ1,Waist circumference adjusted for body mass index,BMI-adjusted waist circumference,GCST009867,11:2742547,Anthropometric
1576,KCNQ1,KCNQ1,Maternal,rs163149-<b>?</b>,8 x 10-11,,NR,'-,'-,'-,KCNQ1,Waist circumference adjusted for body mass index,BMI-adjusted waist circumference,GCST009867,11:2776200,Anthropometric
1577,KCNQ1,KCNQ1,Maternal,rs234886-<b>C</b>,9 x 10-8,,0.83,'-,0.035 unit decrease,[0.019-0.051],KCNQ1,Height,body height,GCST002702,11:2780860,Anthropometric
1578,KCNQ1,KCNQ1,Maternal,rs2237886-<b>T</b>,5 x 10-18,,0.107,'-,0.043 unit increase,[0.033-0.053],KCNQ1,Height,body height,GCST002647,11:2789501,Anthropometric
1579,KCNQ1,KCNQ1,Maternal,rs2237886-<b>T</b>,2 x 10-13,,0.11,'-,0.046 unit increase,[NR],KCNQ1,Height,body height,GCST000817,11:2789501,Anthropometric
1580,KCNQ1,KCNQ1,Maternal,rs143840904-<b>?</b>,1 x 10-17,,NR,'-,0.11436368 unit decrease,[0.088-0.141],KCNQ1,Height,body height,GCST008839,11:2792092,Anthropometric
1581,KCNQ1,KCNQ1,Maternal,rs143840904-<b>?</b>,8 x 10-23,,NR,'-,'-,'-,KCNQ1,Waist circumference adjusted for body mass index,BMI-adjusted waist circumference,GCST009867,11:2792092,Anthropometric
1582,KCNQ1,KCNQ1,Maternal,rs143840904-<b>?</b>,1 x 10-109,,NR,'-,'-,'-,KCNQ1,Height,body height,GCST007841,11:2792092,Anthropometric
1583,KCNQ1,KCNQ1,Maternal,rs61869763-<b>?</b>,3 x 10-27,,NR,'-,0.040659904 unit increase,[0.033-0.048],KCNQ1,Height,body height,GCST008839,11:2792115,Anthropometric
1584,KCNQ1,KCNQ1,Maternal,rs61869763-<b>?</b>,9 x 10-21,,NR,'-,'-,'-,KCNQ1,Waist circumference adjusted for body mass index,BMI-adjusted waist circumference,GCST009867,11:2792115,Anthropometric
1585,KCNQ1,KCNQ1,Maternal,rs150199504-<b>C</b>,3 x 10-6,,0.9917,'-,0.208 unit increase,[0.12-0.3],KCNQ1,Height,body height,GCST008163,11:2793730,Anthropometric
1586,KCNQ1,KCNQ1,Maternal,rs147072329-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,KCNQ1,Waist circumference adjusted for body mass index,BMI-adjusted waist circumference,GCST009867,11:2797727,Anthropometric
1587,KCNQ1,KCNQ1,Maternal,rs2237892-<b>T</b>,9 x 10-13,,0.36,'-,0.0298 unit increase,[0.022-0.038],KCNQ1,Body mass index,body mass index,GCST002461,11:2818521,Anthropometric
1588,KCNQ1,KCNQ1,Maternal,rs60808706-<b>A</b>,1 x 10-38,(Japanese),0.392,'-,0.046 unit increase,[0.038-0.054],KCNQ1,Body mass index,body mass index,GCST004904,11:2836003,Anthropometric
1589,KCNQ1,KCNQ1,Maternal,rs2237897-<b>A</b>,2 x 10-8,,'-,'-,0.0066 unit increase,'-,KCNQ1,Body mass index,body mass index,GCST009764,11:2837316,Anthropometric
1590,KCNQ1,KCNQ1,Maternal,rs2237897-<b>T</b>,1 x 10-30,,0.05,'-,0.038 unit increase,[0.032-0.044],KCNQ1,Body mass index,body mass index,GCST004904,11:2837316,Anthropometric
1944,KLF14,KLF14,Maternal,rs6942396-<b>A</b>,9 x 10-6,,0.291,'-,0.0333 unit increase,[0.019-0.048],"KLF14, TSGA13",Body mass index,body mass index,GCST008158,7:130701531,Anthropometric
1945,KLF14,KLF14,Maternal,rs3909553-<b>?</b>,6 x 10-10,,NR,'-,'-,'-,KLF14,Body mass index,body mass index,GCST007039,7:130732987,Anthropometric
1946,KLF14,KLF14,Maternal,rs3909553-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,KLF14,Body mass index,body mass index,GCST009871,7:130732987,Anthropometric
1947,KLF14,KLF14,Maternal,rs35775580-<b>A</b>,3 x 10-8,,0.953004,'-,0.0180149 unit increase,[0.012-0.024],"KLF14, AC016831.5",Adult body size,body height,GCST010988,7:130735979,Anthropometric
1948,KLF14,KLF14,Maternal,rs35775580-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,"KLF14, AC016831.5",Height,body height,GCST007841,7:130735979,Anthropometric
1962,KLF14,KLF14,Maternal,rs111968456-<b>A</b>,4 x 10-8,,0.001,'-,2.1205 unit decrease,[1.36-2.88],"KLF14, AC016831.5",Hip circumference adjusted for BMI,BMI-adjusted hip circumference,GCST008156,7:130741021,Anthropometric
1964,KLF14,KLF14,Maternal,rs10260148-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,"KLF14, AC016831.5",Waist-hip ratio,waist-hip ratio,GCST007067,7:130746210,Anthropometric
1965,KLF14,KLF14,Maternal,rs6971365-<b>C</b>,3 x 10-8,(women),0.3,'-,0.027 units increase,'-,"AC016831.5, KLF14",Waist-to-hip ratio adjusted for BMI,BMI-adjusted waist-hip ratio,GCST005956,7:130747722,Anthropometric
1966,KLF14,KLF14,Maternal,rs6971365-<b>C</b>,6 x 10-7,,0.29999,'-,'-,'-,"AC016831.5, KLF14",Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test),"BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment",GCST005962,7:130747722,Anthropometric
1967,KLF14,KLF14,Maternal,rs6971365-<b>C</b>,1 x 10-7,(women),0.29999,'-,0.0332 unit increase,'-,"AC016831.5, KLF14",Waist-to-hip ratio adjusted for BMI (age >50),BMI-adjusted waist-hip ratio,GCST005958,7:130747722,Anthropometric
1968,KLF14,KLF14,Maternal,rs6971365-<b>C</b>,3 x 10-6,,0.3,'-,'-,'-,"AC016831.5, KLF14",Waist-to-hip ratio adjusted for BMI x sex interaction,"BMI-adjusted waist-hip ratio, sex interaction measurement",GCST005959,7:130747722,Anthropometric
1976,KLF14,KLF14,Maternal,rs4731702-<b>T</b>,5 x 10-20,,0.4493,'-,'-,'-,"AC016831.5, KLF14",Body fat percentage and HDL-C (pairwise),"body fat percentage, high density lipoprotein cholesterol measurement",GCST011344,7:130748625,Anthropometric
1977,KLF14,KLF14,Maternal,rs6961342-<b>?</b>,7 x 10-17,,NR,'-,'-,'-,"AC016831.5, KLF14",Waist-to-hip ratio adjusted for BMI,BMI-adjusted waist-hip ratio,GCST009858,7:130749185,Anthropometric
1978,KLF14,KLF14,Maternal,rs7783857-<b>C</b>,3 x 10-7,,0.7317,'-,0.0096 unit decrease,[0.0059-0.0133],"AC016831.5, KLF14",Waist-hip ratio,waist-hip ratio,GCST008997,7:130754299,Anthropometric
1979,KLF14,KLF14,Maternal,rs7783857-<b>C</b>,1 x 10-16,,0.7318,'-,0.0157 unit decrease,[0.012-0.019],"AC016831.5, KLF14",Waist-to-hip ratio adjusted for BMI,BMI-adjusted waist-hip ratio,GCST008994,7:130754299,Anthropometric
1980,KLF14,KLF14,Maternal,rs13241538-<b>C</b>,4 x 10-6,"(EA, women)",0.4784,'-,0.0207 unit decrease,[0.012-0.03],"AC016831.5, KLF14",Waist-to-hip ratio adjusted for body mass index,BMI-adjusted waist-hip ratio,GCST002782,7:130755103,Anthropometric
1981,KLF14,KLF14,Maternal,rs13241538-<b>C</b>,9 x 10-6,(women),0.4714,'-,0.0195 unit decrease,[0.011-0.028],"AC016831.5, KLF14",Waist-to-hip ratio adjusted for body mass index,BMI-adjusted waist-hip ratio,GCST002782,7:130755103,Anthropometric
1982,KLF14,KLF14,Maternal,rs13241538-<b>C</b>,2 x 10-6,(EA),0.478,'-,0.0168 unit increase,[0.0099-0.0237],"AC016831.5, KLF14",Hip circumference adjusted for BMI,BMI-adjusted hip circumference,GCST004067,7:130755103,Anthropometric
1983,KLF14,KLF14,Maternal,rs13241538-<b>C</b>,1 x 10-13,"(EA, women)",0.478,'-,0.0334 unit increase,[0.025-0.042],"AC016831.5, KLF14",Hip circumference adjusted for BMI,BMI-adjusted hip circumference,GCST004067,7:130755103,Anthropometric
1986,KLF14,KLF14,Maternal,rs17789506-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,"KLF14, AC016831.5",Hip circumference variance,hip circumference,GCST009109,7:130760815,Anthropometric
1987,KLF14,KLF14,Maternal,rs17789506-<b>?</b>,2 x 10-18,,NR,'-,'-,'-,"KLF14, AC016831.5",Hip circumference,hip circumference,GCST009123,7:130760815,Anthropometric
1990,KLF14,KLF14,Maternal,rs1364422-<b>T</b>,1 x 10-9,"(EA,women)",0.2858,'-,0.0308 unit decrease,[0.021-0.041],"AC016831.5, KLF14",Hip circumference,hip circumference,GCST004066,7:130761222,Anthropometric
1991,KLF14,KLF14,Maternal,rs12667251-<b>?</b>,7 x 10-12,,NR,'-,'-,'-,"KLF14, AC016831.5",Waist circumference variance,waist circumference,GCST009108,7:130764699,Anthropometric
1994,KLF14,KLF14,Maternal,rs972283-<b>?</b>,5 x 10-10,,NR,'-,0.13101 unit decrease,[0.09-0.172],"AC016831.5, KLF14",Body fat percentage,body fat percentage,GCST007064,7:130782095,Anthropometric
1995,KLF14,KLF14,Maternal,rs972283-<b>?</b>,2 x 10-7,(female),NR,'-,0.18011 unit decrease,[0.11-0.25],"AC016831.5, KLF14",Body fat percentage,body fat percentage,GCST007064,7:130782095,Anthropometric
1996,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-10,,0.551,'-,0.038 unit decrease,[0.026-0.05],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007307,7:130782095,Anthropometric
2038,KLF14,KLF14,Maternal,rs4731702-<b>T</b>,5 x 10-9,,0.4493,'-,'-,'-,"AC016831.5, KLF14",Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,7:130748625,Anthropometric
2053,KLF14,KLF14,Maternal,rs972283-<b>G</b>,7 x 10-8,,0.555,'-,0.043 unit decrease,[0.027-0.059],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007309,7:130782095,Anthropometric
2054,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-10,,0.521,'-,0.041 unit decrease,[0.029-0.053],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007310,7:130782095,Anthropometric
2055,KLF14,KLF14,Maternal,rs972283-<b>G</b>,2 x 10-8,,0.521,'-,0.048 unit decrease,[0.03-0.066],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007312,7:130782095,Anthropometric
2056,KLF14,KLF14,Maternal,rs972283-<b>G</b>,3 x 10-7,,0.551,'-,0.049 unit decrease,[0.031-0.067],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007313,7:130782095,Anthropometric
2057,KLF14,KLF14,Maternal,rs972283-<b>G</b>,9 x 10-6,,0.555,'-,0.055 unit decrease,[0.031-0.079],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007315,7:130782095,Anthropometric
2058,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-7,,0.521,'-,0.054 unit decrease,[0.034-0.074],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007316,7:130782095,Anthropometric
2059,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-6,,0.521,'-,0.062 unit decrease,[0.035-0.089],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007318,7:130782095,Anthropometric
2060,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-18,,0.55,'-,0.053 unit decrease,[0.041-0.065],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007319,7:130782095,Anthropometric
2061,KLF14,KLF14,Maternal,rs972283-<b>G</b>,2 x 10-6,,0.544,'-,0.045 unit decrease,[0.027-0.063],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007320,7:130782095,Anthropometric
2062,KLF14,KLF14,Maternal,rs972283-<b>G</b>,4 x 10-15,,0.555,'-,0.063 unit decrease,[0.047-0.079],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007321,7:130782095,Anthropometric
2062,KLF14,KLF14,Maternal,rs972283-<b>G</b>,4 x 10-15,,0.555,'-,0.063 unit decrease,[0.047-0.079],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007321,7:130782095,Anthropometric
2064,KLF14,KLF14,Maternal,rs972283-<b>G</b>,5 x 10-7,,0.522,'-,0.048 unit decrease,[0.028-0.068],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007323,7:130782095,Anthropometric
2065,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-14,,0.521,'-,0.066 unit decrease,[0.048-0.084],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007324,7:130782095,Anthropometric
2066,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-14,,0.55,'-,0.071 unit decrease,[0.053-0.089],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007325,7:130782095,Anthropometric
2067,KLF14,KLF14,Maternal,rs972283-<b>G</b>,3 x 10-12,,0.555,'-,0.086 unit decrease,[0.062-0.11],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007327,7:130782095,Anthropometric
2068,KLF14,KLF14,Maternal,rs972283-<b>G</b>,8 x 10-18,,0.521,'-,0.079 unit decrease,[0.059-0.099],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007328,7:130782095,Anthropometric
2069,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-12,,0.521,'-,0.096 unit decrease,[0.069-0.123],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007330,7:130782095,Anthropometric
2268,MAGI2,MAGI2,Maternal,rs3779273-<b>G</b>,2 x 10-7,,0.586,'-,0.015 kg/m2 increase,[0.0095-0.0213],MAGI2,Body mass index,body mass index,GCST002783,7:78199623,Anthropometric
2269,MAGI2,MAGI2,Maternal,rs3779273-<b>G</b>,2 x 10-6,(EA),0.586,'-,0.015 kg/m2 increase,[0.0088-0.021],MAGI2,Body mass index,body mass index,GCST002783,7:78199623,Anthropometric
2270,MAGI2,MAGI2,Maternal,rs3779273-<b>A</b>,8 x 10-10,,0.4,'-,0.014 unit decrease,[0.01-0.018],MAGI2,Body mass index,body mass index,GCST004904,7:78199623,Anthropometric
2271,MAGI2,MAGI2,Maternal,rs3779273-<b>G</b>,2 x 10-7,,NR,'-,0.013 unit increase,[NR],MAGI2,Body mass index,body mass index,GCST006368,7:78199623,Anthropometric
2272,MAGI2,MAGI2,Maternal,rs1852006-<b>A</b>,7 x 10-18,,0.376,'-,0.0153 unit decrease,[0.012-0.019],MAGI2,Body mass index,body mass index,GCST009001,7:78200451,Anthropometric
2273,MAGI2,MAGI2,Maternal,rs1852006-<b>?</b>,3 x 10-13,,NR,'-,'-,'-,MAGI2,Body mass index,body mass index,GCST007039,7:78200451,Anthropometric
2274,MAGI2,MAGI2,Maternal,rs1852006-<b>A</b>,7 x 10-18,,0.376,'-,0.0153 unit decrease,[0.012-0.019],MAGI2,Body mass index,body mass index,GCST009004,7:78200451,Anthropometric
2275,MAGI2,MAGI2,Maternal,rs1852006-<b>G</b>,7 x 10-10,,0.64299,'-,0.00883089 unit increase,[0.006-0.0116],MAGI2,Adult body size,body height,GCST010988,7:78200451,Anthropometric
2276,MAGI2,MAGI2,Maternal,rs1852006-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,MAGI2,Body mass index,body mass index,GCST009871,7:78200451,Anthropometric
2277,MAGI2,MAGI2,Maternal,rs1852006-<b>G</b>,2 x 10-9,,0.64299,'-,0.00877312 unit increase,[0.0059-0.0116],MAGI2,Body size at age 10,"comparative body size at age 10, self-reported",GCST010989,7:78200451,Anthropometric
2278,MAGI2,MAGI2,Maternal,rs2691543-<b>T</b>,5 x 10-6,,0.97,'-,3.45 cm increase,[1.97-4.93],MAGI2,Height,body height,GCST000839,7:78335471,Anthropometric
2279,MAGI2,MAGI2,Maternal,rs142538175-<b>G</b>,6 x 10-6,(adjusted for subcutaneous fat),NR,'-,0.283 unit decrease,[0.16-0.41],MAGI2,Visceral fat,visceral adipose tissue measurement,GCST008473,7:78345474,Anthropometric
2280,MAGI2,MAGI2,Maternal,rs7805441-<b>?</b>,8 x 10-10,,NR,'-,'-,'-,MAGI2,Body mass index,body mass index,GCST007039,7:78492141,Anthropometric
2281,MAGI2,MAGI2,Maternal,rs62467106-<b>?</b>,8 x 10-10,,NR,'-,'-,'-,MAGI2,Body mass index,body mass index,GCST009871,7:78492946,Anthropometric
2282,MAGI2,MAGI2,Maternal,rs1030015-<b>T</b>,1 x 10-10,,0.5422,'-,0.0109 unit increase,[0.0076-0.0142],MAGI2,Body mass index,body mass index,GCST009004,7:78510264,Anthropometric
2283,MAGI2,MAGI2,Maternal,rs6963840-<b>C</b>,9 x 10-12,,0.844199,'-,0.0129345 unit decrease,[0.0092-0.0166],MAGI2,Adult body size,body height,GCST010988,7:78515054,Anthropometric
2284,MAGI2,MAGI2,Maternal,rs12666870-<b>G</b>,3 x 10-6,(Light activity ),0.249,'-,0.04 min/d increase,[NR],MAGI2,Obesity-related traits,physical activity,GCST001762,7:78529155,Anthropometric
2285,MAGI2,MAGI2,Maternal,rs761019157-<b>A</b>,2 x 10-7,,0.0012,'-,2.1563 unit decrease,[1.35-2.96],"NUP35P2, MAGI2-AS3",Hip circumference adjusted for BMI,BMI-adjusted hip circumference,GCST008156,7:79474805,Anthropometric
2345,MAGI2,MAGI2-AS3,Maternal,rs761019157-<b>A</b>,2 x 10-7,,0.0012,'-,2.1563 unit decrease,[1.35-2.96],"NUP35P2, MAGI2-AS3",Hip circumference adjusted for BMI,BMI-adjusted hip circumference,GCST008156,7:79474805,Anthropometric
2388,NTM,NTM,Maternal,rs11601906-<b>A</b>,2 x 10-6,(Ft4 ),0.021,'-,0.04 ng/dL increase,[NR],NTM,Obesity-related traits,hormone measurement,GCST001762,11:131455352,Anthropometric
2389,NTM,NTM,Maternal,rs12788343-<b>T</b>,4 x 10-12,,0.590818,'-,0.00965197 unit decrease,[0.0069-0.0124],NTM,Adult body size,body height,GCST010988,11:131583018,Anthropometric
2390,NTM,NTM,Maternal,rs12788343-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,NTM,Body mass index,body mass index,GCST007039,11:131583018,Anthropometric
2391,NTM,NTM,Maternal,rs1040102-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,NTM,Body mass index,body mass index,GCST009871,11:131584054,Anthropometric
2392,NTM,NTM,Maternal,rs71483681-<b>T</b>,1 x 10-8,,0.487454,'-,0.00806318 unit decrease,[0.0053-0.0108],NTM,Body size at age 10,"comparative body size at age 10, self-reported",GCST010989,11:131599311,Anthropometric
2393,NTM,NTM,Maternal,rs1506662-<b>A</b>,3 x 10-12,,0.5281,'-,0.0118 unit increase,[0.0085-0.0151],NTM,Body mass index,body mass index,GCST009004,11:131607353,Anthropometric
2394,NTM,NTM,Maternal,rs4936142-<b>?</b>,8 x 10-13,,NR,'-,'-,'-,NTM,Body mass index,body mass index,GCST009871,11:131609374,Anthropometric
2395,NTM,NTM,Maternal,rs1793636-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,NTM,Body mass index,body mass index,GCST009871,11:132065032,Anthropometric
2396,NTM,NTM,Maternal,rs1625427-<b>?</b>,9 x 10-10,,NR,'-,'-,'-,NTM,Body mass index,body mass index,GCST007039,11:132087399,Anthropometric
2397,NTM,NTM,Maternal,rs12222235-<b>T</b>,2 x 10-12,,0.3305,'-,0.0128 unit decrease,[0.0093-0.0163],NTM,Body mass index,body mass index,GCST009004,11:132114436,Anthropometric
2565,PPP1R9A,PPP1R9A,Maternal,rs61749905-<b>A</b>,6 x 10-6,,0.013,'-,0.1606 unit decrease,[0.091-0.23],PPP1R9A,Waist circumference,waist circumference,GCST008151,7:95274165,Anthropometric
2566,PPP1R9A,PPP1R9A,Maternal,rs61749905-<b>A</b>,6 x 10-6,,0.013,'-,0.1606 unit decrease,[0.091-0.23],PPP1R9A,Waist circumference,waist circumference,GCST008160,7:95274165,Anthropometric
2622,RB1,RB1CC1,Maternal,rs7822058-<b>A</b>,3 x 10-7,(Leptin ),0.076,'-,0.04 ng/mL increase,[NR],"NPBWR1, RB1CC1",Obesity-related traits,leptin measurement,GCST001762,8:52772301,Anthropometric
2623,RB1,RB1CC1,Maternal,rs575733898-<b>T</b>,9 x 10-6,,0.0017,'-,0.8346 unit decrease,[0.47-1.2],"NPBWR1, RB1CC1",Waist circumference adjusted for body mass index,BMI-adjusted waist circumference,GCST008161,8:52806413,Anthropometric
2624,RB1,RB1CC1,Maternal,rs10095724-<b>G</b>,1 x 10-10,,0.637545,'-,0.00937064 unit increase,[0.0065-0.0122],"RB1CC1, NPBWR1",Body size at age 10,"comparative body size at age 10, self-reported",GCST010989,8:52826672,Anthropometric
2684,SLC22A2*,SLC22A2*,Maternal,rs2481044-<b>T</b>,5 x 10-7,(EA),0.257,'-,0.024 kg/m2 increase,[0.014-0.033],"SLC22A3, SLC22A2",Body mass index,body mass index,GCST002783,6:160286215,Anthropometric
2685,SLC22A2*,SLC22A2*,Maternal,rs2481044-<b>T</b>,2 x 10-6,,0.26,'-,0.021 kg/m2 increase,[0.012-0.03],"SLC22A3, SLC22A2",Body mass index,body mass index,GCST002783,6:160286215,Anthropometric
2686,SLC22A2*,SLC22A2*,Maternal,rs368123-<b>G</b>,3 x 10-8,(East Asian),0.386,'-,0.032 unit increase,[0.02-0.044],"SLC22A2, SLC22A3",Waist circumference,waist circumference,GCST003335,6:160298561,Anthropometric
2687,SLC22A2*,SLC22A2*,Maternal,rs368123-<b>G</b>,2 x 10-7,(East Asian women),0.386419646,'-,0.03636 unit increase,[0.023-0.05],"SLC22A2, SLC22A3",Waist circumference,waist circumference,GCST003335,6:160298561,Anthropometric
2688,SLC22A2*,SLC22A2*,Maternal,rs401746-<b>?</b>,6 x 10-12,,NR,'-,0.15119 unit increase,[0.11-0.19],"SLC22A2, SLC22A3",Fat-free mass,lean body mass,GCST007063,6:160319208,Anthropometric
2689,SLC22A2*,SLC22A2*,Maternal,rs401746-<b>?</b>,2 x 10-8,(male),NR,'-,0.19635 unit increase,[0.13-0.26],"SLC22A2, SLC22A3",Fat-free mass,lean body mass,GCST007063,6:160319208,Anthropometric
2690,SLC22A2*,SLC22A2*,Maternal,rs622217-<b>T</b>,4 x 10-24,,0.52,'-,0.019 unit increase,[0.015-0.023],"SLC22A2, SLC22A3",Waist-to-hip ratio adjusted for BMI,BMI-adjusted waist-hip ratio,GCST008733,6:160345738,Anthropometric
2691,SLC22A2*,SLC22A2*,Maternal,rs622217-<b>T</b>,5 x 10-8,,0.52,'-,'-,'-,"SLC22A2, SLC22A3",Waist-hip ratio,waist-hip ratio,GCST008734,6:160345738,Anthropometric
2734,SLC22A3*,SLC22A3*,Maternal,rs2481044-<b>T</b>,2 x 10-6,,0.26,'-,0.021 kg/m2 increase,[0.012-0.03],"SLC22A3, SLC22A2",Body mass index,body mass index,GCST002783,6:160286215,Anthropometric
2735,SLC22A3*,SLC22A3*,Maternal,rs2481044-<b>T</b>,5 x 10-7,(EA),0.257,'-,0.024 kg/m2 increase,[0.014-0.033],"SLC22A3, SLC22A2",Body mass index,body mass index,GCST002783,6:160286215,Anthropometric
2736,SLC22A3*,SLC22A3*,Maternal,rs368123-<b>G</b>,3 x 10-8,(East Asian),0.386,'-,0.032 unit increase,[0.02-0.044],"SLC22A2, SLC22A3",Waist circumference,waist circumference,GCST003335,6:160298561,Anthropometric
2737,SLC22A3*,SLC22A3*,Maternal,rs368123-<b>G</b>,2 x 10-7,(East Asian women),0.386419646,'-,0.03636 unit increase,[0.023-0.05],"SLC22A2, SLC22A3",Waist circumference,waist circumference,GCST003335,6:160298561,Anthropometric
2738,SLC22A3*,SLC22A3*,Maternal,rs401746-<b>?</b>,6 x 10-12,,NR,'-,0.15119 unit increase,[0.11-0.19],"SLC22A2, SLC22A3",Fat-free mass,lean body mass,GCST007063,6:160319208,Anthropometric
2739,SLC22A3*,SLC22A3*,Maternal,rs401746-<b>?</b>,2 x 10-8,(male),NR,'-,0.19635 unit increase,[0.13-0.26],"SLC22A2, SLC22A3",Fat-free mass,lean body mass,GCST007063,6:160319208,Anthropometric
2740,SLC22A3*,SLC22A3*,Maternal,rs622217-<b>T</b>,4 x 10-24,,0.52,'-,0.019 unit increase,[0.015-0.023],"SLC22A2, SLC22A3",Waist-to-hip ratio adjusted for BMI,BMI-adjusted waist-hip ratio,GCST008733,6:160345738,Anthropometric
2741,SLC22A3*,SLC22A3*,Maternal,rs622217-<b>T</b>,5 x 10-8,,0.52,'-,'-,'-,"SLC22A2, SLC22A3",Waist-hip ratio,waist-hip ratio,GCST008734,6:160345738,Anthropometric
2742,SLC22A3*,SLC22A3*,Maternal,rs668871-<b>T</b>,7 x 10-12,,0.469,'-,0.0134 unit decrease,[0.0095-0.0173],SLC22A3,Waist-hip ratio,waist-hip ratio,GCST008996,6:160348779,Anthropometric
2743,SLC22A3*,SLC22A3*,Maternal,rs668871-<b>?</b>,6 x 10-28,,NR,'-,'-,'-,SLC22A3,Waist-to-hip ratio adjusted for BMI,BMI-adjusted waist-hip ratio,GCST009858,6:160348779,Anthropometric
2744,SLC22A3*,SLC22A3*,Maternal,rs668871-<b>?</b>,6 x 10-38,,NR,'-,'-,'-,SLC22A3,Height,body height,GCST007841,6:160348779,Anthropometric
2745,SLC22A3*,SLC22A3*,Maternal,rs668871-<b>?</b>,8 x 10-30,,NR,'-,'-,'-,SLC22A3,Waist-hip ratio,waist-hip ratio,GCST007067,6:160348779,Anthropometric
2746,SLC22A3*,SLC22A3*,Maternal,rs474513-<b>A</b>,7 x 10-11,,0.51,'-,0.0116 unit increase,[0.0081-0.0151],SLC22A3,Waist-hip ratio,waist-hip ratio,GCST008997,6:160349280,Anthropometric
2747,SLC22A3*,SLC22A3*,Maternal,rs501470-<b>T</b>,2 x 10-24,,0.5037,'-,0.0174 unit increase,[0.014-0.021],SLC22A3,Waist-to-hip ratio adjusted for BMI,BMI-adjusted waist-hip ratio,GCST008994,6:160349886,Anthropometric
2749,SLC22A3*,SLC22A3*,Maternal,rs539958-<b>T</b>,2 x 10-11,,0.4831,'-,'-,'-,SLC22A3,Body mass index and LDL-C (pairwise),"low density lipoprotein cholesterol measurement, body mass index",GCST011335,6:160351810,Anthropometric
2751,SLC22A3*,SLC22A3*,Maternal,rs539958-<b>T</b>,5 x 10-10,,0.4831,'-,'-,'-,SLC22A3,Body fat percentage and LDL-C (pairwise),"low density lipoprotein cholesterol measurement, body fat percentage",GCST011343,6:160351810,Anthropometric
2752,SLC22A3*,SLC22A3*,Maternal,rs539958-<b>T</b>,7 x 10-10,,0.4831,'-,'-,'-,SLC22A3,Body mass index and systole blood pressure (pairwise),"systolic blood pressure, body mass index",GCST011331,6:160351810,Anthropometric
2753,SLC22A3*,SLC22A3*,Maternal,rs539958-<b>T</b>,3 x 10-10,,0.4831,'-,'-,'-,SLC22A3,Body mass index and coronary artery disease (pairwise),"body mass index, coronary artery disease",GCST011330,6:160351810,Anthropometric
2754,SLC22A3*,SLC22A3*,Maternal,rs487152-<b>A</b>,3 x 10-11,,0.4973,'-,0.0108 unit increase,[0.0077-0.0139],SLC22A3,Body mass index,body mass index,GCST009004,6:160353454,Anthropometric
2755,SLC22A3*,SLC22A3*,Maternal,rs487152-<b>A</b>,2 x 10-12,,0.49,'-,0.017 unit increase,[0.013-0.021],SLC22A3,Body mass index,body mass index,GCST004904,6:160353454,Anthropometric
2756,SLC22A3*,SLC22A3*,Maternal,rs487152-<b>C</b>,2 x 10-12,,NR,'-,0.018 unit decrease,[NR],SLC22A3,Body mass index,body mass index,GCST006368,6:160353454,Anthropometric
2757,SLC22A3*,SLC22A3*,Maternal,rs9364552-<b>?</b>,2 x 10-10,,NR,'-,0.019390795 unit decrease,[0.013-0.025],SLC22A3,Height,body height,GCST008839,6:160361902,Anthropometric
2758,SLC22A3*,SLC22A3*,Maternal,rs3127574-<b>C</b>,2 x 10-8,,0.51,'-,0.019 unit increase,'-,"AL591069.1, SLC22A3",Body mass index (age>50),body mass index,GCST005952,6:160370338,Anthropometric
2759,SLC22A3*,SLC22A3*,Maternal,rs3127574-<b>C</b>,4 x 10-6,,0.51,'-,'-,'-,"AL591069.1, SLC22A3",Body mass index,body mass index,GCST005951,6:160370338,Anthropometric
2760,SLC22A3*,SLC22A3*,Maternal,rs3127574-<b>C</b>,3 x 10-7,,0.51,'-,'-,'-,"AL591069.1, SLC22A3",Body mass index x sex x age interaction (4df test),"sex interaction measurement, body mass index, age at assessment",GCST005950,6:160370338,Anthropometric
2764,SLC22A3*,SLC22A3*,Maternal,rs9365164-<b>?</b>,6 x 10-8,,NR,'-,'-,'-,SLC22A3,Body mass index,body mass index,GCST007039,6:160435811,Anthropometric
2825,SMOC1,SMOC1,Maternal,rs7156508-<b>T</b>,1 x 10-9,,NR,'-,6.079 z-score increase,'-,SMOC1,Triglyceride levels,triglyceride measurement,GCST006436,14:69860617,Anthropometric
2826,SMOC1,SMOC1,Maternal,rs35230100-<b>CATAT</b>,8 x 10-14,,0.431849,'-,0.0534772 unit decrease,[0.04-0.067],SMOC1,Appendicular lean mass,appendicular lean mass,GCST009577,14:69881425,Anthropometric
2827,SMOC1,SMOC1,Maternal,rs35230100-<b>?</b>,1 x 10-10,,NR,'-,0.0137 unit decrease,[0.0094-0.018],SMOC1,Heel bone mineral density,heel bone mineral density,GCST006433,14:69881425,Anthropometric
2828,SMOC1,SMOC1,Maternal,rs1547088-<b>?</b>,1 x 10-33,,NR,'-,'-,'-,SMOC1,Height,body height,GCST007841,14:69946329,Anthropometric
2829,SMOC1,SMOC1,Maternal,rs227425-<b>G</b>,4 x 10-13,(spine),0.53,'-,2.2 unit decrease,[NR],SMOC1,Bone mineral density,bone density,GCST002276,14:69989982,Anthropometric
2830,SMOC1,SMOC1,Maternal,rs227425-<b>G</b>,2 x 10-6,(hip),0.53,'-,1.5 unit decrease,[NR],SMOC1,Bone mineral density,bone density,GCST002276,14:69989982,Anthropometric
2831,SMOC1,SMOC1,Maternal,rs227425-<b>G</b>,4 x 10-7,"(spine, EA)",0.53,'-,'-,'-,SMOC1,Bone mineral density,bone density,GCST002276,14:69989982,Anthropometric
2832,SMOC1,SMOC1,Maternal,rs227425-<b>G</b>,1 x 10-6,"(spine, East Asian)",0.48,'-,'-,'-,SMOC1,Bone mineral density,bone density,GCST002276,14:69989982,Anthropometric
2833,SMOC1,SMOC1,Maternal,rs56031625-<b>C</b>,9 x 10-10,,0.805223,'-,0.0143989 unit increase,[0.0098-0.019],SMOC1,Heel bone mineral density,heel bone mineral density,GCST006979,14:70000573,Anthropometric
2834,SMOC1,SMOC1,Maternal,rs56031625-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,SMOC1,Heel bone mineral density,heel bone mineral density,GCST007066,14:70000573,Anthropometric
2866,SMOC1,SMOC1,Maternal,rs2332175-<b>A</b>,2 x 10-11,,0.529,'-,0.276 unit increase,[0.2-0.36],SMOC1,Digit length ratio (right hand),digit length ratio,GCST005748,14:69878694,Anthropometric
2867,SMOC1,SMOC1,Maternal,rs2332175-<b>A</b>,2 x 10-17,,0.529,'-,0.315 unit increase,[0.24-0.39],SMOC1,Digit length ratio,digit length ratio,GCST005750,14:69878694,Anthropometric
2868,SMOC1,SMOC1,Maternal,rs2332175-<b>A</b>,5 x 10-23,,0.526,'-,0.346 unit increase,[0.28-0.41],SMOC1,Digit length ratio (left hand),digit length ratio,GCST005749,14:69878694,Anthropometric
2869,SMOC1,SMOC1,Maternal,rs2332175-<b>A</b>,3 x 10-22,(EA),0.529,'-,0.36 unit increase,[0.29-0.43],SMOC1,Digit length ratio (left hand),digit length ratio,GCST005749,14:69878694,Anthropometric
2870,SMOC1,SMOC1,Maternal,rs11158820-<b>?</b>,2 x 10-11,,NR,'-,'-,'-,SMOC1,Digit length ratio,digit length ratio,GCST001788,14:69880631,Anthropometric
3010,TP73,TP73,Maternal,rs10910018-<b>A</b>,2 x 10-6,(men),0.04,'-,'-,'-,TP73,Visceral fat,visceral adipose tissue measurement,GCST001525,1:3734845,Anthropometric
3011,TP73,TP73,Maternal,rs12562437-<b>T</b>,2 x 10-6,(men),0.04,'-,'-,'-,TP73,Visceral adipose tissue/subcutaneous adipose tissue ratio,visceral:subcutaneous adipose tissue ratio,GCST001524,1:3734467,Anthropometric
3012,TP73,TP73,Maternal,rs10910018-<b>A</b>,2 x 10-6,(men),0.04,'-,'-,'-,TP73,Visceral fat,visceral adipose tissue measurement,GCST001525,1:3734845,Anthropometric
3013,TP73,TP73,Maternal,rs9662633-<b>A</b>,6 x 10-6,(men),0.05,'-,'-,'-,TP73,Visceral adipose tissue adjusted for BMI,"visceral adipose tissue measurement, body mass index",GCST001523,1:3732998,Anthropometric
3014,TP73,TP73,Maternal,rs34661835-<b>A</b>,3 x 10-6,,0.097,'-,0.0714 unit increase,[0.042-0.101],TP73,Waist-hip ratio,waist-hip ratio,GCST008155,1:3731690,Anthropometric
3021,UBE3A,UBE3A,Maternal,rs8025093-<b>C</b>,4 x 10-6,(BMD ),0.003,'-,0.03 g/cm2 increase,[NR],"SNHG14, UBE3A",Obesity-related traits,bone density,GCST001762,15:25357803,Anthropometric
50,ATP5F1EP2,ATP5F1EP2,Maternal,rs55836809-<b>A</b>,8 x 10-9,,0.779889,'-,0.018354 unit increase,[0.012-0.025],"PDX1, ATP5F1EP2",Birth weight,birth weight,GCST008362,13:27928737,Birth
870,H19,H19,Maternal,rs11042596-<b>T</b>,4 x 10-22,,0.336254,'-,0.026856 unit increase,[0.021-0.032],"H19, IGF2",Birth weight,birth weight,GCST008362,11:2097630,Birth
871,H19,H19,Maternal,rs72851023-<b>T</b>,7 x 10-10,,0.07,'-,0.0463 unit increase,[0.032-0.061],"IGF2, H19",Birth weight,birth weight,GCST005146,11:2109390,Birth
1895,KCNQ1,KCNQ1,Maternal,rs151216-<b>C</b>,6 x 10-9,,0.898719,'-,0.024751 unit increase,[0.016-0.033],"KCNQ1OT1, KCNQ1",Birth weight,birth weight,GCST008362,11:2659585,Birth
1896,KCNQ1,KCNQ1,Maternal,rs231350-<b>C</b>,3 x 10-6,,0.644553,'-,0.012585 unit increase,[0.0073-0.0178],"KCNQ1OT1, KCNQ1",Birth weight,birth weight,GCST008362,11:2692419,Birth
1897,KCNQ1,KCNQ1,Maternal,rs231350-<b>C</b>,5 x 10-8,,0.645376,'-,0.017947 unit increase,[0.012-0.024],"KCNQ1OT1, KCNQ1",Offspring birth weight,"birth weight, parental genotype effect measurement",GCST008363,11:2692419,Birth
1898,KCNQ1,KCNQ1,Maternal,rs234864-<b>A</b>,2 x 10-9,,0.547439,'-,0.015745 unit increase,[0.011-0.021],KCNQ1,Birth weight,birth weight,GCST008362,11:2836067,Birth
2354,MEG3,MEG3,Maternal,rs6575803-<b>C</b>,1 x 10-12,,0.895496,'-,0.031625 unit increase,[0.023-0.04],MEG3,Birth weight,birth weight,GCST008362,14:100791418,Birth
2611,RB1,RB1,Maternal,rs9535006-<b>A</b>,7 x 10-9,,0.25,'-,0.021 z score decrease,[0.013-0.029],"RB1-DT, ITM2B",Birth weight,birth weight,GCST009437,13:48275667,Birth
2612,RB1,RB1,Maternal,rs34217484-<b>A</b>,2 x 10-7,,0.264286,'-,0.018393 unit increase,[0.011-0.025],"RB1-DT, ITM2B",Offspring birth weight,"birth weight, parental genotype effect measurement",GCST008363,13:48280414,Birth
2613,RB1,RB1,Maternal,rs34217484-<b>A</b>,7 x 10-11,,0.26421,'-,0.0192 unit increase,[0.013-0.025],"RB1-DT, ITM2B",Birth weight,birth weight,GCST008362,13:48280414,Birth
2614,RB1,RB1,Maternal,rs2854355-<b>G</b>,2 x 10-8,,0.26,'-,0.024 unit increase,[0.016-0.032],RB1,Birth weight,birth weight,GCST005146,13:48308227,Birth
2632,RB1,RB1-DT,Maternal,rs9535006-<b>A</b>,7 x 10-9,,0.25,'-,0.021 z score decrease,[0.013-0.029],"RB1-DT, ITM2B",Birth weight,birth weight,GCST009437,13:48275667,Birth
2633,RB1,RB1-DT,Maternal,rs34217484-<b>A</b>,2 x 10-7,,0.264286,'-,0.018393 unit increase,[0.011-0.025],"RB1-DT, ITM2B",Offspring birth weight,"birth weight, parental genotype effect measurement",GCST008363,13:48280414,Birth
2634,RB1,RB1-DT,Maternal,rs34217484-<b>A</b>,7 x 10-11,,0.26421,'-,0.0192 unit increase,[0.013-0.025],"RB1-DT, ITM2B",Birth weight,birth weight,GCST008362,13:48280414,Birth
2,ADTRP,ADTRP,Maternal,rs9469930-<b>?</b>,2 x 10-8,,NR,'-,'-,'-,ADTRP,Eosinophil counts,eosinophil count,GCST007065,6:11720988,Blood
3,ADTRP,ADTRP,Maternal,rs760788-<b>T</b>,4 x 10-12,,0.561099,'-,0.013442 SD unit decrease,[0.0096-0.0172],ADTRP,Lymphocyte counts,lymphocyte count,GCST90002316,6:11770472,Blood
4,ADTRP,ADTRP,Maternal,rs760788-<b>T</b>,2 x 10-10,,0.529695,'-,'-,'-,ADTRP,Lymphocyte counts,lymphocyte count,GCST90002320,6:11770472,Blood
5,ADTRP,ADTRP,Maternal,rs760788-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,ADTRP,White blood cell count,leukocyte count,GCST007070,6:11770472,Blood
25,ANO1,ANO1,Maternal,rs7939912-<b>A</b>,7 x 10-14,,0.60492,'-,0.01529 SD unit increase,[0.011-0.019],"ANO1, AP000879.2",Eosinophil counts,eosinophil count,GCST90002298,11:70135990,Blood
26,ANO1,ANO1,Maternal,rs7939912-<b>A</b>,9 x 10-11,,0.605021,'-,0.014747305 unit increase,[0.01-0.019],"ANO1, AP000879.2",Eosinophil percentage of white cells,eosinophil percentage of leukocytes,GCST90002382,11:70135990,Blood
27,ANO1,ANO1,Maternal,rs7939912-<b>A</b>,8 x 10-13,,0.596707,'-,'-,'-,"ANO1, AP000879.2",Eosinophil counts,eosinophil count,GCST90002302,11:70135990,Blood
28,ANO1,ANO1,Maternal,rs7939912-<b>A</b>,5 x 10-13,,0.604998,'-,0.016461702 unit increase,[0.012-0.021],"ANO1, AP000879.2",Eosinophil counts,eosinophil count,GCST90002381,11:70135990,Blood
29,ANO1,ANO1,Maternal,rs7939912-<b>?</b>,2 x 10-12,,NR,'-,'-,'-,"ANO1, AP000879.2",Eosinophil counts,eosinophil count,GCST007065,11:70135990,Blood
31,ANO1,ANO1,Maternal,rs2276066-<b>G</b>,6 x 10-9,,0.647386,'-,0.013533849 unit increase,[0.009-0.0181],ANO1,Basophil count,basophil count,GCST90002379,11:70161205,Blood
32,ANO1,ANO1,Maternal,rs2276066-<b>G</b>,9 x 10-11,,0.648326,'-,0.013903 SD unit increase,[0.0097-0.0181],ANO1,Basophil count,basophil count,GCST90002292,11:70161205,Blood
41,ATP10A,ATP10A,Maternal,"rs2930590-<b>C</b>, rs2925253-<b>A</b>, rs2086907-<b>A</b>, rs2925256-<b>C</b>, rs8025092-<b>C</b>, rs11858433-<b>A</b>, rs2930593-<b>G</b>, rs952121-<b>C</b>, rs7176242-<b>A</b>",5 x 10-17,,0.003,'-,'-,'-,AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,15:25633329|15:25630857|15:25628262|15:25627862|15:25630114|15:25636283|15:25632668|15:25630251|15:25632574,Blood
42,ATP10A,ATP10A,Maternal,"rs2930590-<b>C</b>, rs2925253-<b>A</b>, rs2086907-<b>A</b>, rs2925256-<b>C</b>, rs8025092-<b>T</b>, rs11858433-<b>A</b>, rs2930593-<b>G</b>, rs952121-<b>C</b>, rs7176242-<b>A</b>",2 x 10-9,,0.218,'-,'-,'-,AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,15:25633329|15:25630857|15:25628262|15:25627862|15:25630114|15:25636283|15:25632668|15:25630251|15:25632574,Blood
53,CPA4,CPA4,Maternal,rs4731674-<b>T</b>,9 x 10-311,"(Carboxypeptidase A4, CPA4.9267.2.3)",0.47,'-,0.83 unit increase,[0.79-0.87],"CPA2, CPA4",Blood protein levels,blood protein measurement,GCST005806,7:130292525,Blood
54,CPA4,CPA4,Maternal,rs34587586-<b>T</b>,4 x 10-1248,"(Carboxypeptidase A4, CPA4.9267.2.3)",0.393,'-,1.17 unit decrease,[1.13-1.21],CPA4,Blood protein levels,blood protein measurement,GCST005806,7:130298758,Blood
55,CPA4,CPA4,Maternal,rs729167-<b>C</b>,4 x 10-332,"(CPA4, 9267_2_3)",0.7490625,'-,0.9936119 unit increase,[0.95-1.04],CPA4,Blood protein levels,blood protein measurement,GCST006585,7:130311268,Blood
141,DIO3OS,DIO3OS,Maternal,"rs10142332-<b>G</b>, rs12435279-<b>C</b>, rs12586651-<b>T</b>",3 x 10-7,,0.155,'-,'-,'-,LINC02314 - DIO3OS; No mapped genes; No mapped genes,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,14:101519289,Blood
863,H19,H19,Maternal,rs11042596-<b>G</b>,5 x 10-10,,0.662929,'-,0.014945593 unit decrease,[0.01-0.02],"H19, IGF2",Reticulocyte count,reticulocyte count,GCST90002405,11:2097630,Blood
1862,KCNQ1,KCNQ1,Maternal,rs179429-<b>A</b>,7 x 10-6,(ADP),0.167,'-,'-,'-,KCNQ1,Platelet aggregation,platelet aggregation,GCST000693,11:2529500,Blood
1863,KCNQ1,KCNQ1,Maternal,rs231353-<b>G</b>,2 x 10-9,,0.3493,'-,0.02308014 unit decrease,[0.016-0.031],"KCNQ1OT1, KCNQ1",Plateletcrit,platelet crit,GCST004607,11:2687789,Blood
1864,KCNQ1,KCNQ1,Maternal,rs231353-<b>G</b>,4 x 10-14,,0.357997,'-,0.014844 SD unit decrease,[0.011-0.019],"KCNQ1OT1, KCNQ1",Platelet count,platelet count,GCST90002357,11:2687789,Blood
1865,KCNQ1,KCNQ1,Maternal,rs231353-<b>G</b>,2 x 10-14,,0.465753,'-,'-,'-,"KCNQ1OT1, KCNQ1",Platelet count,platelet count,GCST90002361,11:2687789,Blood
1866,KCNQ1,KCNQ1,Maternal,rs231353-<b>G</b>,3 x 10-26,,0.349972,'-,0.025168354 unit decrease,[0.021-0.03],"KCNQ1OT1, KCNQ1",Plateletcrit,platelet crit,GCST90002400,11:2687789,Blood
1867,KCNQ1,KCNQ1,Maternal,rs231353-<b>G</b>,3 x 10-10,,0.349952,'-,0.014821836 unit decrease,[0.01-0.019],"KCNQ1OT1, KCNQ1",Platelet count,platelet count,GCST90002402,11:2687789,Blood
1868,KCNQ1,KCNQ1,Maternal,rs35957135-<b>A</b>,8 x 10-9,,0.308944,'-,0.014082907 unit decrease,[0.0093-0.0189],"KCNQ1OT1, KCNQ1",Mean platelet volume,mean platelet volume,GCST90002395,11:2698445,Blood
1869,KCNQ1,KCNQ1,Maternal,rs368427206-<b>G</b>,3 x 10-10,,0.274311,'-,'-,'-,"KCNQ1, KCNQ1OT1",Mean platelet volume,mean platelet volume,GCST90002349,11:2699514,Blood
1871,KCNQ1,KCNQ1,Maternal,rs5789271-<b>TG</b>,2 x 10-12,,0.539047,'-,0.016011694 unit decrease,[0.012-0.02],KCNQ1,Plateletcrit,platelet crit,GCST90002400,11:2778640,Blood
1872,KCNQ1,KCNQ1,Maternal,rs163171-<b>C</b>,1 x 10-13,,0.771935,'-,0.02020004 unit decrease,[0.015-0.026],KCNQ1,Plateletcrit,platelet crit,GCST90002400,11:2799835,Blood
1873,KCNQ1,KCNQ1,Maternal,rs202159835-<b>ACTGGGG</b>,2 x 10-11,,0.046903,'-,0.03850774 unit increase,[0.027-0.05],KCNQ1,Platelet count,platelet count,GCST90002402,11:2825181,Blood
1874,KCNQ1,KCNQ1,Maternal,rs4930011-<b>G</b>,5 x 10-10,,0.390332,'-,0.014246749 unit increase,[0.0098-0.0187],KCNQ1,High light scatter reticulocyte percentage of red cells,reticulocyte measurement,GCST90002386,11:2835428,Blood
1875,KCNQ1,KCNQ1,Maternal,rs2237896-<b>?</b>,7 x 10-39,,NR,'-,0.09115 unit decrease,[0.077-0.105],KCNQ1,Hemoglobin A1c levels,HbA1c measurement,GCST006001,11:2837210,Blood
1876,KCNQ1,KCNQ1,Maternal,rs2237896-<b>G</b>,2 x 10-7,,0.6145,'-,0.0251 unit increase,[0.015-0.035],KCNQ1,Glycated hemoglobin levels,HbA1c measurement,GCST007953,11:2837210,Blood
1902,KCNQ1,KCNQ1,Maternal,"rs10832134-<b>C</b>, rs12576156-<b>A</b>, rs11523905-<b>A</b>",3 x 10-15,,0.021,'-,'-,'-,KCNQ1; KCNQ1; KCNQ1,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,11:2481256|11:2477588|11:2477029,Blood
1903,KCNQ1,KCNQ1,Maternal,"rs10832134-<b>C</b>, rs12576156-<b>A</b>, rs11523905-<b>G</b>",4 x 10-13,,0.241,'-,'-,'-,KCNQ1; KCNQ1; KCNQ1,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,11:2481256|11:2477588|11:2477029,Blood
1909,KCNQ1,KCNQ1-AS1,Maternal,rs147445322-<b>?</b>,4 x 10-11,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Hyperuricemia,hyperuricemia,GCST007916,11:2847803,Blood
1911,KCNQ1,KCNQ1DN,Maternal,rs2239897-<b>G</b>,4 x 10-9,,0.0637,'-,0.04672705 unit decrease,[0.031-0.062],KCNQ1DN,Plateletcrit,platelet crit,GCST004607,11:2870735,Blood
2044,KLF14,KLF14,Maternal,rs12154627-<b>C</b>,1 x 10-10,,0.496183,'-,0.014541424 unit increase,[0.01-0.019],"KLF14, AC016831.5",Mean spheric corpuscular volume,mean corpuscular volume,GCST90002397,7:130738173,Blood
2045,KLF14,KLF14,Maternal,rs548547376-<b>G</b>,3 x 10-9,,0.614439,'-,0.0136949895 unit decrease,[0.0092-0.0182],"AC016831.5, KLF14",Lymphocyte counts,lymphocyte count,GCST90002388,7:130757689,Blood
2046,KLF14,KLF14,Maternal,rs548547376-<b>G</b>,3 x 10-9,,0.614439,'-,0.0136949895 unit decrease,[0.0092-0.0182],"AC016831.5, KLF14",Monocyte count,monocyte count,GCST90002393,7:130757689,Blood
2047,KLF14,KLF14,Maternal,rs35964477-<b>A</b>,2 x 10-12,,0.488573,'-,0.015698439 unit decrease,[0.011-0.02],"KLF14, AC016831.5",High light scatter reticulocyte count,reticulocyte count,GCST90002385,7:130777100,Blood
2048,KLF14,KLF14,Maternal,rs35964477-<b>A</b>,4 x 10-12,,0.488573,'-,0.0154870795 unit decrease,[0.011-0.02],"KLF14, AC016831.5",High light scatter reticulocyte percentage of red cells,reticulocyte measurement,GCST90002386,7:130777100,Blood
2049,KLF14,KLF14,Maternal,rs35964477-<b>A</b>,1 x 10-14,,0.488589,'-,0.01731081 unit decrease,[0.013-0.022],"KLF14, AC016831.5",Reticulocyte count,reticulocyte count,GCST90002405,7:130777100,Blood
2050,KLF14,KLF14,Maternal,rs35964477-<b>A</b>,4 x 10-14,,0.488581,'-,0.016932609 unit decrease,[0.013-0.021],"KLF14, AC016831.5",Reticulocyte fraction of red cells,reticulocyte measurement,GCST90002406,7:130777100,Blood
2077,KLF14,KLF14,Maternal,rs972283-<b>A</b>,7 x 10-9,,0.491048,'-,0.04650017 unit decrease,[0.031-0.062],"AC016831.5, KLF14",Medication use (calcium channel blockers),Calcium channel blocker use measurement,GCST007929,7:130782095,Blood
2298,MAGI2,MAGI2,Maternal,rs798338-<b>A</b>,4 x 10-6,,0.354,'-,0.111 unit decrease,[0.058-0.164],MAGI2,Lead levels in blood,blood lead measurement,GCST002831,7:78287721,Blood
2320,MAGI2,MAGI2,Maternal,rs1496766-<b>C</b>,5 x 10-6,,0.014,2.84,'-,[1.81-4.44],MAGI2,Acute lymphoblastic leukemia (childhood),acute lymphoblastic leukemia,GCST001693,7:78702149,Blood
2372,NAA60,NAA60,Maternal,rs9922570-<b>C</b>,3 x 10-11,,0.047029,'-,0.03486924 unit increase,[0.025-0.045],"AC025283.2, NAA60, AC004224.2",Eosinophil percentage of white cells,eosinophil percentage of leukocytes,GCST90002382,16:3471071,Blood
2373,NAA60,NAA60,Maternal,rs9922570-<b>C</b>,1 x 10-10,,0.047035,'-,0.03367872 unit increase,[0.023-0.044],"AC025283.2, NAA60, AC004224.2",Eosinophil counts,eosinophil count,GCST90002381,16:3471071,Blood
2374,NAA60,NAA60,Maternal,rs9922570-<b>C</b>,7 x 10-11,,0.046941,'-,0.03067 SD unit increase,[0.021-0.04],"AC025283.2, NAA60, AC004224.2",Eosinophil counts,eosinophil count,GCST90002298,16:3471071,Blood
2375,NAA60,NAA60,Maternal,rs9922570-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,"AC025283.2, NAA60, AC004224.2",Eosinophil counts,eosinophil count,GCST007065,16:3471071,Blood
2382,NLRP2,NLRP2,Maternal,rs1671135-<b>C</b>,3 x 10-9,,NR,1.0752687,'-,[1.05-1.11],NLRP2,Venous thromboembolism,venous thromboembolism,GCST009030,19:55000505,Blood
2383,NLRP2,NLRP2,Maternal,rs1671135-<b>?</b>,2 x 10-9,,NR,'-,0.0758 unit increase,[0.051-0.101],NLRP2,Venous thromboembolism,venous thromboembolism,GCST009029,19:55000505,Blood
2400,NTM,NTM,Maternal,rs12098973-<b>G</b>,1 x 10-6,(Dichotomous variable),NR,2.17,'-,[1.59-3.03],NTM,Cardiac Troponin-T levels,cardiac troponin T measurement,GCST001776,11:131937277,Blood
2410,NTM,NTM,Maternal,rs1040103-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,"AP003025.2, NTM",White blood cell count,leukocyte count,GCST007070,11:131572257,Blood
2426,NTM,NTM,Maternal,"rs4937627-<b>C</b>, rs12419920-<b>T</b>, rs12575010-<b>A</b>, rs992564-<b>G</b>, rs11222647-<b>G</b>, rs12278021-<b>G</b>, rs11222652-<b>C</b>, rs7107326-<b>C</b>, rs11222631-<b>A</b>, rs11222653-<b>A</b>",2 x 10-14,,0.273,'-,'-,'-,NTM; NTM; NTM; NTM; NTM; NTM; NTM; NTM; NTM; NTM,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,11:131481990|11:131466286|11:131474218|11:131466180|11:131461593|11:131462231|11:131463268|11:131462673|11:131456474|11:131463704,Blood
2539,PHLDA2,PHLDA2,Maternal,rs3847646-<b>T</b>,5 x 10-6,,NR,'-,0.03 unit decrease,[NR],"NAP1L4, PHLDA2",Calcium levels,calcium measurement,GCST000769,11:2932493,Blood
2606,RB1,RB1,Maternal,rs11839271-<b>T</b>,2 x 10-14,,0.698992,'-,0.015781 SD unit decrease,[0.012-0.02],"LPAR6, RB1",Lymphocyte counts,lymphocyte count,GCST90002316,13:48402537,Blood
2607,RB1,RB1,Maternal,rs11839271-<b>T</b>,4 x 10-11,,0.699696,'-,0.015975589 unit decrease,[0.011-0.021],"LPAR6, RB1",Lymphocyte counts,lymphocyte count,GCST90002388,13:48402537,Blood
2608,RB1,RB1,Maternal,rs11839271-<b>T</b>,4 x 10-11,,0.699696,'-,0.015975589 unit decrease,[0.011-0.021],"LPAR6, RB1",Monocyte count,monocyte count,GCST90002393,13:48402537,Blood
2609,RB1,RB1,Maternal,rs1359688-<b>A</b>,9 x 10-12,,0.27006,'-,'-,'-,"RB1, LINC01077",Lymphocyte counts,lymphocyte count,GCST90002320,13:48571936,Blood
2629,RB1,RB1CC1,Maternal,rs150387260-<b>A</b>,2 x 10-6,,NR,'-,0.405 unit increase,[0.24-0.57],"NPBWR1, RB1CC1",Mitochondrial DNA copy number (white blood cells),mitochondrial DNA measurement,GCST007398,8:52792336,Blood
2635,RBP5,RBP5,Maternal,rs3813735-<b>G</b>,6 x 10-9,,0.229975,'-,0.01547936 unit increase,[0.01-0.021],RBP5,Plateletcrit,platelet crit,GCST90002400,12:7122556,Blood
2636,RBP5,RBP5,Maternal,rs10845160-<b>C</b>,5 x 10-11,,0.104653,'-,'-,'-,RBP5,Platelet count,platelet count,GCST90002361,12:7122950,Blood
2792,SLC22A3*,SLC22A3*,Maternal,rs2102503-<b>G</b>,2 x 10-9,,0.206785,'-,0.016309874 unit increase,[0.011-0.022],SLC22A3,Mean spheric corpuscular volume,mean corpuscular volume,GCST90002397,6:160355500,Blood
2793,SLC22A3*,SLC22A3*,Maternal,rs3106166-<b>G</b>,3 x 10-11,,0.463213,'-,0.014807621 unit decrease,[0.01-0.019],SLC22A3,Mean reticulocyte volume,mean reticulocyte volume,GCST90002396,6:160417329,Blood
2794,SLC22A3*,SLC22A3*,Maternal,rs9457925-<b>?</b>,2 x 10-17,(LPA),'-,'-,1.614 unit increase,[NR],SLC22A3,Blood protein levels,blood protein measurement,GCST010104,6:160427711,Blood
2795,SLC22A3*,SLC22A3*,Maternal,rs2292334-<b>A</b>,3 x 10-12,,0.385767,'-,0.013385 SD unit decrease,[0.0096-0.0171],SLC22A3,Monocyte count,monocyte count,GCST90002340,6:160437156,Blood
2796,SLC22A3*,SLC22A3*,Maternal,rs2292334-<b>A</b>,2 x 10-11,,0.389658,'-,0.015319709 unit decrease,[0.011-0.02],SLC22A3,Monocyte percentage of white cells,monocyte percentage of leukocytes,GCST90002394,6:160437156,Blood
2797,SLC22A3*,SLC22A3*,Maternal,rs189821701-<b>T</b>,2 x 10-33,"(Angiostatin, PLG.3710.49.2)",0.007,'-,1.87 unit decrease,[1.56-2.18],SLC22A3,Blood protein levels,blood protein measurement,GCST005806,6:160441777,Blood
2798,SLC22A3*,SLC22A3*,Maternal,rs7769879-<b>C</b>,2 x 10-11,,0.391554,'-,'-,'-,SLC22A3,Monocyte count,monocyte count,GCST90002344,6:160444613,Blood
2838,SMOC1,SMOC1,Maternal,rs55796722-<b>T</b>,8 x 10-23,,0.832524,'-,0.029119551 unit increase,[0.023-0.035],SMOC1,Mean corpuscular hemoglobin,mean corpuscular hemoglobin,GCST90002390,14:69861693,Blood
2839,SMOC1,SMOC1,Maternal,rs55796722-<b>T</b>,1 x 10-18,,0.83253,'-,0.0286529 unit increase,[0.023-0.034],SMOC1,Mean corpuscular volume,mean corpuscular volume,GCST90002392,14:69861693,Blood
2840,SMOC1,SMOC1,Maternal,rs55796722-<b>T</b>,5 x 10-12,,NR,'-,0.03938 unit decrease,[0.029-0.05],SMOC1,Red cell distribution width,red blood cell distribution width,GCST006804,14:69861693,Blood
2841,SMOC1,SMOC1,Maternal,rs55796722-<b>T</b>,8 x 10-10,,0.83239,'-,0.017248 SD unit increase,[0.012-0.023],SMOC1,Mean corpuscular hemoglobin concentration,mean corpuscular hemoglobin concentration,GCST90002328,14:69861693,Blood
2842,SMOC1,SMOC1,Maternal,rs749396-<b>G</b>,4 x 10-6,"(SMOC1, 5694_57_3)",0.92765625,'-,0.2170476 unit increase,[0.13-0.31],SMOC1,Blood protein levels,blood protein measurement,GCST006585,14:69878006,Blood
2843,SMOC1,SMOC1,Maternal,rs1958078-<b>C</b>,2 x 10-15,"(SMOC1, 13118_5_3)",0.86421875,'-,0.2555848 unit increase,[0.19-0.32],SMOC1,Blood protein levels,blood protein measurement,GCST006585,14:69888141,Blood
2844,SMOC1,SMOC1,Maternal,rs1958078-<b>C</b>,3 x 10-15,,0.8428,'-,0.03868551 unit decrease,[0.029-0.048],SMOC1,Red cell distribution width,red blood cell distribution width,GCST004621,14:69888141,Blood
2845,SMOC1,SMOC1,Maternal,rs1958078-<b>C</b>,2 x 10-11,,0.8428,'-,0.03292623 unit increase,[0.023-0.043],SMOC1,Mean corpuscular hemoglobin,mean corpuscular hemoglobin,GCST004630,14:69888141,Blood
2846,SMOC1,SMOC1,Maternal,rs1958078-<b>C</b>,1 x 10-32,,0.843128,'-,0.032088 SD unit increase,[0.027-0.037],SMOC1,Mean corpuscular hemoglobin,mean corpuscular hemoglobin concentration,GCST90002322,14:69888141,Blood
2847,SMOC1,SMOC1,Maternal,rs1958078-<b>C</b>,2 x 10-30,"(SPARC-related modular calcium-binding protein 1, SMOC1.13118.5.3)",0.834,'-,0.38 unit increase,[0.32-0.44],SMOC1,Blood protein levels,blood protein measurement,GCST005806,14:69888141,Blood
2848,SMOC1,SMOC1,Maternal,rs1958078-<b>C</b>,2 x 10-28,,0.842197,'-,0.028033 SD unit increase,[0.023-0.033],SMOC1,Mean corpuscular volume,mean corpuscular volume,GCST90002334,14:69888141,Blood
2849,SMOC1,SMOC1,Maternal,rs1958078-<b>C</b>,8 x 10-26,,0.863438,'-,'-,'-,SMOC1,Mean corpuscular volume,mean corpuscular volume,GCST90002338,14:69888141,Blood
2850,SMOC1,SMOC1,Maternal,rs1958078-<b>A</b>,4 x 10-27,,0.15839,'-,0.028252 SD unit increase,[0.023-0.033],SMOC1,Red cell distribution width,red blood cell distribution width,GCST90002369,14:69888141,Blood
2851,SMOC1,SMOC1,Maternal,rs1958078-<b>A</b>,2 x 10-26,,0.165193,'-,'-,'-,SMOC1,Red cell distribution width,red blood cell distribution width,GCST90002372,14:69888141,Blood
2852,SMOC1,SMOC1,Maternal,rs1958078-<b>?</b>,1 x 10-24,,NR,'-,'-,'-,SMOC1,Red cell distribution width,red blood cell distribution width,GCST007074,14:69888141,Blood
2853,SMOC1,SMOC1,Maternal,rs1958078-<b>?</b>,5 x 10-28,,NR,'-,'-,'-,SMOC1,Mean corpuscular hemoglobin,mean corpuscular hemoglobin,GCST007068,14:69888141,Blood
2854,SMOC1,SMOC1,Maternal,rs1958078-<b>C</b>,2 x 10-20,,0.843574,'-,0.028693182 unit decrease,[0.023-0.035],SMOC1,Red cell distribution width,red blood cell distribution width,GCST90002404,14:69888141,Blood
2855,SMOC1,SMOC1,Maternal,rs1958078-<b>C</b>,1 x 10-29,,0.866744,'-,'-,'-,SMOC1,Mean corpuscular hemoglobin,mean corpuscular hemoglobin concentration,GCST90002326,14:69888141,Blood
2856,SMOC1,SMOC1,Maternal,rs11627546-<b>C</b>,1 x 10-9,"(EA, MCV)",0.84,'-,0.162 unit increase,[0.099-0.225],SMOC1,Red blood cell traits,mean corpuscular volume,GCST001765,14:69899207,Blood
2857,SMOC1,SMOC1,Maternal,rs227448-<b>?</b>,4 x 10-9,,NR,'-,'-,'-,SMOC1,Red blood cell count,erythrocyte count,GCST007069,14:69973059,Blood
2858,SMOC1,SMOC1,Maternal,rs7160726-<b>G</b>,3 x 10-16,"(SPARC-related modular calcium-binding protein 1, SMOC1.13118.5.3)",0.443,'-,0.2 unit decrease,[0.16-0.24],SMOC1,Blood protein levels,blood protein measurement,GCST005806,14:70006095,Blood
2888,SVOPL,SVOPL,Maternal,"rs11769043-<b>A</b>, rs17160472-<b>G</b>, rs7798990-<b>C</b>, rs296917-<b>T</b>, rs11769011-<b>G</b>, rs17160478-<b>T</b>",9 x 10-6,,0.061,'-,'-,'-,SVOPL; SVOPL; SVOPL; SVOPL; SVOPL; SVOPL,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,7:138694160|7:138694681|7:138687094|7:138693060|7:138694200|7:138698792,Blood
3016,TP73,TP73,Maternal,"rs3765753-<b>G</b>, rs17379833-<b>A</b>",5 x 10-13,,0.334,'-,'-,'-,TP73; TP73,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,1:3705742|1:3703616,Blood
3017,TP73,TP73,Maternal,"rs3765753-<b>T</b>, rs17379833-<b>A</b>",5 x 10-13,,0.28,'-,'-,'-,TP73; TP73,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,1:3705742|1:3703616,Blood
3827,KCNQ1DN,KCNQ1DN,Maternal,rs2239897-<b>G</b>,4 x 10-9,,0.0637,'-,0.04672705 unit decrease,[0.031-0.062],KCNQ1DN,Plateletcrit,platelet crit,GCST004607,11:2870735,Blood
33,ANO1,ANO1,Maternal,rs3781663-<b>?</b>,8 x 10-6,(disease-free survival),'-,2.24,'-,[1.57-3.19],ANO1,Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,11:70153146,Cancer
41,ATP10A,ATP10A,Maternal,"rs2930590-<b>C</b>, rs2925253-<b>A</b>, rs2086907-<b>A</b>, rs2925256-<b>C</b>, rs8025092-<b>C</b>, rs11858433-<b>A</b>, rs2930593-<b>G</b>, rs952121-<b>C</b>, rs7176242-<b>A</b>",5 x 10-17,,0.003,'-,'-,'-,AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,15:25633329|15:25630857|15:25628262|15:25627862|15:25630114|15:25636283|15:25632668|15:25630251|15:25632574,Cancer
42,ATP10A,ATP10A,Maternal,"rs2930590-<b>C</b>, rs2925253-<b>A</b>, rs2086907-<b>A</b>, rs2925256-<b>C</b>, rs8025092-<b>T</b>, rs11858433-<b>A</b>, rs2930593-<b>G</b>, rs952121-<b>C</b>, rs7176242-<b>A</b>",2 x 10-9,,0.218,'-,'-,'-,AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,15:25633329|15:25630857|15:25628262|15:25627862|15:25630114|15:25636283|15:25632668|15:25630251|15:25632574,Cancer
43,ATP10A,ATP10A,Maternal,rs12906552-<b>T</b>,2 x 10-8,,0.250262,'-,'-,'-,ATP10A,Cutaneous melanoma or hair colour,"cutaneous melanoma, hair color",GCST010302,15:25861110,Cancer
45,ATP10A,ATP10A,Maternal,rs4906759-<b>T</b>,2 x 10-7,,0.06,'-,0.55 unit increase,[0.34-0.75],ATP10A,Response to radiotherapy in prostate cancer (overall toxicity),"response to radiation, prostate carcinoma",GCST003583,15:25730061,Cancer
141,DIO3OS,DIO3OS,Maternal,"rs10142332-<b>G</b>, rs12435279-<b>C</b>, rs12586651-<b>T</b>",3 x 10-7,,0.155,'-,'-,'-,LINC02314 - DIO3OS; No mapped genes; No mapped genes,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,14:101519289,Cancer
869,H19,H19,Maternal,rs7482894-<b>T</b>,4 x 10-14,,0.65,'-,0.0147 unit increase,[0.011-0.019],"IGF2, H19",Urate levels,urate measurement,GCST011119,11:2100034,Cancer
873,H19,H19,Maternal,rs217727-<b>A</b>,4 x 10-14,(EA),0.1929,'-,0.0598 unit decrease,[0.044-0.075],H19,Breast cancer,breast carcinoma,GCST004988,11:1995678,Cancer
874,H19,H19,Maternal,rs78276179-<b>C</b>,5 x 10-6,,0.089914211,1.1871005,'-,[1.102555221-1.278128967],H19,Squamous cell lung carcinoma,squamous cell lung carcinoma,GCST004750,11:2000263,Cancer
1894,KCNQ1,KCNQ1,Maternal,rs60808706-<b>A</b>,6 x 10-9,(East Asian),0.3902,'-,0.0345 mg/dL increase,[0.023-0.046],KCNQ1,Urate levels,urate measurement,GCST008972,11:2836003,Cancer
1902,KCNQ1,KCNQ1,Maternal,"rs10832134-<b>C</b>, rs12576156-<b>A</b>, rs11523905-<b>A</b>",3 x 10-15,,0.021,'-,'-,'-,KCNQ1; KCNQ1; KCNQ1,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,11:2481256|11:2477588|11:2477029,Cancer
1903,KCNQ1,KCNQ1,Maternal,"rs10832134-<b>C</b>, rs12576156-<b>A</b>, rs11523905-<b>G</b>",4 x 10-13,,0.241,'-,'-,'-,KCNQ1; KCNQ1; KCNQ1,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,11:2481256|11:2477588|11:2477029,Cancer
2319,MAGI2,MAGI2,Maternal,rs798336-<b>T</b>,2 x 10-6,,0.88,'-,'-,'-,MAGI2,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,7:78285026,Cancer
2320,MAGI2,MAGI2,Maternal,rs1496766-<b>C</b>,5 x 10-6,,0.014,2.84,'-,[1.81-4.44],MAGI2,Acute lymphoblastic leukemia (childhood),acute lymphoblastic leukemia,GCST001693,7:78702149,Cancer
2355,MEG3,MEG3,Maternal,rs2295389-<b>G</b>,2 x 10-6,(EA),0.3539,'-,0.0345 unit decrease,[0.02-0.049],"MEG3, AL117190.1, AL117190.2",Breast cancer,breast carcinoma,GCST004988,14:100851974,Cancer
2426,NTM,NTM,Maternal,"rs4937627-<b>C</b>, rs12419920-<b>T</b>, rs12575010-<b>A</b>, rs992564-<b>G</b>, rs11222647-<b>G</b>, rs12278021-<b>G</b>, rs11222652-<b>C</b>, rs7107326-<b>C</b>, rs11222631-<b>A</b>, rs11222653-<b>A</b>",2 x 10-14,,0.273,'-,'-,'-,NTM; NTM; NTM; NTM; NTM; NTM; NTM; NTM; NTM; NTM,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,11:131481990|11:131466286|11:131474218|11:131466180|11:131461593|11:131462231|11:131463268|11:131462673|11:131456474|11:131463704,Cancer
2427,NTM,NTM,Maternal,rs112479596-<b>C</b>,1 x 10-6,,0.02604,1.4688601,'-,NR,NTM,Non-Hodgkin's lymphoma,non-Hodgkins lymphoma,GCST90011819,11:131936594,Cancer
2428,NTM,NTM,Maternal,rs145397878-<b>C</b>,2 x 10-6,,0.005,5.81,'-,[2.80-12.09],NTM,Familial lung adenocarcinoma,"lung adenocarcinoma, family history of lung cancer",GCST006087,11:132170004,Cancer
2461,OSBPL5,OSBPL5,Maternal,rs1466045-<b>A</b>,8 x 10-6,,NR,'-,4.46 z score increase,'-,OSBPL5,Cisplatin-induced ototoxicity,"ototoxicity, response to cisplatin",GCST003898,11:3128167,Cancer
2730,SLC22A2*,SLC22A2*,Maternal,rs316025-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,SLC22A2,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,6:160262349,Cancer
2731,SLC22A2*,SLC22A2*,Maternal,rs3908804-<b>A</b>,2 x 10-6,,0.042,2.11,'-,[1.55-2.88],"SLC22A2, SLC22A3",Familial squamous cell lung carcinoma,"squamous cell lung carcinoma, family history of lung cancer",GCST006088,6:160282296,Cancer
2812,SLC22A3*,SLC22A3*,Maternal,rs505870-<b>A</b>,5 x 10-11,,0.48,'-,0.012 unit decrease,[0.0084-0.0156],SLC22A3,Urate levels,urate measurement,GCST011119,6:160350331,Cancer
2813,SLC22A3*,SLC22A3*,Maternal,rs3908804-<b>A</b>,2 x 10-6,,0.042,2.11,'-,[1.55-2.88],"SLC22A2, SLC22A3",Familial squamous cell lung carcinoma,"squamous cell lung carcinoma, family history of lung cancer",GCST006088,6:160282296,Cancer
2814,SLC22A3*,SLC22A3*,Maternal,rs9364554-<b>T</b>,5 x 10-33,,0.28,1.11,'-,[1.09-1.13],SLC22A3,Prostate cancer,prostate carcinoma,GCST006085,6:160412632,Cancer
2815,SLC22A3*,SLC22A3*,Maternal,rs9364554-<b>T</b>,6 x 10-12,,0.279,1.14,'-,[1.10-1.18],SLC22A3,Prostate cancer,prostate carcinoma,GCST002944,6:160412632,Cancer
2816,SLC22A3*,SLC22A3*,Maternal,rs9364554-<b>T</b>,6 x 10-10,,0.29,1.17,'-,[1.08-1.26],SLC22A3,Prostate cancer,prostate carcinoma,GCST000152,6:160412632,Cancer
2817,SLC22A3*,SLC22A3*,Maternal,rs12194182-<b>C</b>,1 x 10-10,,NR,1.1210762,'-,[1.08-1.16],SLC22A3,Cancer (pleiotropy),cancer,GCST90011822,6:160413483,Cancer
2818,SLC22A3*,SLC22A3*,Maternal,rs12194182-<b>C</b>,4 x 10-13,,NR,1.1188185,'-,NR,SLC22A3,Prostate cancer,prostate carcinoma,GCST90011808,6:160413483,Cancer
2819,SLC22A3*,SLC22A3*,Maternal,rs7758229-<b>T</b>,8 x 10-9,(distal colon cancer),NR,1.28,'-,[1.18-1.39],SLC22A3,Colorectal cancer,colorectal cancer,GCST000948,6:160419220,Cancer
2820,SLC22A3*,SLC22A3*,Maternal,rs7758229-<b>T</b>,4 x 10-12,,0.31,1.15,'-,[1.10‐1.20],SLC22A3,Prostate cancer,prostate carcinoma,GCST002890,6:160419220,Cancer
2821,SLC22A3*,SLC22A3*,Maternal,rs3123636-<b>C</b>,3 x 10-9,,0.356,1.37,'-,[1.23-1.51],SLC22A3,Prostate cancer,prostate carcinoma,GCST003586,6:160421505,Cancer
2822,SLC22A3*,SLC22A3*,Maternal,rs9351730-<b>?</b> x rs9364554-<b>?</b>,5 x 10-6,,NR,1.25,'-,[1.13-1.37],AL606923.2 - AL606923.1 x SLC22A3,Prostate cancer (SNP x SNP interaction),prostate carcinoma,GCST001370,6:68584593|6:160412632,Cancer
2887,SVOPL,SVOPL,Maternal,rs28625106-<b>A</b>,5 x 10-6,,0.041,2.46,'-,[1.67-3.63],SVOPL,Familial squamous cell lung carcinoma,"squamous cell lung carcinoma, family history of lung cancer",GCST006088,7:138667056,Cancer
2888,SVOPL,SVOPL,Maternal,"rs11769043-<b>A</b>, rs17160472-<b>G</b>, rs7798990-<b>C</b>, rs296917-<b>T</b>, rs11769011-<b>G</b>, rs17160478-<b>T</b>",9 x 10-6,,0.061,'-,'-,'-,SVOPL; SVOPL; SVOPL; SVOPL; SVOPL; SVOPL,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,7:138694160|7:138694681|7:138687094|7:138693060|7:138694200|7:138698792,Cancer
3016,TP73,TP73,Maternal,"rs3765753-<b>G</b>, rs17379833-<b>A</b>",5 x 10-13,,0.334,'-,'-,'-,TP73; TP73,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,1:3705742|1:3703616,Cancer
3017,TP73,TP73,Maternal,"rs3765753-<b>T</b>, rs17379833-<b>A</b>",5 x 10-13,,0.28,'-,'-,'-,TP73; TP73,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,1:3705742|1:3703616,Cancer
20,ANO1,ANO1,Maternal,rs875106-<b>A</b>,8 x 10-16,,0.5229,'-,0.1217 mmHg decrease,[0.092-0.151],ANO1,Diastolic blood pressure,diastolic blood pressure,GCST006630,11:70159535,Cardiovascular
21,ANO1,ANO1,Maternal,rs7127129-<b>G</b>,2 x 10-9,,0.41,'-,0.015 cm decrease,[0.0091-0.0209],ANO1,Aortic root size,aortic root size,GCST004651,11:70181807,Cardiovascular
35,ATP10A,ATP10A,Maternal,rs17636733-<b>?</b>,2 x 10-7,(recessive),NR,'-,'-,'-,"ATP10A, AC023449.1",Cardiac hypertrophy,cardiac hypertrophy,GCST000960,15:25667192,Cardiovascular
36,ATP10A,ATP10A,Maternal,rs10873612-<b>C</b>,1 x 10-9,,0.4039,'-,0.1096 mmHg increase,[0.075-0.145],ATP10A,Diastolic blood pressure,diastolic blood pressure,GCST006627,15:25860455,Cardiovascular
138,DIO3OS,DIO3OS,Maternal,rs11626434-<b>G</b>,8 x 10-10,,0.6384,'-,0.1345 unit increase,[0.092-0.177],"LINC02314, DIO3OS",Pulse pressure,pulse pressure measurement,GCST006626,14:101532106,Cardiovascular
849,H19,H19,Maternal,rs217727-<b>A</b>,4 x 10-6,(Japanese),0.3913,'-,0.0644 unit increase,[0.037-0.092],H19,Hypertension,hypertension,GCST007707,11:1995678,Cardiovascular
850,H19,H19,Maternal,rs217727-<b>G</b>,8 x 10-7,,'-,'-,0.183 unit decrease,'-,H19,Pulse pressure,pulse pressure measurement,GCST007096,11:1995678,Cardiovascular
851,H19,H19,Maternal,rs217727-<b>G</b>,1 x 10-9,,'-,'-,0.339 unit decrease,'-,H19,Systolic blood pressure,systolic blood pressure,GCST007099,11:1995678,Cardiovascular
852,H19,H19,Maternal,rs217727-<b>G</b>,2 x 10-6,,'-,'-,0.159 unit decrease,'-,H19,Diastolic blood pressure,diastolic blood pressure,GCST007094,11:1995678,Cardiovascular
853,H19,H19,Maternal,rs217727-<b>?</b>,7 x 10-15,,NR,'-,'-,'-,H19,Systolic blood pressure (cigarette smoking interaction),"smoking status measurement, systolic blood pressure",GCST006188,11:1995678,Cardiovascular
854,H19,H19,Maternal,rs217727-<b>?</b>,1 x 10-8,,'-,'-,'-,'-,H19,Diastolic blood pressure (cigarette smoking interaction),"smoking status measurement, diastolic blood pressure",GCST006187,11:1995678,Cardiovascular
855,H19,H19,Maternal,rs117212336-<b>T</b>,2 x 10-7,,0.044348902,'-,0.707 unit increase,[0.44-0.97],"H19, IGF2",Systolic blood pressure,systolic blood pressure,GCST004279,11:2095084,Cardiovascular
1591,KCNQ1,KCNQ1,Maternal,rs12271931-<b>A</b>,4 x 10-12,,0.93,'-,3.92 ms increase,[2.8-5.04],KCNQ1,QT interval,QT interval,GCST005171,11:2457289,Cardiovascular
1592,KCNQ1,KCNQ1,Maternal,rs16928285-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,KCNQ1,Electrocardiographic traits (multivariate),electrocardiography,GCST011010,11:2459910,Cardiovascular
1593,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-28,,0.053,'-,4.89 unit decrease,[4.03-5.75],KCNQ1,QT interval,QT interval,GCST002500,11:2463573,Cardiovascular
1594,KCNQ1,KCNQ1,Maternal,rs2074238-<b>?</b>,2 x 10-12,,NR,'-,4.779583 unit increase,[3.45-6.11],KCNQ1,QT interval,QT interval,GCST008043,11:2463573,Cardiovascular
1595,KCNQ1,KCNQ1,Maternal,rs2074238-<b>C</b>,7 x 10-28,,0.92,'-,5.405 unit increase,[4.44-6.37],KCNQ1,QT interval,QT interval,GCST007218,11:2463573,Cardiovascular
1596,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-13,,0.088,'-,0.066 bpm increase,[0.048-0.084],KCNQ1,QT dynamics during exercise,QT interval,GCST90010359,11:2463573,Cardiovascular
1597,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-9,(male),0.088004,'-,0.0839159 bpm increase,[0.056-0.112],KCNQ1,QT dynamics during exercise,QT interval,GCST90010359,11:2463573,Cardiovascular
1598,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-40,(336 ms),0.0826217,'-,0.132541 unit decrease,[0.11-0.15],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1599,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-41,(338 ms),0.0826217,'-,0.135777 unit decrease,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1600,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-39,(340 ms),0.0826217,'-,0.132415 unit decrease,[0.11-0.15],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1601,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-35,(342 ms),0.0826217,'-,0.123869 unit decrease,[0.1-0.14],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1602,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-31,(344 ms),0.0826217,'-,0.116777 unit decrease,[0.097-0.137],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1603,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-28,(346 ms),0.0826217,'-,0.112538 unit decrease,[0.093-0.132],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1604,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-26,(348 ms),0.0826217,'-,0.107548 unit decrease,[0.088-0.127],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1605,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-25,(350 ms),0.0826217,'-,0.106311 unit decrease,[0.086-0.126],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1606,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,9 x 10-26,(352 ms),0.0826217,'-,0.10636 unit decrease,[0.087-0.126],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1607,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-25,(354 ms),0.0826217,'-,0.104262 unit decrease,[0.084-0.124],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1608,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-23,(356 ms),0.0826217,'-,0.101042 unit decrease,[0.081-0.121],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1609,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-23,(358 ms),0.0826217,'-,0.100378 unit decrease,[0.081-0.12],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1610,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-20,(360 ms),0.0826217,'-,0.0945735 unit decrease,[0.075-0.114],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1611,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-18,(362 ms),0.0826217,'-,0.0877157 unit decrease,[0.068-0.108],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1612,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-18,(364 ms),0.0826217,'-,0.0891186 unit decrease,[0.069-0.109],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1613,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-19,(366 ms),0.0826217,'-,0.0906017 unit decrease,[0.071-0.11],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1614,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-17,(368 ms),0.0826217,'-,0.0855223 unit decrease,[0.066-0.105],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1615,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-15,(370 ms),0.0826217,'-,0.0796447 unit decrease,[0.06-0.1],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1616,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-15,(372 ms),0.0826217,'-,0.0815277 unit decrease,[0.062-0.101],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1617,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-16,(374 ms),0.0826217,'-,0.0817416 unit decrease,[0.062-0.102],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1618,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-13,(376 ms),0.0826217,'-,0.0741215 unit decrease,[0.054-0.094],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1619,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-10,(378 ms),0.0826217,'-,0.0634459 unit decrease,[0.044-0.083],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1620,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,7 x 10-9,(380 ms),0.0826217,'-,0.0586989 unit decrease,[0.039-0.079],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1621,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-8,(382 ms),0.0826217,'-,0.056331 unit decrease,[0.036-0.076],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1622,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-62,(242 ms),0.0826217,'-,0.164785 unit increase,[0.15-0.18],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1623,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-55,(244 ms),0.0826217,'-,0.155861 unit increase,[0.14-0.18],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1624,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-48,(246 ms),0.0826217,'-,0.145356 unit increase,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1625,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-41,(248 ms),0.0826217,'-,0.133766 unit increase,[0.11-0.15],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1626,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-34,(250 ms),0.0826217,'-,0.12214 unit increase,[0.1-0.14],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1627,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-28,(252 ms),0.0826217,'-,0.110392 unit increase,[0.091-0.13],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1628,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-22,(254 ms),0.0826217,'-,0.09622 unit increase,[0.076-0.116],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1629,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-16,(256 ms),0.0826217,'-,0.0815301 unit increase,[0.062-0.101],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1630,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-12,(258 ms),0.0826217,'-,0.0703721 unit increase,[0.051-0.09],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1631,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-9,(260 ms),0.0826217,'-,0.0602876 unit increase,[0.04-0.08],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1632,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-11,(280 ms),0.0826217,'-,0.067568 unit decrease,[0.048-0.087],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1633,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-14,(282 ms),0.0826217,'-,0.0762876 unit decrease,[0.056-0.096],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1634,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-16,(284 ms),0.0826217,'-,0.0836031 unit decrease,[0.064-0.103],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1635,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-20,(286 ms),0.0826217,'-,0.0929137 unit decrease,[0.073-0.113],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1636,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-23,(288 ms),0.0826217,'-,0.101096 unit decrease,[0.081-0.121],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1637,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-26,(290 ms),0.0826217,'-,0.107918 unit decrease,[0.088-0.128],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1638,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,7 x 10-30,(292 ms),0.0826217,'-,0.114474 unit decrease,[0.095-0.134],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1639,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,7 x 10-33,(294 ms),0.0826217,'-,0.120513 unit decrease,[0.1-0.14],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1640,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-35,(296 ms),0.0826217,'-,0.124787 unit decrease,[0.1-0.14],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1641,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-38,(298 ms),0.0826217,'-,0.130052 unit decrease,[0.11-0.15],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1642,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-42,(300 ms),0.0826217,'-,0.136457 unit decrease,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1643,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-45,(302 ms),0.0826217,'-,0.14139 unit decrease,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1644,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-46,(304 ms),0.0826217,'-,0.142626 unit decrease,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1645,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-46,(306 ms),0.0826217,'-,0.142466 unit decrease,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1646,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-48,(308 ms),0.0826217,'-,0.146193 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1647,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-52,(310 ms),0.0826217,'-,0.15288 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1648,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-54,(312 ms),0.0826217,'-,0.154664 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1649,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-52,(314 ms),0.0826217,'-,0.152541 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1650,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-53,(316 ms),0.0826217,'-,0.153228 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1651,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,7 x 10-54,(318 ms),0.0826217,'-,0.15448 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1652,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-51,(320 ms),0.0826217,'-,0.151237 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1653,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,7 x 10-51,(322 ms),0.0826217,'-,0.149839 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1654,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-52,(324 ms),0.0826217,'-,0.152341 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1655,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-50,(326 ms),0.0826217,'-,0.149862 unit decrease,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1656,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-46,(328 ms),0.0826217,'-,0.142834 unit decrease,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1657,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-43,(330 ms),0.0826217,'-,0.138801 unit decrease,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1658,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-42,(332 ms),0.0826217,'-,0.137309 unit decrease,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1659,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-39,(334 ms),0.0826217,'-,0.131552 unit decrease,[0.11-0.15],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1660,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-118,(222 ms),0.0826217,'-,0.226792 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1661,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-118,(224 ms),0.0826217,'-,0.226434 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1662,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-115,(226 ms),0.0826217,'-,0.223299 unit increase,[0.2-0.24],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1663,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-108,(228 ms),0.0826217,'-,0.216202 unit increase,[0.2-0.24],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1664,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,7 x 10-101,(230 ms),0.0826217,'-,0.20872 unit increase,[0.19-0.23],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1665,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-95,(232 ms),0.0826217,'-,0.203136 unit increase,[0.18-0.22],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1666,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-89,(234 ms),0.0826217,'-,0.198013 unit increase,[0.18-0.22],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1667,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-84,(236 ms),0.0826217,'-,0.191091 unit increase,[0.17-0.21],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1668,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-75,(238 ms),0.0826217,'-,0.18086 unit increase,[0.16-0.2],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1669,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-129,(206 ms),0.0826217,'-,0.235118 unit increase,[0.22-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1670,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-8,(110 ms),0.0826217,'-,0.0524111 unit increase,[0.033-0.072],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1671,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-8,(114 ms),0.0826217,'-,0.0538376 unit increase,[0.034-0.073],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1672,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-9,(116 ms),0.0826217,'-,0.0572405 unit increase,[0.038-0.077],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1673,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-10,(118 ms),0.0826217,'-,0.0587314 unit increase,[0.039-0.078],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1674,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-10,(120 ms),0.0826217,'-,0.061937 unit increase,[0.043-0.081],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1675,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-12,(122 ms),0.0826217,'-,0.0681845 unit increase,[0.049-0.088],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1676,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-15,(124 ms),0.0826217,'-,0.0762264 unit increase,[0.057-0.096],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1677,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-16,(126 ms),0.0826217,'-,0.0794804 unit increase,[0.06-0.099],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1678,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-16,(128 ms),0.0826217,'-,0.0782557 unit increase,[0.059-0.098],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1679,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-15,(130 ms),0.0826217,'-,0.0767944 unit increase,[0.057-0.096],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1680,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-15,(132 ms),0.0826217,'-,0.0766059 unit increase,[0.057-0.096],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1681,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-16,(134 ms),0.0826217,'-,0.0801997 unit increase,[0.061-0.1],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1682,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-21,(136 ms),0.0826217,'-,0.0916465 unit increase,[0.072-0.111],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1683,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-25,(138 ms),0.0826217,'-,0.0999359 unit increase,[0.081-0.119],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1684,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-26,(140 ms),0.0826217,'-,0.102083 unit increase,[0.083-0.122],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1685,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-28,(142 ms),0.0826217,'-,0.106368 unit increase,[0.087-0.126],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1686,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-31,(144 ms),0.0826217,'-,0.112001 unit increase,[0.092-0.132],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1687,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,7 x 10-32,(146 ms),0.0826217,'-,0.112049 unit increase,[0.093-0.131],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1688,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-33,(148 ms),0.0826217,'-,0.115365 unit increase,[0.096-0.135],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1689,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-37,(150 ms),0.0826217,'-,0.1222 unit increase,[0.1-0.14],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1690,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,7 x 10-42,(152 ms),0.0826217,'-,0.129679 unit increase,[0.11-0.15],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1691,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-47,(154 ms),0.0826217,'-,0.137903 unit increase,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1692,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-50,(156 ms),0.0826217,'-,0.143657 unit increase,[0.12-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1693,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-51,(158 ms),0.0826217,'-,0.14448 unit increase,[0.13-0.16],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1694,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-53,(160 ms),0.0826217,'-,0.14815 unit increase,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1695,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-57,(162 ms),0.0826217,'-,0.154438 unit increase,[0.13-0.17],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1696,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-59,(164 ms),0.0826217,'-,0.157442 unit increase,[0.14-0.18],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1697,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-63,(166 ms),0.0826217,'-,0.162291 unit increase,[0.14-0.18],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1698,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-71,(168 ms),0.0826217,'-,0.171581 unit increase,[0.15-0.19],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1699,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-76,(170 ms),0.0826217,'-,0.177677 unit increase,[0.16-0.2],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1700,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-77,(172 ms),0.0826217,'-,0.179683 unit increase,[0.16-0.2],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1701,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-79,(174 ms),0.0826217,'-,0.183855 unit increase,[0.16-0.2],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1702,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-86,(176 ms),0.0826217,'-,0.190808 unit increase,[0.17-0.21],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1703,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-91,(178 ms),0.0826217,'-,0.196038 unit increase,[0.18-0.22],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1704,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-95,(180 ms),0.0826217,'-,0.199729 unit increase,[0.18-0.22],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1705,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-99,(182 ms),0.0826217,'-,0.203747 unit increase,[0.18-0.22],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1706,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-105,(184 ms),0.0826217,'-,0.211016 unit increase,[0.19-0.23],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1707,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-109,(186 ms),0.0826217,'-,0.21577 unit increase,[0.2-0.24],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1708,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-110,(188 ms),0.0826217,'-,0.216304 unit increase,[0.2-0.24],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1709,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-109,(190 ms),0.0826217,'-,0.217931 unit increase,[0.2-0.24],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1710,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-116,(192 ms),0.0826217,'-,0.222102 unit increase,[0.2-0.24],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1711,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-117,(194 ms),0.0826217,'-,0.2236 unit increase,[0.2-0.24],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1712,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-117,(196 ms),0.0826217,'-,0.22447 unit increase,[0.2-0.24],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1713,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-119,(198 ms),0.0826217,'-,0.227381 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1714,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,6 x 10-123,(200 ms),0.0826217,'-,0.229971 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1715,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-124,(202 ms),0.0826217,'-,0.23106 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1716,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-127,(204 ms),0.0826217,'-,0.233373 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1717,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,8 x 10-127,(208 ms),0.0826217,'-,0.234975 unit increase,[0.22-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1718,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-129,(210 ms),0.0826217,'-,0.235045 unit increase,[0.22-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1719,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-129,(212 ms),0.0826217,'-,0.235245 unit increase,[0.22-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1720,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-126,(214 ms),0.0826217,'-,0.233128 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1721,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-124,(216 ms),0.0826217,'-,0.230858 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1722,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-124,(218 ms),0.0826217,'-,0.231008 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1723,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,4 x 10-123,(220 ms),0.0826217,'-,0.22957 unit increase,[0.21-0.25],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1724,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,7 x 10-34,,0.088,'-,0.12 unit decrease,[0.1-0.14],KCNQ1,T wave morphology restitution during exercise (MTAG),T wave morphology measurement,GCST009068,11:2463573,Cardiovascular
1725,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,1 x 10-59,,0.088,'-,0.138 unit decrease,[0.12-0.15],KCNQ1,T wave morphology restitution during recovery from exercise,T wave morphology measurement,GCST009069,11:2463573,Cardiovascular
1726,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,5 x 10-58,,0.088,'-,0.174 unit decrease,[0.15-0.2],KCNQ1,T wave morphology restitution during recovery from exercise (MTAG),T wave morphology measurement,GCST009017,11:2463573,Cardiovascular
1727,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,3 x 10-17,,0.06,'-,7.88 msec decrease,[6.16-9.59],KCNQ1,QT interval,QT interval,GCST000363,11:2463573,Cardiovascular
1728,KCNQ1,KCNQ1,Maternal,rs2074238-<b>T</b>,2 x 10-67,(240 ms),0.0826217,'-,0.171783 unit increase,[0.15-0.19],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2463573,Cardiovascular
1729,KCNQ1,KCNQ1,Maternal,rs16928297-<b>G</b>,2 x 10-6,,0.51,'-,1.25 unit increase,[0.74-1.76],KCNQ1,QT interval,QT interval,GCST001746,11:2464890,Cardiovascular
1730,KCNQ1,KCNQ1,Maternal,rs16928297-<b>?</b>,7 x 10-11,,NR,'-,1.398405 unit increase,[0.98-1.82],KCNQ1,QT interval,QT interval,GCST008043,11:2464890,Cardiovascular
1731,KCNQ1,KCNQ1,Maternal,rs7122937-<b>T</b>,1 x 10-54,,0.188,'-,1.93 unit increase,[1.69-2.17],KCNQ1,QT interval,QT interval,GCST002500,11:2465320,Cardiovascular
1732,KCNQ1,KCNQ1,Maternal,rs7122937-<b>?</b>,2 x 10-11,,NR,'-,1.439996 unit increase,[1.02-1.86],KCNQ1,QT interval,QT interval,GCST008043,11:2465320,Cardiovascular
1733,KCNQ1,KCNQ1,Maternal,rs12296050-<b>?</b>,8 x 10-11,,NR,'-,1.397762 unit increase,[0.98-1.82],KCNQ1,QT interval,QT interval,GCST008043,11:2468112,Cardiovascular
1734,KCNQ1,KCNQ1,Maternal,rs12296050-<b>T</b>,8 x 10-11,(QT interval),0.15,'-,13.16 % s.d. increase,[9.19-17.12],KCNQ1,Electrocardiographic traits,QT interval,GCST000561,11:2468112,Cardiovascular
1735,KCNQ1,KCNQ1,Maternal,rs12296050-<b>T</b>,3 x 10-17,,0.2,'-,1.44 ms increase,[0.95-1.93],KCNQ1,QT interval,QT interval,GCST000364,11:2468112,Cardiovascular
1736,KCNQ1,KCNQ1,Maternal,rs12576239-<b>T</b>,1 x 10-15,,0.13,'-,1.75 msec increase,[1.41-2.09],KCNQ1,QT interval,QT interval,GCST000363,11:2481089,Cardiovascular
1737,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,9 x 10-12,(330 ms),0.947658,'-,0.084894 unit decrease,[0.06-0.11],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1738,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,3 x 10-12,(332 ms),0.947658,'-,0.0866018 unit decrease,[0.062-0.111],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1739,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,7 x 10-12,(334 ms),0.947658,'-,0.0854882 unit decrease,[0.061-0.11],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1740,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,7 x 10-12,(336 ms),0.947658,'-,0.0865788 unit decrease,[0.062-0.111],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1741,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,2 x 10-11,(338 ms),0.947658,'-,0.0853695 unit decrease,[0.061-0.11],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1742,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-10,(340 ms),0.947658,'-,0.0805768 unit decrease,[0.056-0.105],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1743,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,4 x 10-9,(342 ms),0.947658,'-,0.0748777 unit decrease,[0.05-0.1],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1744,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,3 x 10-9,(344 ms),0.947658,'-,0.0747566 unit decrease,[0.05-0.099],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1745,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,2 x 10-9,(346 ms),0.947658,'-,0.0759881 unit decrease,[0.051-0.101],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1746,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,3 x 10-13,(210 ms),0.947658,'-,0.0864296 unit increase,[0.062-0.111],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1747,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,3 x 10-13,(220 ms),0.947658,'-,0.0856456 unit increase,[0.061-0.11],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1748,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,8 x 10-9,(170 ms),0.947658,'-,0.0686092 unit increase,[0.044-0.093],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1749,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,3 x 10-9,(172 ms),0.947658,'-,0.070969 unit increase,[0.047-0.095],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1750,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,2 x 10-9,(174 ms),0.947658,'-,0.0745033 unit increase,[0.05-0.099],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1751,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,5 x 10-10,(182 ms),0.947658,'-,0.0717813 unit increase,[0.047-0.096],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1752,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-9,(184 ms),0.947658,'-,0.0707854 unit increase,[0.046-0.095],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1753,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-11,(192 ms),0.947658,'-,0.0803834 unit increase,[0.056-0.105],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1754,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,2 x 10-11,(194 ms),0.947658,'-,0.0799228 unit increase,[0.056-0.104],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1755,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-11,(196 ms),0.947658,'-,0.0807567 unit increase,[0.056-0.105],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1756,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,4 x 10-12,(198 ms),0.947658,'-,0.0828412 unit increase,[0.058-0.107],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1757,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-12,(200 ms),0.947658,'-,0.0853102 unit increase,[0.061-0.11],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1758,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-12,(202 ms),0.947658,'-,0.083455 unit increase,[0.059-0.108],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1759,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,2 x 10-12,(204 ms),0.947658,'-,0.0820635 unit increase,[0.058-0.106],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1760,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,9 x 10-13,(206 ms),0.947658,'-,0.083749 unit increase,[0.059-0.108],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1761,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,2 x 10-12,(208 ms),0.947658,'-,0.0855706 unit increase,[0.061-0.11],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1762,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,5 x 10-13,(212 ms),0.947658,'-,0.086382 unit increase,[0.062-0.111],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1763,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,7 x 10-13,(214 ms),0.947658,'-,0.08408 unit increase,[0.06-0.108],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1764,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,3 x 10-12,(216 ms),0.947658,'-,0.0818312 unit increase,[0.057-0.106],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1765,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,8 x 10-13,(218 ms),0.947658,'-,0.0838755 unit increase,[0.059-0.108],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1766,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,8 x 10-12,(222 ms),0.947658,'-,0.0822799 unit increase,[0.058-0.107],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1767,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-11,(224 ms),0.947658,'-,0.0789911 unit increase,[0.055-0.103],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1768,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,2 x 10-11,(226 ms),0.947658,'-,0.0784958 unit increase,[0.054-0.103],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1769,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-10,(228 ms),0.947658,'-,0.0757344 unit increase,[0.051-0.1],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1770,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,6 x 10-10,(230 ms),0.947658,'-,0.0724155 unit increase,[0.048-0.097],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1771,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,9 x 10-10,(232 ms),0.947658,'-,0.0722035 unit increase,[0.048-0.097],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1772,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,4 x 10-9,(234 ms),0.947658,'-,0.0717468 unit increase,[0.047-0.096],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1773,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-8,(236 ms),0.947658,'-,0.0673314 unit increase,[0.043-0.092],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1774,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,3 x 10-10,(300 ms),0.947658,'-,0.0766294 unit decrease,[0.052-0.101],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1775,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,8 x 10-10,(302 ms),0.947658,'-,0.0747045 unit decrease,[0.05-0.099],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1776,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,3 x 10-10,(304 ms),0.947658,'-,0.0768601 unit decrease,[0.052-0.101],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1777,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,5 x 10-11,(306 ms),0.947658,'-,0.0804991 unit decrease,[0.056-0.105],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1778,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-10,(308 ms),0.947658,'-,0.0790351 unit decrease,[0.054-0.104],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1779,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,6 x 10-10,(316 ms),0.947658,'-,0.0776235 unit decrease,[0.053-0.102],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1780,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-10,(318 ms),0.947658,'-,0.0791306 unit decrease,[0.055-0.104],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1781,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-10,(320 ms),0.947658,'-,0.0800748 unit decrease,[0.055-0.105],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1782,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,4 x 10-10,(322 ms),0.947658,'-,0.0778547 unit decrease,[0.053-0.102],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1783,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,8 x 10-11,(324 ms),0.947658,'-,0.0816194 unit decrease,[0.057-0.106],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1784,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,1 x 10-11,(326 ms),0.947658,'-,0.0844993 unit decrease,[0.06-0.109],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1785,KCNQ1,KCNQ1,Maternal,rs117236107-<b>G</b>,5 x 10-12,(328 ms),0.947658,'-,0.0857118 unit decrease,[0.061-0.11],KCNQ1,Electrocardiogram morphology (amplitude at temporal datapoints),electrocardiography,GCST010796,11:2503382,Cardiovascular
1786,KCNQ1,KCNQ1,Maternal,rs179405-<b>?</b>,2 x 10-8,,'-,1.38,'-,[1.23-1.54],KCNQ1,Long QT syndrome,Familial long QT syndrome,GCST010651,11:2504165,Cardiovascular
1787,KCNQ1,KCNQ1,Maternal,rs7947981-<b>G</b>,3 x 10-7,(QT),0.111,'-,'-,'-,KCNQ1,Electrocardiographic traits,QT interval,GCST002542,11:2605104,Cardiovascular
1788,KCNQ1,KCNQ1,Maternal,rs78695585-<b>A</b>,3 x 10-9,,0.04,'-,3.48 ms increase,[2.32-4.64],"KCNQ1, KCNQ1OT1",QT interval,QT interval,GCST005171,11:2623314,Cardiovascular
1789,KCNQ1,KCNQ1,Maternal,rs80127491-<b>?</b>,5 x 10-8,,NR,'-,'-,'-,"KCNQ1OT1, KCNQ1",Electrocardiographic traits (multivariate),electrocardiography,GCST011010,11:2624564,Cardiovascular
1790,KCNQ1,KCNQ1,Maternal,rs10832417-<b>T</b>,4 x 10-7,"(MAP, response to intervention)",0.31,'-,1.05 mmHg decrease,[0.64-1.46],"KCNQ1OT1, KCNQ1",Blood pressure measurement (high sodium intervention),"mean arterial pressure, response to high sodium diet",GCST002249,11:2631427,Cardiovascular
1791,KCNQ1,KCNQ1,Maternal,rs10832417-<b>T</b>,1 x 10-6,"(SBP, response to intervention)",0.31,'-,1.3 mmHg decrease,[0.77-1.83],"KCNQ1OT1, KCNQ1",Blood pressure measurement (high sodium intervention),"systolic blood pressure, response to high sodium diet",GCST002249,11:2631427,Cardiovascular
1792,KCNQ1,KCNQ1,Maternal,rs874031-<b>?</b>,6 x 10-9,,NR,'-,5.612 unit increase,[3.72-7.5],"KCNQ1OT1, KCNQ1",QT interval,QT interval,GCST008043,11:2691336,Cardiovascular
1793,KCNQ1,KCNQ1,Maternal,rs874031-<b>?</b>,4 x 10-9,(Hispanic/Latino),NR,'-,5.710829 unit increase,[3.81-7.61],"KCNQ1OT1, KCNQ1",QT interval,QT interval,GCST008043,11:2691336,Cardiovascular
1794,KCNQ1,KCNQ1,Maternal,rs231906-<b>A</b>,2 x 10-6,,0.64,'-,1.51 unit increase,[0.88-2.14],KCNQ1,QT interval,QT interval,GCST001746,11:2731379,Cardiovascular
1949,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,1 x 10-8,(EA),NR,'-,0.02 unit decrease,NR,"AC016831.5, KLF14",Triglyceride levels,triglyceride measurement,GCST008076,7:130739885,Cardiovascular
1950,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,9 x 10-6,(Asian),NR,'-,0.015 unit decrease,NR,"AC016831.5, KLF14",Triglyceride levels,triglyceride measurement,GCST008076,7:130739885,Cardiovascular
1951,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,2 x 10-17,(EA),NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:130739885,Cardiovascular
1952,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,4 x 10-16,,NR,'-,0.018 unit decrease,NR,"AC016831.5, KLF14",Triglyceride levels,triglyceride measurement,GCST008076,7:130739885,Cardiovascular
1953,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,1 x 10-6,(Hispanic),NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:130739885,Cardiovascular
1954,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,6 x 10-25,,NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:130739885,Cardiovascular
1955,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,8 x 10-15,(EA),NR,'-,0.02 unit decrease,NR,"AC016831.5, KLF14",Triglyceride levels in current drinkers,"triglyceride measurement, alcohol drinking",GCST008087,7:130739885,Cardiovascular
1956,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,3 x 10-6,(Asian),NR,'-,0.014 unit decrease,NR,"AC016831.5, KLF14",Triglyceride levels in current drinkers,"triglyceride measurement, alcohol drinking",GCST008087,7:130739885,Cardiovascular
1957,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,4 x 10-23,,NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"triglyceride measurement, alcohol drinking",GCST008083,7:130739885,Cardiovascular
1958,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,1 x 10-6,(Hispanic),NR,'-,0.032 unit decrease,NR,"AC016831.5, KLF14",Triglyceride levels in current drinkers,"triglyceride measurement, alcohol drinking",GCST008087,7:130739885,Cardiovascular
1959,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,6 x 10-24,,NR,'-,0.018 unit decrease,NR,"AC016831.5, KLF14",Triglyceride levels in current drinkers,"triglyceride measurement, alcohol drinking",GCST008087,7:130739885,Cardiovascular
1960,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,1 x 10-15,(EA),NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"triglyceride measurement, alcohol drinking",GCST008083,7:130739885,Cardiovascular
1961,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,2 x 10-6,(Hispanic),NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"triglyceride measurement, alcohol drinking",GCST008083,7:130739885,Cardiovascular
1963,KLF14,KLF14,Maternal,rs4731701-<b>C</b>,3 x 10-61,,0.506912,'-,0.0328926 unit increase,[0.029-0.037],"AC016831.5, KLF14",Triglyceride levels,triglyceride measurement,GCST010244,7:130746171,Cardiovascular
1969,KLF14,KLF14,Maternal,rs13241165-<b>A</b>,3 x 10-13,(EA),0.518,'-,0.03 unit increase,'-,"AC016831.5, KLF14",Triglycerides,triglyceride measurement,GCST007142,7:130747779,Cardiovascular
1970,KLF14,KLF14,Maternal,rs13241165-<b>A</b>,2 x 10-14,,NR,'-,0.029 unit increase,'-,"AC016831.5, KLF14",Triglycerides,triglyceride measurement,GCST007142,7:130747779,Cardiovascular
1971,KLF14,KLF14,Maternal,rs13241165-<b>?</b>,1 x 10-9,,NR,'-,0.02579994 unit decrease,[0.018-0.034],"AC016831.5, KLF14",Triglyceride levels,triglyceride measurement,GCST008046,7:130747779,Cardiovascular
1972,KLF14,KLF14,Maternal,rs4731702-<b>C</b>,2 x 10-13,(EA),0.518,'-,0.03 unit increase,'-,"AC016831.5, KLF14",Triglycerides,triglyceride measurement,GCST007142,7:130748625,Cardiovascular
1973,KLF14,KLF14,Maternal,rs4731702-<b>C</b>,2 x 10-14,,NR,'-,0.029 unit increase,'-,"AC016831.5, KLF14",Triglycerides,triglyceride measurement,GCST007142,7:130748625,Cardiovascular
1974,KLF14,KLF14,Maternal,rs4731702-<b>?</b>,1 x 10-9,,NR,'-,0.02578935 unit decrease,[0.018-0.034],"AC016831.5, KLF14",Triglyceride levels,triglyceride measurement,GCST008046,7:130748625,Cardiovascular
1975,KLF14,KLF14,Maternal,rs4731702-<b>T</b>,4 x 10-11,,0.4493,'-,'-,'-,"AC016831.5, KLF14",Body fat percentage and triglycerides (pairwise),"triglyceride measurement, body fat percentage",GCST011342,7:130748625,Cardiovascular
1984,KLF14,KLF14,Maternal,rs34518086-<b>?</b>,7 x 10-11,,0.5138,'-,0.0181 mg dl-1 increase,[0.013-0.024],"AC016831.5, KLF14",Triglycerides,triglyceride measurement,GCST006613,7:130757845,Cardiovascular
1985,KLF14,KLF14,Maternal,rs35363532-<b>?</b>,2 x 10-39,,NR,'-,0.0344 unit decrease,[0.03-0.039],"KLF14, AC016831.5",Triglyceride levels,triglyceride measurement,GCST010173,7:130760670,Cardiovascular
1988,KLF14,KLF14,Maternal,rs11765979-<b>A</b>,3 x 10-13,(EA),0.52,'-,0.03 unit increase,'-,"AC016831.5, KLF14",Triglycerides,triglyceride measurement,GCST007142,7:130761118,Cardiovascular
1989,KLF14,KLF14,Maternal,rs11765979-<b>A</b>,1 x 10-14,,NR,'-,0.029 unit increase,'-,"AC016831.5, KLF14",Triglycerides,triglyceride measurement,GCST007142,7:130761118,Cardiovascular
1992,KLF14,KLF14,Maternal,rs1562398-<b>C</b>,2 x 10-11,(EA),0.568,'-,0.028 unit decrease,'-,"KLF14, AC016831.5",Triglycerides,triglyceride measurement,GCST007142,7:130773172,Cardiovascular
1993,KLF14,KLF14,Maternal,rs1562398-<b>C</b>,3 x 10-13,,NR,'-,0.028 unit decrease,'-,"KLF14, AC016831.5",Triglycerides,triglyceride measurement,GCST007142,7:130773172,Cardiovascular
1997,KLF14,KLF14,Maternal,rs12154627-<b>?</b>,4 x 10-13,,NR,'-,'-,'-,"KLF14, AC016831.5",Systolic blood pressure,systolic blood pressure,GCST007087,7:130738173,Cardiovascular
1998,KLF14,KLF14,Maternal,rs6974288-<b>?</b>,3 x 10-12,,NR,'-,'-,'-,"KLF14, AC016831.5",Cardiovascular disease,cardiovascular disease,GCST007072,7:130739451,Cardiovascular
1999,KLF14,KLF14,Maternal,rs34072724-<b>A</b>,4 x 10-19,,0.487,'-,0.2181 mmHg decrease,[0.17-0.27],"KLF14, AC016831.5",Systolic blood pressure,systolic blood pressure,GCST006624,7:130747710,Cardiovascular
2000,KLF14,KLF14,Maternal,rs13234407-<b>A</b>,3 x 10-9,,0.4645,'-,0.1928 mmHg decrease,[0.13-0.26],"KLF14, AC016831.5",Systolic blood pressure,systolic blood pressure,GCST007267,7:130753455,Cardiovascular
2001,KLF14,KLF14,Maternal,rs7783857-<b>C</b>,2 x 10-6,,0.7155,'-,0.0297 unit decrease,[0.018-0.042],"AC016831.5, KLF14",Coronary artery disease,coronary artery disease,GCST005196,7:130754299,Cardiovascular
2072,KLF14,KLF14,Maternal,rs1364422-<b>C</b>,5 x 10-35,,0.719852,'-,0.0270358 unit increase,[0.023-0.031],"AC016831.5, KLF14",Apolipoprotein A1 levels,apolipoprotein A 1 measurement,GCST010241,7:130761222,Cardiovascular
2074,KLF14,KLF14,Maternal,rs185963-<b>T</b>,2 x 10-9,,0.434857,'-,0.050627008 unit increase,[0.034-0.067],"KLF14, AC016831.5",Medication use (beta blocking agents),Beta blocking agent use measurement,GCST007927,7:130765392,Cardiovascular
2296,MAGI2,MAGI2,Maternal,rs113805659-<b>?</b>,3 x 10-7,,NR,'-,0.185 unit decrease,[0.1-0.27],MAGI2,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,7:78663475,Cardiovascular
2299,MAGI2,MAGI2,Maternal,rs113527903-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,MAGI2,PR interval in Tripanosoma cruzi seropositivity,"PR interval, Trypanosoma cruzi seropositivity",GCST002279,7:78209193,Cardiovascular
2297,MAGI2,MAGI2,Maternal,rs113805659-<b>?</b>,1 x 10-7,,NR,'-,0.191 unit decrease,[0.11-0.27],MAGI2,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:78663475,Cardiovascular
2348,MEG3,MEG3,Maternal,rs11622263-<b>?</b>,4 x 10-6,(AA),NR,194.87,'-,[185.78-203.96],MEG3,Peripheral arterial disease (traffic-related air pollution interaction),"peripheral arterial disease, traffic air pollution measurement",GCST004482,14:100814324,Cardiovascular
2356,MEG3,MEG3,Maternal,rs2400940-<b>T</b>,4 x 10-8,(EA),NR,'-,2.5285 unit increase,NR,"MEG3, DLK1",Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension,"response to diuretic, diastolic blood pressure change measurement, hypertension",GCST009646,14:100758585,Cardiovascular
2398,NTM,NTM,Maternal,rs2658882-<b>?</b>,9 x 10-6,(total PUFA),NR,'-,'-,'-,"NTM-AS1, NTM",Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome,polyunsaturated fatty acid measurement,GCST010313,11:131645762,Cardiovascular
2399,NTM,NTM,Maternal,rs11827555-<b>?</b>,4 x 10-6,(AA),NR,4.84,'-,[3.74-5.94],NTM,Peripheral arterial disease (traffic-related air pollution interaction),"peripheral arterial disease, traffic air pollution measurement",GCST004482,11:131855008,Cardiovascular
2400,NTM,NTM,Maternal,rs12098973-<b>G</b>,1 x 10-6,(Dichotomous variable),NR,2.17,'-,[1.59-3.03],NTM,Cardiac Troponin-T levels,cardiac troponin T measurement,GCST001776,11:131937277,Cardiovascular
2457,NTM,NTM-AS1,Maternal,rs2658882-<b>?</b>,9 x 10-6,(total PUFA),NR,'-,'-,'-,"NTM-AS1, NTM",Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome,polyunsaturated fatty acid measurement,GCST010313,11:131645762,Cardiovascular
2625,RB1,RB1CC1,Maternal,rs7011049-<b>?</b>,7 x 10-6,"(Male, Puberty)",NR,'-,0.125 unit decrease,[0.07-0.18],"RB1CC1, NPBWR1",Systolic blood pressure,systolic blood pressure,GCST003670,8:52921452,Cardiovascular
2692,SLC22A2*,SLC22A2*,Maternal,rs147010904-<b>T</b>,9 x 10-20,,'-,'-,18.38 unit increase,[14.89-21.87],SLC22A2,Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms,"lipoprotein A measurement, apolipoprotein A 1 measurement",GCST004399,6:160204267,Cardiovascular
2693,SLC22A2*,SLC22A2*,Maternal,rs143520616-<b>T</b>,5 x 10-8,,'-,'-,2.39 mg/dL increase,[0.05-4.73],SLC22A2,Lipoprotein (a) levels,lipoprotein A measurement,GCST004398,6:160210138,Cardiovascular
2694,SLC22A2*,SLC22A2*,Maternal,rs144217738-<b>G</b>,7 x 10-8,,NR,'-,0.34 unit increase,[0.22-0.46],"SLC22A3, SLC22A2",Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention),"lipoprotein A measurement, coronary artery disease",GCST008433,6:160289794,Cardiovascular
2695,SLC22A2*,SLC22A2*,Maternal,rs3120139-<b>A</b>,4 x 10-9,,0.13,'-,0.32 mg/dL increase,[0.22-0.42],"SLC22A3, SLC22A2",Lp (a) levels,apolipoprotein A 1 measurement,GCST001218,6:160320590,Cardiovascular
2696,SLC22A2*,SLC22A2*,Maternal,rs9295128-<b>T</b>,4 x 10-11,,0.01694,'-,11.72 (nmol/min/ml) increase,[8.25-15.19],"SLC22A3, SLC22A2",Lipoprotein phospholipase A2 activity in cardiovascular disease,"lipoprotein-associated phospholipase A(2) measurement, acute coronary syndrome, coronary artery disease",GCST004963,6:160330499,Cardiovascular
2697,SLC22A2*,SLC22A2*,Maternal,rs520829-<b>G</b>,3 x 10-29,,'-,'-,3.58 mg/dL decrease,[3.03-4.13],"SLC22A2, SLC22A3",Lipoprotein (a) levels,lipoprotein A measurement,GCST004398,6:160346873,Cardiovascular
2748,SLC22A3*,SLC22A3*,Maternal,rs539958-<b>T</b>,2 x 10-12,,0.4831,'-,'-,'-,SLC22A3,Body fat percentage and triglycerides (pairwise),"triglyceride measurement, body fat percentage",GCST011342,6:160351810,Cardiovascular
2750,SLC22A3*,SLC22A3*,Maternal,rs539958-<b>T</b>,1 x 10-14,,0.4831,'-,'-,'-,SLC22A3,Body mass index and triglycerides (pairwise),"triglyceride measurement, body mass index",GCST011334,6:160351810,Cardiovascular
2752,SLC22A3*,SLC22A3*,Maternal,rs539958-<b>T</b>,7 x 10-10,,0.4831,'-,'-,'-,SLC22A3,Body mass index and systole blood pressure (pairwise),"systolic blood pressure, body mass index",GCST011331,6:160351810,Cardiovascular
2761,SLC22A3*,SLC22A3*,Maternal,rs3105749-<b>G</b>,4 x 10-8,(EA),0.519,'-,0.023 unit decrease,'-,SLC22A3,Triglycerides,triglyceride measurement,GCST007142,6:160399946,Cardiovascular
2762,SLC22A3*,SLC22A3*,Maternal,rs3105749-<b>G</b>,4 x 10-9,,NR,'-,0.022 unit decrease,'-,SLC22A3,Triglycerides,triglyceride measurement,GCST007142,6:160399946,Cardiovascular
2763,SLC22A3*,SLC22A3*,Maternal,rs376563-<b>T</b>,1 x 10-6,(EA),0.481,'-,0.02 unit decrease,'-,SLC22A3,Triglycerides,triglyceride measurement,GCST007142,6:160430734,Cardiovascular
2765,SLC22A3*,SLC22A3*,Maternal,rs144217738-<b>G</b>,7 x 10-8,,NR,'-,0.34 unit increase,[0.22-0.46],"SLC22A3, SLC22A2",Lipoprotein (a) levels in coronary artery disease (percutaneous coronary intervention),"lipoprotein A measurement, coronary artery disease",GCST008433,6:160289794,Cardiovascular
2766,SLC22A3*,SLC22A3*,Maternal,rs3120139-<b>A</b>,4 x 10-9,,0.13,'-,0.32 mg/dL increase,[0.22-0.42],"SLC22A3, SLC22A2",Lp (a) levels,apolipoprotein A 1 measurement,GCST001218,6:160320590,Cardiovascular
2767,SLC22A3*,SLC22A3*,Maternal,rs9295128-<b>T</b>,4 x 10-11,,0.01694,'-,11.72 (nmol/min/ml) increase,[8.25-15.19],"SLC22A3, SLC22A2",Lipoprotein phospholipase A2 activity in cardiovascular disease,"lipoprotein-associated phospholipase A(2) measurement, acute coronary syndrome, coronary artery disease",GCST004963,6:160330499,Cardiovascular
2768,SLC22A3*,SLC22A3*,Maternal,rs520829-<b>G</b>,3 x 10-29,,'-,'-,3.58 mg/dL decrease,[3.03-4.13],"SLC22A2, SLC22A3",Lipoprotein (a) levels,lipoprotein A measurement,GCST004398,6:160346873,Cardiovascular
2769,SLC22A3*,SLC22A3*,Maternal,rs555754-<b>G</b>,1 x 10-11,,0.5252,'-,0.1392 unit increase,[0.099-0.179],SLC22A3,Pulse pressure,pulse pressure measurement,GCST006626,6:160348391,Cardiovascular
2770,SLC22A3*,SLC22A3*,Maternal,rs1018234-<b>T</b>,6 x 10-16,,'-,'-,2.49 mg/dL decrease,[1.76-3.22],"SLC22A3, AL591069.1",Lipoprotein (a) levels,lipoprotein A measurement,GCST004398,6:160375026,Cardiovascular
2771,SLC22A3*,SLC22A3*,Maternal,rs12204009-<b>C</b>,3 x 10-51,,'-,'-,32.86 mg/dL increase,[28.31-37.41],"AL591069.1, SLC22A3",Lipoprotein (a) levels,lipoprotein A measurement,GCST004398,6:160378214,Cardiovascular
2772,SLC22A3*,SLC22A3*,Maternal,rs149302195-<b>T</b>,2 x 10-17,,'-,'-,10.14 unit decrease,[7.57-12.71],"AL591069.1, SLC22A3",Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms,"lipoprotein A measurement, apolipoprotein A 1 measurement",GCST004399,6:160382662,Cardiovascular
2773,SLC22A3*,SLC22A3*,Maternal,rs78439586-<b>A</b>,3 x 10-29,,'-,'-,5.91 unit decrease,[4.83-6.99],SLC22A3,Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms,"lipoprotein A measurement, apolipoprotein A 1 measurement",GCST004399,6:160399890,Cardiovascular
2774,SLC22A3*,SLC22A3*,Maternal,rs78439586-<b>A</b>,1 x 10-47,,'-,'-,6.68 mg/dL decrease,[5.38-7.98],SLC22A3,Lipoprotein (a) levels,lipoprotein A measurement,GCST004398,6:160399890,Cardiovascular
2775,SLC22A3*,SLC22A3*,Maternal,rs141463285-<b>A</b>,6 x 10-18,,'-,'-,24.12 mg/dL increase,[18.98-29.26],SLC22A3,Lipoprotein (a) levels,lipoprotein A measurement,GCST004398,6:160417614,Cardiovascular
2776,SLC22A3*,SLC22A3*,Maternal,rs141463285-<b>A</b>,3 x 10-15,,'-,'-,17.96 unit increase,[13.74-22.18],SLC22A3,Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms,"lipoprotein A measurement, apolipoprotein A 1 measurement",GCST004399,6:160417614,Cardiovascular
2777,SLC22A3*,SLC22A3*,Maternal,rs2048327-<b>C</b>,1 x 10-6,,NR,1.07,'-,[1.05-1.10],SLC22A3,Coronary artery disease,coronary artery disease,GCST002289,6:160442500,Cardiovascular
2778,SLC22A3*,SLC22A3*,Maternal,rs7769879-<b>C</b>,4 x 10-168,,'-,'-,6.74 unit increase,[6.27-7.21],SLC22A3,Lipoprotein(a) levels adjusted for apolipoprotein(a) isoforms,"lipoprotein A measurement, apolipoprotein A 1 measurement",GCST004399,6:160444613,Cardiovascular
2779,SLC22A3*,SLC22A3*,Maternal,rs143665477-<b>C</b>,3 x 10-41,,'-,'-,39.71 mg/dL increase,[34.59-44.83],SLC22A3,Lipoprotein (a) levels,lipoprotein A measurement,GCST004398,6:160446240,Cardiovascular
2780,SLC22A3*,SLC22A3*,Maternal,rs2457574-<b>A</b>,3 x 10-63,,'-,'-,4.75 mg/dL decrease,[4.21-5.29],SLC22A3,Lipoprotein (a) levels,lipoprotein A measurement,GCST004398,6:160447669,Cardiovascular
2781,SLC22A3*,SLC22A3*,Maternal,"rs7767084-<b>T</b>, rs10755578-<b>C</b>, rs3127599-<b>C</b>, rs2048327-<b>C</b>",4 x 10-15,,0.02,1.82,'-,[1.57-2.12],LPA; LPA; LPAL2; SLC22A3,Coronary heart disease,coronary artery disease,GCST000341,6:160541471|6:160548706|6:160486102|6:160442500,Cardiovascular
2782,SLC22A3*,SLC22A3*,Maternal,"rs7767084-<b>T</b>, rs10755578-<b>G</b>, rs3127599-<b>T</b>, rs2048327-<b>C</b>",1 x 10-9,,0.16,1.2,'-,[1.13-1.28],LPA; LPA; LPAL2; SLC22A3,Coronary heart disease,coronary artery disease,GCST000341,6:160541471|6:160548706|6:160486102|6:160442500,Cardiovascular
2753,SLC22A3*,SLC22A3*,Maternal,rs539958-<b>T</b>,3 x 10-10,,0.4831,'-,'-,'-,SLC22A3,Body mass index and coronary artery disease (pairwise),"body mass index, coronary artery disease",GCST011330,6:160351810,Cardiovascular
2835,SMOC1,SMOC1,Maternal,rs227426-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,SMOC1,Systolic blood pressure,systolic blood pressure,GCST007087,14:69989947,Cardiovascular
2836,SMOC1,SMOC1,Maternal,rs55784307-<b>A</b>,3 x 10-8,,0.1817,1.06,'-,[1.04-1.09],"SMOC1, SLC8A3",Peripheral artery disease,peripheral arterial disease,GCST008474,14:70034647,Cardiovascular
2825,SMOC1,SMOC1,Maternal,rs7156508-<b>T</b>,1 x 10-9,,NR,'-,6.079 z-score increase,'-,SMOC1,Triglyceride levels,triglyceride measurement,GCST006436,14:69860617,Cardiovascular
2002,KLF14,KLF14,Maternal,rs12154627-<b>T</b>,3 x 10-24,,0.5636,'-,'-,'-,"KLF14, AC016831.5",HDL cholesterol x physical activity interaction (2df test),"HDL cholesterol change measurement, physical activity",GCST007282,7:130738173,Cholesterol
2003,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,2 x 10-14,,NR,'-,0.008052 unit increase,NR,"AC016831.5, KLF14",HDL cholesterol levels,high density lipoprotein cholesterol measurement,GCST008070,7:130739885,Cholesterol
2004,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,2 x 10-22,(EA),NR,'-,0.011 unit increase,NR,"AC016831.5, KLF14",HDL cholesterol levels in current drinkers,"alcohol drinking, high density lipoprotein cholesterol measurement",GCST008085,7:130739885,Cholesterol
2005,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,7 x 10-13,(EA),NR,'-,0.01134 unit increase,NR,"AC016831.5, KLF14",HDL cholesterol levels,high density lipoprotein cholesterol measurement,GCST008070,7:130739885,Cholesterol
2006,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,2 x 10-22,,NR,'-,0.008 unit increase,NR,"AC016831.5, KLF14",HDL cholesterol levels in current drinkers,"alcohol drinking, high density lipoprotein cholesterol measurement",GCST008085,7:130739885,Cholesterol
2007,KLF14,KLF14,Maternal,rs13234269-<b>?</b>,1 x 10-8,,'-,'-,0.0266 unit decrease,[0.017-0.036],"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST011348,7:130744427,Cholesterol
2008,KLF14,KLF14,Maternal,rs4731701-<b>C</b>,1 x 10-54,,0.506998,'-,0.029758 unit decrease,[0.026-0.034],"AC016831.5, KLF14",HDL cholesterol levels,high density lipoprotein cholesterol measurement,GCST010242,7:130746171,Cholesterol
2009,KLF14,KLF14,Maternal,rs6971365-<b>T</b>,2 x 10-18,,0.7147,'-,0.0262 mg dl-1 increase,[0.02-0.032],"AC016831.5, KLF14",HDL cholesterol,high density lipoprotein cholesterol measurement,GCST006611,7:130747722,Cholesterol
2010,KLF14,KLF14,Maternal,rs13241165-<b>T</b>,8 x 10-10,,0.51,'-,0.037 s.d. increase,[0.025-0.049],"AC016831.5, KLF14",HDL cholesterol,high density lipoprotein cholesterol measurement,GCST002899,7:130747779,Cholesterol
2011,KLF14,KLF14,Maternal,rs13241165-<b>?</b>,6 x 10-9,,NR,'-,0.6779438 unit increase,[0.45-0.91],"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST008035,7:130747779,Cholesterol
2012,KLF14,KLF14,Maternal,rs13241165-<b>A</b>,6 x 10-17,(EA),0.518,'-,0.031 unit decrease,'-,"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130747779,Cholesterol
2013,KLF14,KLF14,Maternal,rs13241165-<b>A</b>,2 x 10-6,(Hispanic),0.572,'-,0.059 unit decrease,'-,"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130747779,Cholesterol
2014,KLF14,KLF14,Maternal,rs13241165-<b>A</b>,2 x 10-21,,NR,'-,0.033 unit decrease,'-,"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130747779,Cholesterol
2015,KLF14,KLF14,Maternal,rs4731702-<b>T</b>,1 x 10-14,,0.4367,'-,0.0085 unit increase,[0.0063-0.0107],"AC016831.5, KLF14",HDL cholesterol levels,high density lipoprotein cholesterol measurement,GCST008685,7:130748625,Cholesterol
2016,KLF14,KLF14,Maternal,rs4731702-<b>T</b>,1 x 10-17,(Trans-ethnic initial),0.46,'-,0.0294 unit increase,[0.023-0.036],"AC016831.5, KLF14",HDL cholesterol levels,high density lipoprotein cholesterol measurement,GCST004232,7:130748625,Cholesterol
2017,KLF14,KLF14,Maternal,rs4731702-<b>?</b>,7 x 10-9,,NR,'-,0.6755981 unit increase,[0.45-0.9],"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST008035,7:130748625,Cholesterol
2018,KLF14,KLF14,Maternal,rs4731702-<b>T</b>,1 x 10-15,,0.48,'-,0.59 mg/dL increase,[0.45-0.73],"AC016831.5, KLF14",HDL cholesterol,high density lipoprotein cholesterol measurement,GCST000755,7:130748625,Cholesterol
2019,KLF14,KLF14,Maternal,rs4731702-<b>T</b>,5 x 10-17,,0.49,'-,0.029 unit increase,[NR],"AC016831.5, KLF14",HDL cholesterol,high density lipoprotein cholesterol measurement,GCST002223,7:130748625,Cholesterol
2020,KLF14,KLF14,Maternal,rs4731702-<b>C</b>,5 x 10-17,(EA),0.518,'-,0.031 unit decrease,'-,"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130748625,Cholesterol
2021,KLF14,KLF14,Maternal,rs4731702-<b>C</b>,2 x 10-6,(Hispanic),0.573,'-,0.059 unit decrease,'-,"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130748625,Cholesterol
2022,KLF14,KLF14,Maternal,rs4731702-<b>C</b>,2 x 10-21,,NR,'-,0.033 unit decrease,'-,"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130748625,Cholesterol
2023,KLF14,KLF14,Maternal,rs13230111-<b>G</b>,4 x 10-8,,0.48,'-,0.67 unit increase,[0.43-0.91],"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST90010361,7:130752365,Cholesterol
2024,KLF14,KLF14,Maternal,rs3996352-<b>A</b>,2 x 10-15,,0.5568,'-,0.0084 unit decrease,[0.0062-0.0106],"AC016831.5, KLF14",HDL cholesterol levels,high density lipoprotein cholesterol measurement,GCST008685,7:130760175,Cholesterol
2025,KLF14,KLF14,Maternal,rs35363532-<b>C</b>,3 x 10-22,,0.508297,'-,0.0186209 unit increase,[0.015-0.022],"KLF14, AC016831.5",Low density lipoprotein cholesterol levels,low density lipoprotein cholesterol measurement,GCST90002412,7:130760670,Cholesterol
2026,KLF14,KLF14,Maternal,rs11765979-<b>A</b>,5 x 10-17,(EA),0.52,'-,0.032 unit decrease,'-,"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130761118,Cholesterol
2027,KLF14,KLF14,Maternal,rs11765979-<b>A</b>,1 x 10-6,(Hispanic),0.572,'-,0.061 unit decrease,'-,"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130761118,Cholesterol
2028,KLF14,KLF14,Maternal,rs11765979-<b>A</b>,1 x 10-21,,NR,'-,0.033 unit decrease,'-,"AC016831.5, KLF14",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130761118,Cholesterol
2029,KLF14,KLF14,Maternal,rs1562398-<b>C</b>,2 x 10-14,(EA),0.568,'-,0.029 unit increase,'-,"KLF14, AC016831.5",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130773172,Cholesterol
2030,KLF14,KLF14,Maternal,rs1562398-<b>C</b>,6 x 10-6,(Hispanic),0.49,'-,0.056 unit increase,'-,"KLF14, AC016831.5",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130773172,Cholesterol
2031,KLF14,KLF14,Maternal,rs1562398-<b>C</b>,4 x 10-20,,NR,'-,0.032 unit increase,'-,"KLF14, AC016831.5",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,7:130773172,Cholesterol
2032,KLF14,KLF14,Maternal,rs11762784-<b>?</b>,1 x 10-16,,NR,'-,0.007549 unit increase,[0.0056-0.0095],"AC016831.5, KLF14",HDL cholesterol levels x long total sleep time interaction (2df test),"sleep duration, high density lipoprotein cholesterol measurement",GCST009368,7:130739885,Cholesterol
2033,KLF14,KLF14,Maternal,rs13234407-<b>?</b>,3 x 10-17,,NR,'-,0.007863 unit increase,[0.006-0.0097],"KLF14, AC016831.5",HDL cholesterol levels x short total sleep time interaction (2df test),"sleep duration, high density lipoprotein cholesterol measurement",GCST009367,7:130753455,Cholesterol
2076,KLF14,KLF14,Maternal,rs972283-<b>A</b>,1 x 10-10,,0.488765,'-,0.03592304 unit decrease,[0.025-0.047],"AC016831.5, KLF14",Medication use (HMG CoA reductase inhibitors),HMG CoA reductase inhibitor use measurement,GCST007931,7:130782095,Cholesterol
2078,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,3 x 10-30,(EA),NR,'-,'-,'-,"AC016831.5, KLF14",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:130739885,Cholesterol
2079,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,6 x 10-32,,NR,'-,'-,'-,"AC016831.5, KLF14",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:130739885,Cholesterol
2080,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,6 x 10-37,,NR,'-,'-,'-,"AC016831.5, KLF14",HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"alcohol drinking, high density lipoprotein cholesterol measurement",GCST008084,7:130739885,Cholesterol
2081,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,1 x 10-31,(EA),NR,'-,'-,'-,"AC016831.5, KLF14",HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"alcohol drinking, high density lipoprotein cholesterol measurement",GCST008084,7:130739885,Cholesterol
2288,MAGI2,MAGI2,Maternal,rs6466171-<b>?</b>,3 x 10-11,(EA),NR,'-,0.8267 unit increase,[0.4-1.26],MAGI2,LDL cholesterol levels x short total sleep time interaction (2df test),"sleep duration, low density lipoprotein cholesterol measurement",GCST009365,7:78364977,Cholesterol
2289,MAGI2,MAGI2,Maternal,rs6466171-<b>?</b>,2 x 10-6,(EA),NR,'-,2.674 unit increase,[1.58-3.77],MAGI2,LDL cholesterol levels x short total sleep time interaction (1df test),"sleep duration, low density lipoprotein cholesterol measurement",GCST009359,7:78364977,Cholesterol
2290,MAGI2,MAGI2,Maternal,rs10244093-<b>?</b>,3 x 10-9,,NR,'-,0.6898 unit decrease,[0.32-1.06],MAGI2,LDL cholesterol levels x short total sleep time interaction (2df test),"sleep duration, low density lipoprotein cholesterol measurement",GCST009365,7:78371701,Cholesterol
2535,PHLDA2,PHLDA2,Maternal,rs7935422-<b>T</b>,2 x 10-8,(EA),0.599,'-,0.022 unit increase,'-,"PHLDA2, NAP1L4",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,11:2937308,Cholesterol
2536,PHLDA2,PHLDA2,Maternal,rs7935422-<b>T</b>,2 x 10-8,,NR,'-,0.02 unit increase,'-,"PHLDA2, NAP1L4",High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST007140,11:2937308,Cholesterol
2677,SLC22A18,SLC22A18,Maternal,rs16928809-<b>A</b>,6 x 10-14,,NR,'-,0.026047025 unit decrease,[0.019-0.033],SLC22A18,High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST009151,11:2915722,Cholesterol
2678,SLC22A18,SLC22A18,Maternal,rs16928809-<b>A</b>,4 x 10-8,,0.09,'-,0.029 unit decrease,'-,SLC22A18,High density lipoprotein cholesterol levels,high density lipoprotein cholesterol measurement,GCST009148,11:2915722,Cholesterol
2679,SLC22A18,SLC22A18,Maternal,rs16928809-<b>G</b>,1 x 10-15,,0.90691,'-,0.0263539 unit increase,[0.02-0.033],SLC22A18,HDL cholesterol levels,high density lipoprotein cholesterol measurement,GCST010242,11:2915722,Cholesterol
2783,SLC22A3*,SLC22A3*,Maternal,rs3105749-<b>G</b>,3 x 10-6,(EA),0.519,'-,0.022 unit decrease,'-,SLC22A3,Low density lipoprotein cholesterol levels,low density lipoprotein cholesterol measurement,GCST007141,6:160399946,Cholesterol
2784,SLC22A3*,SLC22A3*,Maternal,rs3105749-<b>G</b>,3 x 10-6,(EA),0.519,'-,0.022 unit decrease,'-,SLC22A3,Total cholesterol levels,total cholesterol measurement,GCST007143,6:160399946,Cholesterol
37,ATP10A,ATP10A,Maternal,rs883496-<b>?</b>,6 x 10-9,,0.47,'-,23.44 unit decrease,'-,ATP10A,HOMA-B (corrected for HOMA-IR),HOMA-B,GCST010724,15:25685156,Diabetes
38,ATP10A,ATP10A,Maternal,rs10152552-<b>?</b>,6 x 10-9,,0.47,'-,23.44 unit increase,'-,ATP10A,HOMA-B (corrected for HOMA-IR),HOMA-B,GCST010724,15:25686118,Diabetes
49,ATP5F1EP2,ATP5F1EP2,Maternal,rs4581570-<b>?</b>,9 x 10-10,,NR,'-,0.03311 unit increase,[0.023-0.044],"ATP5F1EP2, PDX1",Blood sugar levels,glucose measurement,GCST006002,13:27936575,Diabetes
862,H19,H19,Maternal,rs11042596-<b>G</b>,2 x 10-8,,0.6649,1.04,'-,[1.03-1.05],"H19, IGF2",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2097630,Diabetes
865,H19,H19,Maternal,rs78896587-<b>T</b>,1 x 10-9,,'-,'-,0.20937194 unit decrease,[0.14-0.28],"H19, IGF2",Type 1 diabetes,type I diabetes mellitus,GCST90000529,11:2055620,Diabetes
1798,KCNQ1,KCNQ1,Maternal,rs2283159-<b>T</b>,1 x 10-11,,NR,0.8314428,'-,[0.788276051248055-0.876973378828353],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2548673,Diabetes
1799,KCNQ1,KCNQ1,Maternal,rs2283164-<b>A</b>,1 x 10-7,,0.9468,1.08,'-,[1.05-1.12],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2557933,Diabetes
1800,KCNQ1,KCNQ1,Maternal,rs80102379-<b>G</b>,9 x 10-8,,0.9822,1.15,'-,[1.09-1.21],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2612947,Diabetes
1801,KCNQ1,KCNQ1,Maternal,rs2106463-<b>A</b>,3 x 10-24,,NR,0.8716614,'-,[0.848891758178977-0.895041827744204],"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2618062,Diabetes
1802,KCNQ1,KCNQ1,Maternal,rs77402029-<b>G</b>,3 x 10-24,,0.9,1.17,'-,1.13-1.20,"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2619190,Diabetes
1803,KCNQ1,KCNQ1,Maternal,rs117601636-<b>A</b>,1 x 10-7,(Japanese),NR,1.15959,'-,[1.09783-1.22483],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST003400,11:2620807,Diabetes
1804,KCNQ1,KCNQ1,Maternal,rs231349-<b>T</b>,2 x 10-11,,0.1024,1.07,'-,[1.05-1.10],"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2651591,Diabetes
1805,KCNQ1,KCNQ1,Maternal,rs231362-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST007077,11:2670241,Diabetes
1806,KCNQ1,KCNQ1,Maternal,rs231362-<b>G</b>,3 x 10-13,,'-,1.08,'-,[1.06-1.10],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST000712,11:2670241,Diabetes
1807,KCNQ1,KCNQ1,Maternal,rs231362-<b>G</b>,2 x 10-11,,0.498,'-,0.064 unit increase,[0.044-0.084],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2670241,Diabetes
1808,KCNQ1,KCNQ1,Maternal,rs231362-<b>G</b>,4 x 10-9,(EA),0.498,'-,0.0679 unit increase,[0.045-0.09],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2670241,Diabetes
1809,KCNQ1,KCNQ1,Maternal,rs231361-<b>A</b>,1 x 10-9,,0.285885252,1.09,'-,[1.06-1.12],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST005047,11:2670270,Diabetes
1810,KCNQ1,KCNQ1,Maternal,rs231361-<b>G</b>,2 x 10-9,,0.656,'-,0.08 unit decrease,[0.055-0.105],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST010556,11:2670270,Diabetes
1811,KCNQ1,KCNQ1,Maternal,rs231361-<b>A</b>,5 x 10-25,,0.2564,1.08,'-,[1.07-1.10],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2670270,Diabetes
1812,KCNQ1,KCNQ1,Maternal,rs231356-<b>T</b>,4 x 10-8,,0.27,1.09,'-,[1.06-1.13],"KCNQ1, KCNQ1OT1",Type 2 diabetes,type II diabetes mellitus,GCST002560,11:2684113,Diabetes
1813,KCNQ1,KCNQ1,Maternal,rs463924-<b>T</b>,4 x 10-15,,NR,1.0952718,'-,[1.07072996268252-1.12037619350107],"KCNQ1OT1, KCNQ1",Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2696450,Diabetes
1814,KCNQ1,KCNQ1,Maternal,rs2411884-<b>?</b>,2 x 10-9,,NR,'-,0.03869 unit decrease,[0.026-0.051],KCNQ1,Blood sugar levels,glucose measurement,GCST006002,11:2714304,Diabetes
1815,KCNQ1,KCNQ1,Maternal,rs2283220-<b>A</b>,1 x 10-9,,0.6896,1.05,'-,[1.03-1.06],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2734318,Diabetes
1816,KCNQ1,KCNQ1,Maternal,rs8181588-<b>A</b>,5 x 10-9,,0.48,1.3,'-,[NR],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002224,11:2810311,Diabetes
1817,KCNQ1,KCNQ1,Maternal,rs163177-<b>C</b>,1 x 10-6,,0.43,1.21,'-,'-,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004305,11:2817183,Diabetes
1818,KCNQ1,KCNQ1,Maternal,rs2237892-<b>C</b>,1 x 10-7,,0.657,1.32,'-,[1.19-1.46],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST001666,11:2818521,Diabetes
1819,KCNQ1,KCNQ1,Maternal,rs2237892-<b>T</b>,1 x 10-9,(EA),0.0626,'-,0.1389 unit decrease,[0.094-0.183],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2818521,Diabetes
1820,KCNQ1,KCNQ1,Maternal,rs2237892-<b>T</b>,9 x 10-10,,0.062489595,'-,0.096 unit decrease,[0.065-0.127],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST006867,11:2818521,Diabetes
1821,KCNQ1,KCNQ1,Maternal,rs2237892-<b>C</b>,1 x 10-26,,0.59,1.33,'-,[1.27-1.41],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST000383,11:2818521,Diabetes
1822,KCNQ1,KCNQ1,Maternal,rs2237892-<b>C</b>,2 x 10-42,,0.61,1.45,'-,[1.34-1.47],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST000219,11:2818521,Diabetes
1823,KCNQ1,KCNQ1,Maternal,rs2237892-<b>C</b>,4 x 10-6,,NR,1.2,'-,[1.11-1.29],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST001070,11:2818521,Diabetes
1824,KCNQ1,KCNQ1,Maternal,rs2237892-<b>C</b>,4 x 10-29,,0.61,1.3,'-,[1.24-1.36],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002128,11:2818521,Diabetes
1825,KCNQ1,KCNQ1,Maternal,rs2237892-<b>T</b>,2 x 10-63,,0.0626,'-,0.215 unit decrease,[0.19-0.24],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2818521,Diabetes
1826,KCNQ1,KCNQ1,Maternal,rs2237892-<b>?</b>,5 x 10-7,,0.62,1.2048193,'-,[1.12-1.3],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010436,11:2818521,Diabetes
1827,KCNQ1,KCNQ1,Maternal,rs233449-<b>G</b>,5 x 10-12,(Conditioned),0.82,'-,'-,'-,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2822573,Diabetes
1828,KCNQ1,KCNQ1,Maternal,rs233450-<b>G</b>,3 x 10-13,(conditional),NR,0.92083675,'-,[0.900697932960294-0.941425809104531],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2822818,Diabetes
1829,KCNQ1,KCNQ1,Maternal,rs163182-<b>C</b>,2 x 10-17,,0.34,1.28,'-,[NR],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST001173,11:2822986,Diabetes
1830,KCNQ1,KCNQ1,Maternal,rs163184-<b>G</b>,2 x 10-14,,0.5,1.09,'-,[1.04-1.13],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002352,11:2825839,Diabetes
1831,KCNQ1,KCNQ1,Maternal,rs163184-<b>G</b>,1 x 10-7,,0.41,1.24,'-,[1.14-1.34],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:2825839,Diabetes
1832,KCNQ1,KCNQ1,Maternal,rs163184-<b>G</b>,9 x 10-15,(men),NR,1.12,'-,[1.09-1.16],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST005047,11:2825839,Diabetes
1833,KCNQ1,KCNQ1,Maternal,rs163184-<b>G</b>,1 x 10-11,,0.498159619,1.09,'-,[1.06-1.11],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST005047,11:2825839,Diabetes
1834,KCNQ1,KCNQ1,Maternal,rs163184-<b>G</b>,5 x 10-14,(EA),0.493,'-,0.079 unit increase,[0.058-0.1],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004894,11:2825839,Diabetes
1835,KCNQ1,KCNQ1,Maternal,rs163184-<b>G</b>,3 x 10-6,(additive model),NR,1.114,'-,[1.07-1.16],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST006801,11:2825839,Diabetes
1836,KCNQ1,KCNQ1,Maternal,rs2283228-<b>A</b>,8 x 10-13,,0.79,1.5,'-,[1.35-1.66],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:2828300,Diabetes
1837,KCNQ1,KCNQ1,Maternal,rs2283228-<b>A</b>,1 x 10-10,(AA),0.89,1.2,'-,[1.14-1.27],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002560,11:2828300,Diabetes
1838,KCNQ1,KCNQ1,Maternal,rs2283228-<b>A</b>,5 x 10-13,,0.89,1.19,'-,[1.13-1.24],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002560,11:2828300,Diabetes
1839,KCNQ1,KCNQ1,Maternal,rs234853-<b>G</b>,7 x 10-16,,0.2482,1.08,'-,[1.06-1.10],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2829598,Diabetes
1840,KCNQ1,KCNQ1,Maternal,rs2237895-<b>C</b>,3 x 10-54,,0.4231,'-,0.0725 unit increase,[0.063-0.082],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010555,11:2835964,Diabetes
1841,KCNQ1,KCNQ1,Maternal,rs2237895-<b>?</b>,3 x 10-23,,NR,'-,'-,'-,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST007077,11:2835964,Diabetes
1842,KCNQ1,KCNQ1,Maternal,rs2237895-<b>C</b>,6 x 10-52,,0.426,1.12,'-,[1.11-1.14],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2835964,Diabetes
1843,KCNQ1,KCNQ1,Maternal,rs2237895-<b>C</b>,1 x 10-9,,0.33,1.29,'-,[1.19-1.40],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST000601,11:2835964,Diabetes
1844,KCNQ1,KCNQ1,Maternal,rs2237895-<b>C</b>,4 x 10-9,,0.31,1.25,'-,[1.16=1.34],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010436,11:2835964,Diabetes
1845,KCNQ1,KCNQ1,Maternal,rs60808706-<b>?</b>,5 x 10-27,,NR,'-,0.05117 unit decrease,[0.042-0.06],KCNQ1,Blood sugar levels,glucose measurement,GCST006002,11:2836003,Diabetes
1846,KCNQ1,KCNQ1,Maternal,rs76868685-<b>C</b>,3 x 10-7,(Conditioned),0.995,'-,'-,'-,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2836784,Diabetes
1847,KCNQ1,KCNQ1,Maternal,rs2237896-<b>G</b>,3 x 10-70,(Japanese),NR,1.32546,'-,[1.28479-1.36741],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST003400,11:2837210,Diabetes
1848,KCNQ1,KCNQ1,Maternal,rs2237896-<b>G</b>,1 x 10-32,,0.26,1.3623978,'-,NR,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST008833,11:2837210,Diabetes
1849,KCNQ1,KCNQ1,Maternal,"rs2237896-<b>A</b>, rs163184-<b>T</b>, rs1049549-<b>T</b>, rs3888647-<b>G</b>",1 x 10-14,,NR,0.61,'-,'-,KCNQ1; KCNQ1; CD81; PHLDA2 - NAP1L4,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:2837210|11:2825839|11:2397200|11:2932452,Diabetes
1850,KCNQ1,KCNQ1,Maternal,"rs2237896-<b>A</b>, rs163184-<b>T</b>, rs1049549-<b>T</b>, rs3888647-<b>A</b>",7 x 10-11,,NR,0.38,'-,'-,KCNQ1; KCNQ1; CD81; PHLDA2 - NAP1L4,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:2837210|11:2825839|11:2397200|11:2932452,Diabetes
1851,KCNQ1,KCNQ1,Maternal,rs2237897-<b>C</b>,9 x 10-15,,NR,1.31,'-,[1.22-1.41],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST002317,11:2837316,Diabetes
1852,KCNQ1,KCNQ1,Maternal,rs2237897-<b>T</b>,3 x 10-168,,0.388979615,0.7859327,'-,[0.772628119-0.799466407],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST90013693,11:2837316,Diabetes
1853,KCNQ1,KCNQ1,Maternal,rs2237897-<b>C</b>,2 x 10-245,,0.632,1.28,'-,[1.26-1.30],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010118,11:2837316,Diabetes
1854,KCNQ1,KCNQ1,Maternal,rs2237897-<b>T</b>,8 x 10-11,,0.198644,'-,0.192775 unit decrease,[0.13-0.25],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010554,11:2837316,Diabetes
1855,KCNQ1,KCNQ1,Maternal,rs2237897-<b>C</b>,8 x 10-171,,0.6218,'-,0.26 unit increase,[0.24-0.28],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010553,11:2837316,Diabetes
1856,KCNQ1,KCNQ1,Maternal,rs2237897-<b>C</b>,2 x 10-9,,0.908,'-,0.143 unit increase,[0.096-0.19],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010556,11:2837316,Diabetes
1857,KCNQ1,KCNQ1,Maternal,rs2237897-<b>C</b>,8 x 10-32,,0.9543,1.23,'-,[1.19-1.27],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST009379,11:2837316,Diabetes
1858,KCNQ1,KCNQ1,Maternal,rs2237897-<b>C</b>,1 x 10-16,,0.34,1.33,'-,[1.24-1.41],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST000221,11:2837316,Diabetes
1859,KCNQ1,KCNQ1,Maternal,rs2237897-<b>?</b>,7 x 10-6,(DI),'-,'-,1.75 unit increase,[0.75-2.75],KCNQ1,Glucose homeostasis traits,"disposition index measurement, glucose homeostasis measurement",GCST002726,11:2837316,Diabetes
1860,KCNQ1,KCNQ1,Maternal,rs2237897-<b>C</b>,2 x 10-226,,0.7624,'-,0.2199 unit increase,[0.21-0.23],KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST010557,11:2837316,Diabetes
1861,KCNQ1,KCNQ1,Maternal,rs2237897-<b>C</b>,3 x 10-168,,0.62,1.3,'-,1.27-1.32,KCNQ1,Type 2 diabetes,type II diabetes mellitus,GCST007847,11:2837316,Diabetes
1905,KCNQ1,KCNQ1,Maternal,rs4930011-<b>G</b>,4 x 10-13,,0.389262,'-,0.08729263 unit increase,[0.064-0.111],KCNQ1,Medication use (drugs used in diabetes),Drugs used in diabetes use measurement,GCST007923,11:2835428,Diabetes
2035,KLF14,KLF14,Maternal,rs3996350-<b>G</b>,1 x 10-18,,0.5585,'-,0.0347 unit increase,[0.027-0.042],"KLF14, AC016831.5",Type 2 diabetes,type II diabetes mellitus,GCST010557,7:130742296,Diabetes
2036,KLF14,KLF14,Maternal,rs13234269-<b>A</b>,7 x 10-14,,0.492515171,'-,0.0583 unit decrease,[0.043-0.074],"AC016831.5, KLF14",Type 2 diabetes,type II diabetes mellitus,GCST006867,7:130744427,Diabetes
2037,KLF14,KLF14,Maternal,rs10260148-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,"KLF14, AC016831.5",Type 2 diabetes,type II diabetes mellitus,GCST007077,7:130746210,Diabetes
2038,KLF14,KLF14,Maternal,rs4731702-<b>T</b>,5 x 10-9,,0.4493,'-,'-,'-,"AC016831.5, KLF14",Body fat percentage and type 2 diabetes (pairwise),"body fat percentage, type II diabetes mellitus",GCST011337,7:130748625,Diabetes
2039,KLF14,KLF14,Maternal,rs6467314-<b>G</b>,2 x 10-6,(female),NR,1.09,'-,[1.05-1.13],"KLF14, AC016831.5",Type 2 diabetes,type II diabetes mellitus,GCST005047,7:130757382,Diabetes
2040,KLF14,KLF14,Maternal,rs3996352-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"AC016831.5, KLF14",Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,7:130760175,Diabetes
2041,KLF14,KLF14,Maternal,rs1562396-<b>G</b>,1 x 10-17,,0.3186,1.06,'-,[1.05-1.08],"KLF14, AC016831.5",Type 2 diabetes,type II diabetes mellitus,GCST009379,7:130773155,Diabetes
2042,KLF14,KLF14,Maternal,rs1562398-<b>G</b>,2 x 10-18,,0.4169,'-,0.041 unit increase,[0.032-0.05],"KLF14, AC016831.5",Type 2 diabetes,type II diabetes mellitus,GCST010555,7:130773172,Diabetes
2043,KLF14,KLF14,Maternal,rs972283-<b>G</b>,2 x 10-10,,'-,1.07,'-,[1.05-1.10],"AC016831.5, KLF14",Type 2 diabetes,type II diabetes mellitus,GCST000712,7:130782095,Diabetes
2295,MAGI2,MAGI2,Maternal,rs3779272-<b>T</b>,1 x 10-8,,0.5782,'-,0.0213 unit increase,[0.014-0.029],MAGI2,Type 2 diabetes,type II diabetes mellitus,GCST010557,7:78199674,Diabetes
2296,MAGI2,MAGI2,Maternal,rs113805659-<b>?</b>,3 x 10-7,,NR,'-,0.185 unit decrease,[0.1-0.27],MAGI2,Coronary artery calcified atherosclerotic plaque (130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005173,7:78663475,Diabetes
2297,MAGI2,MAGI2,Maternal,rs113805659-<b>?</b>,1 x 10-7,,NR,'-,0.191 unit decrease,[0.11-0.27],MAGI2,Coronary artery calcified atherosclerotic plaque (90 or 130 HU threshold) in type 2 diabetes,"coronary artery calcification, type II diabetes mellitus",GCST005175,7:78663475,Diabetes
2349,MEG3,MEG3,Maternal,rs73347525-<b>G</b>,7 x 10-9,,0.1897,'-,0.0485 unit decrease,[0.032-0.065],MEG3,Type 2 diabetes,type II diabetes mellitus,GCST010555,14:100788835,Diabetes
2350,MEG3,MEG3,Maternal,rs73347525-<b>A</b>,7 x 10-11,,0.756,1.06,'-,[1.04-1.08],MEG3,Type 2 diabetes,type II diabetes mellitus,GCST010118,14:100788835,Diabetes
2351,MEG3,MEG3,Maternal,rs112324411-<b>C</b>,1 x 10-12,,0.9377,'-,0.0729 unit increase,[0.053-0.093],MEG3,Type 2 diabetes,type II diabetes mellitus,GCST010557,14:100792247,Diabetes
2352,MEG3,MEG3,Maternal,rs941576-<b>A</b>,1 x 10-10,,0.57,1.11,'-,[1.06-1.16],"AL117190.2, AL117190.1, MEG3",Type 1 diabetes,type I diabetes mellitus,GCST000539,14:100839708,Diabetes
2353,MEG3,MEG3,Maternal,rs56994090-<b>T</b>,1 x 10-11,,0.59,1.1363636,'-,'-,"AL117190.2, MEG3, AL117190.1",Type 1 diabetes,type I diabetes mellitus,GCST005536,14:100840110,Diabetes
2409,NTM,NTM,Maternal,rs111530275-<b>G</b>,6 x 10-6,,0.96,'-,1.86 g/day increase,[1.06-2.66],NTM,Intake of total sugars,sugar consumption measurement,GCST008759,11:132126544,Diabetes
2537,PHLDA2,PHLDA2,Maternal,"rs2237896-<b>A</b>, rs163184-<b>T</b>, rs1049549-<b>T</b>, rs3888647-<b>G</b>",1 x 10-14,,NR,0.61,'-,'-,KCNQ1; KCNQ1; CD81; PHLDA2 - NAP1L4,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:2837210|11:2825839|11:2397200|11:2932452,Diabetes
2538,PHLDA2,PHLDA2,Maternal,"rs2237896-<b>A</b>, rs163184-<b>T</b>, rs1049549-<b>T</b>, rs3888647-<b>A</b>",7 x 10-11,,NR,0.38,'-,'-,KCNQ1; KCNQ1; CD81; PHLDA2 - NAP1L4,Type 2 diabetes,type II diabetes mellitus,GCST004758,11:2837210|11:2825839|11:2397200|11:2932452,Diabetes
2699,SLC22A2*,SLC22A2*,Maternal,rs622217-<b>T</b>,2 x 10-10,,0.52,1.05,'-,[1.03-1.07],"SLC22A2, SLC22A3",Type 2 diabetes,type II diabetes mellitus,GCST004894,6:160345738,Diabetes
2700,SLC22A2*,SLC22A2*,Maternal,rs622217-<b>C</b>,3 x 10-10,,0.483931554,'-,0.0485 unit decrease,[0.033-0.064],"SLC22A2, SLC22A3",Type 2 diabetes,type II diabetes mellitus,GCST006867,6:160345738,Diabetes
2730,SLC22A2*,SLC22A2*,Maternal,rs316025-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,SLC22A2,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,6:160262349,Diabetes
2786,SLC22A3*,SLC22A3*,Maternal,rs622217-<b>T</b>,2 x 10-10,,0.52,1.05,'-,[1.03-1.07],"SLC22A2, SLC22A3",Type 2 diabetes,type II diabetes mellitus,GCST004894,6:160345738,Diabetes
2787,SLC22A3*,SLC22A3*,Maternal,rs622217-<b>C</b>,3 x 10-10,,0.483931554,'-,0.0485 unit decrease,[0.033-0.064],"SLC22A2, SLC22A3",Type 2 diabetes,type II diabetes mellitus,GCST006867,6:160345738,Diabetes
2788,SLC22A3*,SLC22A3*,Maternal,rs474513-<b>A</b>,8 x 10-10,,0.5169,1.04,'-,[1.03-1.05],SLC22A3,Type 2 diabetes,type II diabetes mellitus,GCST009379,6:160349280,Diabetes
2789,SLC22A3*,SLC22A3*,Maternal,rs501470-<b>G</b>,2 x 10-17,,0.4559,'-,0.032 unit decrease,[0.025-0.039],SLC22A3,Type 2 diabetes,type II diabetes mellitus,GCST010557,6:160349886,Diabetes
2790,SLC22A3*,SLC22A3*,Maternal,rs543159-<b>A</b>,4 x 10-10,,0.482,'-,0.035 unit increase,[0.023-0.047],SLC22A3,Glycine levels,glycine measurement,GCST007638,6:160354985,Diabetes
2791,SLC22A3*,SLC22A3*,Maternal,rs543159-<b>C</b>,1 x 10-12,,0.5203,'-,0.0324 unit increase,[0.023-0.041],SLC22A3,Type 2 diabetes,type II diabetes mellitus,GCST010555,6:160354985,Diabetes
3828,KCNQ1DN,KCNQ1DN,Maternal,rs140215710-<b>A</b>,4 x 10-8,,0.010339,'-,0.412643 unit increase,[0.27-0.56],"CDKN1C, KCNQ1DN",Type 1 diabetes,type I diabetes mellitus,GCST90014023,11:2881830,Diabetes
3846,CDKN1C,CDKN1C,Maternal,rs140215710-<b>A</b>,4 x 10-8,,0.010339,'-,0.412643 unit increase,[0.27-0.56],"CDKN1C, KCNQ1DN",Type 1 diabetes,type I diabetes mellitus,GCST90014023,11:2881830,Diabetes
1904,KCNQ1,KCNQ1,Maternal,rs231361-<b>A</b>,4 x 10-8,,0.250479,'-,0.073669426 unit increase,[0.047-0.1],"KCNQ1, KCNQ1OT1",Medication use (drugs used in diabetes),Drugs used in diabetes use measurement,GCST007923,11:2670270,Diabetes
23,ANO1,ANO1,Maternal,rs875107-<b>A</b>,2 x 10-9,,0.517213131,'-,0.0032043 unit decrease,[NR],ANO1,Diverticular disease,diverticular disease,GCST006479,11:70159268,Digestive System
24,ANO1,ANO1,Maternal,rs2186797-<b>?</b>,4 x 10-8,,0.0642,0.96,'-,[0.94-0.97],ANO1,Haemorrhoidal disease,hemorrhoid,GCST90014033,11:70161664,Digestive System
33,ANO1,ANO1,Maternal,rs3781663-<b>?</b>,8 x 10-6,(disease-free survival),'-,2.24,'-,[1.57-3.19],ANO1,Survival in rectal cancer,"disease free survival, rectum cancer",GCST002821,11:70153146,Digestive System
864,H19,H19,Maternal,rs4930144-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,"IGF2, H19",Celiac disease,celiac disease,GCST002112,11:2027258,Digestive System
2294,MAGI2,MAGI2,Maternal,rs10485879-<b>?</b>,4 x 10-7,,NR,1.5518312,'-,[NR],MAGI2,Colonoscopy-negative controls vs population controls,colorectal health,GCST005147,7:78275813,Digestive System
2361,MEG8,MEG8,Maternal,rs7141987-<b>G</b>,7 x 10-7,,0.42,1.77,'-,[NR],MEG8,Esophageal adenocarcinoma x gastroesophageal reflux disease interaction,"esophageal adenocarcinoma, gastroesophageal reflux disease",GCST006531,14:101025887,Digestive System
2730,SLC22A2*,SLC22A2*,Maternal,rs316025-<b>?</b>,1 x 10-12,,'-,'-,'-,'-,SLC22A2,Type 2 diabetes or prostate cancer (pleiotropy),"prostate carcinoma, type II diabetes mellitus",GCST011320,6:160262349,Digestive System
2819,SLC22A3*,SLC22A3*,Maternal,rs7758229-<b>T</b>,8 x 10-9,(distal colon cancer),NR,1.28,'-,[1.18-1.39],SLC22A3,Colorectal cancer,colorectal cancer,GCST000948,6:160419220,Digestive System
7,ADTRP,ADTRP,Maternal,rs185569610-<b>C</b>,3 x 10-6,(AA),0.999,'-,0.359 unit increase,'-,ADTRP,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,6:11785127,Drug Response
44,ATP10A,ATP10A,Maternal,rs145738725-<b>A</b>,2 x 10-6,,0.01304,'-,14.46 unit increase,[8.49-20.42],"ATP10A, AC023449.1",Phenylephrine infusion rate during anesthesia,response to phenylephrine,GCST008755,15:25581314,Drug Response
45,ATP10A,ATP10A,Maternal,rs4906759-<b>T</b>,2 x 10-7,,0.06,'-,0.55 unit increase,[0.34-0.75],ATP10A,Response to radiotherapy in prostate cancer (overall toxicity),"response to radiation, prostate carcinoma",GCST003583,15:25730061,Drug Response
46,ATP10A,ATP10A,Maternal,rs6576456-<b>?</b>,8 x 10-6,"(endpoint 3, dominant)",'-,2.4390244,'-,[NR],ATP10A,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,15:25764093,Drug Response
1904,KCNQ1,KCNQ1,Maternal,rs231361-<b>A</b>,4 x 10-8,,0.250479,'-,0.073669426 unit increase,[0.047-0.1],"KCNQ1, KCNQ1OT1",Medication use (drugs used in diabetes),Drugs used in diabetes use measurement,GCST007923,11:2670270,Drug Response
1905,KCNQ1,KCNQ1,Maternal,rs4930011-<b>G</b>,4 x 10-13,,0.389262,'-,0.08729263 unit increase,[0.064-0.111],KCNQ1,Medication use (drugs used in diabetes),Drugs used in diabetes use measurement,GCST007923,11:2835428,Drug Response
2073,KLF14,KLF14,Maternal,rs74446409-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"KLF14, TSGA13",Glucocorticoid-induced osteonecrosis (age 10 years and older),"response to glucocorticoid, osteonecrosis",GCST003081,7:130711940,Drug Response
2074,KLF14,KLF14,Maternal,rs185963-<b>T</b>,2 x 10-9,,0.434857,'-,0.050627008 unit increase,[0.034-0.067],"KLF14, AC016831.5",Medication use (beta blocking agents),Beta blocking agent use measurement,GCST007927,7:130765392,Drug Response
2075,KLF14,KLF14,Maternal,rs34748838-<b>T</b>,2 x 10-15,,0.489913,'-,0.04805376 unit decrease,[0.036-0.06],"KLF14, AC016831.5",Medication use (agents acting on the renin-angiotensin system),Agents acting on the renin-angiotensin system use measurement,GCST007930,7:130774483,Drug Response
2076,KLF14,KLF14,Maternal,rs972283-<b>A</b>,1 x 10-10,,0.488765,'-,0.03592304 unit decrease,[0.025-0.047],"AC016831.5, KLF14",Medication use (HMG CoA reductase inhibitors),HMG CoA reductase inhibitor use measurement,GCST007931,7:130782095,Drug Response
2077,KLF14,KLF14,Maternal,rs972283-<b>A</b>,7 x 10-9,,0.491048,'-,0.04650017 unit decrease,[0.031-0.062],"AC016831.5, KLF14",Medication use (calcium channel blockers),Calcium channel blocker use measurement,GCST007929,7:130782095,Drug Response
2321,MAGI2,MAGI2,Maternal,rs17150687-<b>C</b>,3 x 10-6,"(Bupropion, Sexual side effects)",0.02,'-,'-,'-,"AC006043.1, MAGI2",Response to anti-depressant treatment in major depressive disorder,"antidepressant-induced sexual dysfunction, response to bupropion, response to antidepressant",GCST001308,7:78413974,Drug Response
2323,MAGI2,MAGI2,Maternal,rs12539913-<b>A</b>,8 x 10-8,(Imidazole derivatives [G01AF]),0.059,2.77,'-,'-,"AC006355.2, MAGI2",Adverse response to drug,"adverse effect, response to drug",GCST009028,7:79143230,Drug Response
2322,MAGI2,MAGI2,Maternal,rs78723182-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,MAGI2,Response to lamotrigine and valproic acid in genetic generalized epilepsy,"generalised epilepsy, response to anticonvulsant",GCST010292,7:78891976,Drug Response
2356,MEG3,MEG3,Maternal,rs2400940-<b>T</b>,4 x 10-8,(EA),NR,'-,2.5285 unit increase,NR,"MEG3, DLK1",Diastolic blood pressure response to thiazide and thiazide-like diuretics in hypertension,"response to diuretic, diastolic blood pressure change measurement, hypertension",GCST009646,14:100758585,Drug Response
2461,OSBPL5,OSBPL5,Maternal,rs1466045-<b>A</b>,8 x 10-6,,NR,'-,4.46 z score increase,'-,OSBPL5,Cisplatin-induced ototoxicity,"ototoxicity, response to cisplatin",GCST003898,11:3128167,Drug Response
2571,PPP1R9A,PPP1R9A,Maternal,rs192462116-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"PPP1R9A, PPP1R9A-AS1",Glucocorticoid-induced osteonecrosis (age 10 years and older),"response to glucocorticoid, osteonecrosis",GCST003081,7:95138094,Drug Response
2575,PPP1R9A,PPP1R9A-AS1,Maternal,rs192462116-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"PPP1R9A, PPP1R9A-AS1",Glucocorticoid-induced osteonecrosis (age 10 years and older),"response to glucocorticoid, osteonecrosis",GCST003081,7:95138094,Drug Response
2616,RB1,RB1,Maternal,rs183816717-<b>A</b>,2 x 10-6,(AA),0.999,'-,0.465 unit increase,'-,RB1,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,13:48445893,Drug Response
2617,RB1,RB1,Maternal,rs185837131-<b>T</b>,2 x 10-6,(AA),0.999,'-,0.453 unit increase,'-,RB1,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,13:48455468,Drug Response
2618,RB1,RB1,Maternal,rs187785117-<b>T</b>,2 x 10-6,(AA),0.999,'-,0.405 unit increase,'-,RB1,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,13:48575735,Drug Response
2619,RB1,RB1,Maternal,rs193251247-<b>A</b>,2 x 10-6,(AA),0.999,'-,0.4 unit increase,'-,RB1,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,13:48589044,Drug Response
2631,RB1,RB1CC1,Maternal,rs35551581-<b>?</b>,4 x 10-6,,NR,1.600512,'-,NR,"NPBWR1, RB1CC1",Response to antidepressants (symptom remission),response to antidepressant,GCST007061,8:52844839,Drug Response
2824,SLC22A3*,SLC22A3*,Maternal,rs2504916-<b>T</b>,2 x 10-6,,NR,'-,0.306 ug/L increase,[0.18-0.43],SLC22A3,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,6:160402996,Drug Response
2864,SMOC1,SMOC1,Maternal,rs8012912-<b>?</b>,7 x 10-6,"(endpoint 5, East Asian, additive)",'-,1.62,'-,[NR],SMOC1,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,14:70007490,Drug Response
2865,SMOC1,SMOC1,Maternal,rs11158827-<b>?</b>,8 x 10-6,"(endpoint 5, East Asian, additive)",'-,1.62,'-,[NR],SMOC1,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,14:70012457,Drug Response
22,ANO1,ANO1,Maternal,rs11604809-<b>?</b>,7 x 10-6,,NR,'-,4.505 z-score decrease,'-,"ANO1, FADD",General cognitive ability,intelligence,GCST006269,11:70199230,Educational and Intelligence
139,DIO3OS,DIO3OS,Maternal,rs10134381-<b>C</b>,2 x 10-9,(MTAG),0.1574,'-,0.0109 unit increase,[0.0074-0.0144],"LINC02314, DIO3OS",Educational attainment (MTAG),self reported educational attainment,GCST006571,14:101529062,Educational and Intelligence
273,DLX5,DLX5,Maternal,rs6951996-<b>A</b>,1 x 10-8,,0.0522,'-,0.0182 unit decrease,[0.012-0.024],"DLX6-AS1, DLX5",Educational attainment (years of education),self reported educational attainment,GCST006442,7:97017125,Educational and Intelligence
274,DLX5,DLX5,Maternal,rs982346-<b>?</b>,3 x 10-6,,NR,'-,4.684 z-score decrease,'-,"DLX5, DLX6-AS1",General cognitive ability,intelligence,GCST006269,7:97020059,Educational and Intelligence
275,DLX5,DLX5,Maternal,rs982346-<b>A</b>,2 x 10-9,(MTAG),0.0521,'-,0.018 unit decrease,[0.012-0.024],"DLX5, DLX6-AS1",Educational attainment (MTAG),self reported educational attainment,GCST006571,7:97020059,Educational and Intelligence
2291,MAGI2,MAGI2,Maternal,rs1859596-<b>T</b>,4 x 10-6,(reading),0.35,'-,0.111 unit increase,[0.064-0.158],"MAGI2-AS3, NUP35P2",Reading or mathematical ability,reading,GCST002522,7:79480326,Educational and Intelligence
2346,MAGI2,MAGI2-AS3,Maternal,rs1859596-<b>T</b>,4 x 10-6,(reading),0.35,'-,0.111 unit increase,[0.064-0.158],"MAGI2-AS3, NUP35P2",Reading or mathematical ability,reading,GCST002522,7:79480326,Educational and Intelligence
2360,MEG8,MEG8,Maternal,rs2180386-<b>A</b>,7 x 10-6,,0.38,'-,0.21 unit decrease,[NR],"RTL1, MEG8, AL117190.1",Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,14:100898928,Educational and Intelligence
2402,NTM,NTM,Maternal,rs7108020-<b>A</b>,4 x 10-14,,0.6475,'-,0.0111 unit increase,[0.0082-0.014],NTM,Educational attainment (years of education),self reported educational attainment,GCST006442,11:131419926,Educational and Intelligence
2403,NTM,NTM,Maternal,rs7108020-<b>A</b>,1 x 10-15,(MTAG),0.6475,'-,0.011 unit increase,[0.0083-0.0137],NTM,Educational attainment (MTAG),self reported educational attainment,GCST006571,11:131419926,Educational and Intelligence
2404,NTM,NTM,Maternal,rs7108020-<b>A</b>,2 x 10-9,(MTAG),0.6544,'-,0.0104 unit increase,[0.0071-0.0137],NTM,Highest math class taken (MTAG),mathematical ability,GCST006568,11:131419926,Educational and Intelligence
2405,NTM,NTM,Maternal,rs1550973-<b>A</b>,2 x 10-9,,0.3506,'-,0.0139657 unit decrease,NR,NTM,Educational attainment (years of education),self reported educational attainment,GCST003676,11:131421834,Educational and Intelligence
2406,NTM,NTM,Maternal,rs1550972-<b>?</b>,1 x 10-8,,NR,'-,0.0118359495 unit decrease,[0.0078-0.0159],NTM,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:131421915,Educational and Intelligence
2407,NTM,NTM,Maternal,rs148837593-<b>?</b>,7 x 10-6,,NR,'-,0.0077708 unit increase,[0.0044-0.0112],NTM,Reaction time,reaction time measurement,GCST006268,11:131859504,Educational and Intelligence
2568,PPP1R9A,PPP1R9A,Maternal,rs9649194-<b>T</b>,2 x 10-8,(MTAG),0.5545,'-,0.0094 unit decrease,[0.0061-0.0127],"PPP1R9A-AS1, PPP1R9A",Highest math class taken (MTAG),mathematical ability,GCST006568,7:95125673,Educational and Intelligence
2569,PPP1R9A,PPP1R9A,Maternal,rs9649194-<b>T</b>,1 x 10-10,(MTAG),0.5546,'-,0.0116 unit decrease,[0.0081-0.0151],"PPP1R9A-AS1, PPP1R9A",Self-reported math ability (MTAG),mathematical ability,GCST006569,7:95125673,Educational and Intelligence
2570,PPP1R9A,PPP1R9A,Maternal,rs10953137-<b>G</b>,6 x 10-10,,0.4561,'-,0.0121 unit increase,[0.0082-0.016],"PPP1R9A-AS1, PPP1R9A",Self-reported math ability,mathematical ability,GCST006573,7:95138960,Educational and Intelligence
2572,PPP1R9A,PPP1R9A-AS1,Maternal,rs9649194-<b>T</b>,2 x 10-8,(MTAG),0.5545,'-,0.0094 unit decrease,[0.0061-0.0127],"PPP1R9A-AS1, PPP1R9A",Highest math class taken (MTAG),mathematical ability,GCST006568,7:95125673,Educational and Intelligence
2573,PPP1R9A,PPP1R9A-AS1,Maternal,rs9649194-<b>T</b>,1 x 10-10,(MTAG),0.5546,'-,0.0116 unit decrease,[0.0081-0.0151],"PPP1R9A-AS1, PPP1R9A",Self-reported math ability (MTAG),mathematical ability,GCST006569,7:95125673,Educational and Intelligence
2574,PPP1R9A,PPP1R9A-AS1,Maternal,rs10953137-<b>G</b>,6 x 10-10,,0.4561,'-,0.0121 unit increase,[0.0082-0.016],"PPP1R9A-AS1, PPP1R9A",Self-reported math ability,mathematical ability,GCST006573,7:95138960,Educational and Intelligence
2698,SLC22A2*,SLC22A2*,Maternal,rs7774140-<b>?</b>,5 x 10-6,,NR,'-,4.564 z-score decrease,'-,"SLC22A3, SLC22A2",General cognitive ability,intelligence,GCST006269,6:160323374,Educational and Intelligence
2785,SLC22A3*,SLC22A3*,Maternal,rs7774140-<b>?</b>,5 x 10-6,,NR,'-,4.564 z-score decrease,'-,"SLC22A3, SLC22A2",General cognitive ability,intelligence,GCST006269,6:160323374,Educational and Intelligence
1,ADTRP,ADTRP,Maternal,rs2294426-<b>?</b>,4 x 10-8,"(Maternal alcohol consumption, 1df)",NR,'-,'-,'-,"ADTRP, AL022724.3",Orofacial clefts (maternal alcohol consumption interaction),"alcohol consumption measurement, Orofacial clefting syndrome, cleft lip",GCST001082,6:11729849,Facial Morphology
43,ATP10A,ATP10A,Maternal,rs12906552-<b>T</b>,2 x 10-8,,0.250262,'-,'-,'-,ATP10A,Cutaneous melanoma or hair colour,"cutaneous melanoma, hair color",GCST010302,15:25861110,Facial Morphology
47,ATP10A,ATP10A,Maternal,rs2066710-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,ATP10A,Hair color,hair colour measurement,GCST007082,15:25678340,Facial Morphology
276,DLX5,DLX5,Maternal,rs10241381-<b>G</b>,4 x 10-6,,0.4479,'-,0.1424 unit increase,[0.082-0.202],"SDHAF3, DLX5","Facial morphology (factor 8, orbital inclination due to vertical and horizontal position of exocanthion)",eye morphology measurement,GCST004312,7:97035969,Facial Morphology
1534,KCNK9,KCNK9,Maternal,rs888349-<b>G</b>,5 x 10-6,,0.2201,'-,0.1673 unit increase,[0.096-0.239],KCNK9,"Facial morphology (factor 3, length of philtrum)",lip morphology measurement,GCST004307,8:139657502,Facial Morphology
1795,KCNQ1,KCNQ1,Maternal,rs35474939-<b>T</b>,9 x 10-7,,0.1341,'-,0.2202 unit decrease,[0.13-0.31],KCNQ1,"Facial morphology (factor 13, vertical position of alar curvature relative to upper lip)","nose morphology measurement, mouth morphology measurement",GCST004317,11:2503729,Facial Morphology
2292,MAGI2,MAGI2,Maternal,rs17522138-<b>T</b>,2 x 10-7,,0.05777,'-,0.3339 unit decrease,[0.21-0.46],MAGI2,Facial morphology (factor 19),facial morphology measurement,GCST004323,7:78111904,Facial Morphology
856,H19,H19,Maternal,rs11042596-<b>G</b>,5 x 10-8,,0.34,'-,0.04 unit increase,[0.020-0.060],"H19, IGF2",Length of menstrual cycle,menstrual cycle measurement,GCST006958,11:2097630,Female Reproductive System
857,H19,H19,Maternal,rs6578985-<b>?</b>,6 x 10-6,"(AAM-CT, EA)",NR,'-,'-,'-,"H19, IGF2",Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,11:2116909,Female Reproductive System
858,H19,H19,Maternal,rs6578987-<b>?</b>,3 x 10-6,"(AAM-CT, Chinese)",NR,'-,'-,'-,"H19, IGF2",Femoral neck bone geometry and menarche (age at onset),age at menopause,GCST001950,11:2116909,Female Reproductive System
873,H19,H19,Maternal,rs217727-<b>A</b>,4 x 10-14,(EA),0.1929,'-,0.0598 unit decrease,[0.044-0.075],H19,Breast cancer,breast carcinoma,GCST004988,11:1995678,Female Reproductive System
1535,KCNK9,KCNK9,Maternal,rs62520182-<b>?</b>,8 x 10-20,,NR,'-,'-,'-,KCNK9,Menarche (age at onset),age at menarche,GCST007078,8:139633808,Female Reproductive System
1536,KCNK9,KCNK9,Maternal,rs1469039-<b>A</b>,4 x 10-12,,0.19,'-,0.05 unit increase,[0.036-0.064],KCNK9,Menarche (age at onset),age at menarche,GCST002541,8:139639536,Female Reproductive System
2034,KLF14,KLF14,Maternal,rs35775580-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"KLF14, AC016831.5",Menarche (age at onset),age at menarche,GCST007078,7:130735979,Female Reproductive System
2293,MAGI2,MAGI2,Maternal,rs62468583-<b>?</b>,3 x 10-8,,NR,'-,'-,'-,MAGI2,Menarche (age at onset),age at menarche,GCST007078,7:78534107,Female Reproductive System
2319,MAGI2,MAGI2,Maternal,rs798336-<b>T</b>,2 x 10-6,,0.88,'-,'-,'-,MAGI2,Mammographic density (dense area),"dense area measurement, mammographic density measurement",GCST002667,7:78285026,Female Reproductive System
2355,MEG3,MEG3,Maternal,rs2295389-<b>G</b>,2 x 10-6,(EA),0.3539,'-,0.0345 unit decrease,[0.02-0.049],"MEG3, AL117190.1, AL117190.2",Breast cancer,breast carcinoma,GCST004988,14:100851974,Female Reproductive System
2362,MEG8,MEG8,Maternal,rs1950626-<b>G</b>,3 x 10-7,(Hispanic),0.79,2.96,'-,[1.96-4.48],"MEG8, AL117190.1",Pelvic organ prolapse (moderate/severe),pelvic organ prolapse,GCST003225,14:100907636,Female Reproductive System
2626,RB1,RB1CC1,Maternal,rs10808874-<b>C</b>,4 x 10-6,,0.803879945,'-,0.16748436 unit decrease,[0.097-0.238],"RB1CC1, NPBWR1",Menstruation quality of life impact (dysmenorrhea),"quality of life during menstruation measurement, dysmenorrheic pain measurement",GCST006636,8:52793206,Female Reproductive System
2627,RB1,RB1CC1,Maternal,rs16918254-<b>A</b>,1 x 10-8,,0.92,'-,0.05 unit increase,[0.032-0.068],"RB1CC1, NPBWR1",Menarche (age at onset),age at menarche,GCST002541,8:52856653,Female Reproductive System
2628,RB1,RB1CC1,Maternal,rs62507083-<b>?</b>,7 x 10-11,,NR,'-,'-,'-,"NPBWR1, RB1CC1",Menarche (age at onset),age at menarche,GCST007078,8:52930220,Female Reproductive System
859,H19,H19,Maternal,rs4930103-<b>A</b>,5 x 10-16,(H19-ICR-CpG02),0.49,'-,'-,'-,"H19, IGF2",DNA methylation (parent-of-origin),DNA methylation,GCST002057,11:2003314,Genetic Regulation
860,H19,H19,Maternal,rs4930103-<b>G</b>,1 x 10-14,(H19-ICR),0.397,'-,'-,'-,"H19, IGF2",DNA methylation (variation),DNA methylation,GCST002058,11:2003314,Genetic Regulation
861,H19,H19,Maternal,rs3890907-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"H19, IGF2",DNA methylation variation (age effect),DNA methylation,GCST006660,11:2006913,Genetic Regulation
1796,KCNQ1,KCNQ1,Maternal,rs2237896-<b>G</b>,7 x 10-9,,0.96,'-,0.017 unit increase,'-,KCNQ1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009067,11:2837210,Genetic Regulation
1797,KCNQ1,KCNQ1,Maternal,rs2237896-<b>A</b>,2 x 10-22,,0.4,'-,0.043 unit increase,NR,KCNQ1,Mosaic loss of chromosome Y (Y chromosome dosage),mosaic loss of chromosome Y measurement,GCST009066,11:2837210,Genetic Regulation
140,DIO3OS,DIO3OS,Maternal,rs11626434-<b>C</b>,2 x 10-16,,0.36,'-,0.053 unit increase,[0.039-0.067],"LINC02314, DIO3OS",Free thyroxine concentration,thyroxine measurement,GCST006896,14:101532106,Hormone
2051,KLF14,KLF14,Maternal,rs34748838-<b>T</b>,2 x 10-9,,0.490131,'-,0.00599464 unit increase,[0.0042-0.0078],"KLF14, AC016831.5",Sex hormone-binding globulin levels,sex hormone-binding globulin measurement,GCST90012111,7:130774483,Hormone
2052,KLF14,KLF14,Maternal,rs34748838-<b>T</b>,2 x 10-20,,0.490131,'-,0.00808041 unit increase,[0.0064-0.0097],"KLF14, AC016831.5",Sex hormone-binding globulin levels adjusted for BMI,sex hormone-binding globulin measurement,GCST90012110,7:130774483,Hormone
2040,KLF14,KLF14,Maternal,rs3996352-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"AC016831.5, KLF14",Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,7:130760175,Hormone
2053,KLF14,KLF14,Maternal,rs972283-<b>G</b>,7 x 10-8,,0.555,'-,0.043 unit decrease,[0.027-0.059],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007309,7:130782095,Hormone
2054,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-10,,0.521,'-,0.041 unit decrease,[0.029-0.053],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007310,7:130782095,Hormone
2055,KLF14,KLF14,Maternal,rs972283-<b>G</b>,2 x 10-8,,0.521,'-,0.048 unit decrease,[0.03-0.066],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007312,7:130782095,Hormone
2056,KLF14,KLF14,Maternal,rs972283-<b>G</b>,3 x 10-7,,0.551,'-,0.049 unit decrease,[0.031-0.067],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007313,7:130782095,Hormone
2057,KLF14,KLF14,Maternal,rs972283-<b>G</b>,9 x 10-6,,0.555,'-,0.055 unit decrease,[0.031-0.079],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007315,7:130782095,Hormone
2058,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-7,,0.521,'-,0.054 unit decrease,[0.034-0.074],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007316,7:130782095,Hormone
2059,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-6,,0.521,'-,0.062 unit decrease,[0.035-0.089],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007318,7:130782095,Hormone
2060,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-18,,0.55,'-,0.053 unit decrease,[0.041-0.065],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007319,7:130782095,Hormone
2061,KLF14,KLF14,Maternal,rs972283-<b>G</b>,2 x 10-6,,0.544,'-,0.045 unit decrease,[0.027-0.063],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007320,7:130782095,Hormone
2062,KLF14,KLF14,Maternal,rs972283-<b>G</b>,4 x 10-15,,0.555,'-,0.063 unit decrease,[0.047-0.079],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007321,7:130782095,Hormone
2063,KLF14,KLF14,Maternal,rs972283-<b>G</b>,4 x 10-18,,0.521,'-,0.056 unit decrease,[0.044-0.068],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007322,7:130782095,Hormone
2064,KLF14,KLF14,Maternal,rs972283-<b>G</b>,5 x 10-7,,0.522,'-,0.048 unit decrease,[0.028-0.068],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007323,7:130782095,Hormone
2065,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-14,,0.521,'-,0.066 unit decrease,[0.048-0.084],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007324,7:130782095,Hormone
2066,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-14,,0.55,'-,0.071 unit decrease,[0.053-0.089],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007325,7:130782095,Hormone
2067,KLF14,KLF14,Maternal,rs972283-<b>G</b>,3 x 10-12,,0.555,'-,0.086 unit decrease,[0.062-0.11],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007327,7:130782095,Hormone
2068,KLF14,KLF14,Maternal,rs972283-<b>G</b>,8 x 10-18,,0.521,'-,0.079 unit decrease,[0.059-0.099],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007328,7:130782095,Hormone
2069,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-12,,0.521,'-,0.096 unit decrease,[0.069-0.123],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007330,7:130782095,Hormone
2075,KLF14,KLF14,Maternal,rs34748838-<b>T</b>,2 x 10-15,,0.489913,'-,0.04805376 unit decrease,[0.036-0.06],"KLF14, AC016831.5",Medication use (agents acting on the renin-angiotensin system),Agents acting on the renin-angiotensin system use measurement,GCST007930,7:130774483,Hormone
2799,SLC22A3*,SLC22A3*,Maternal,rs555754-<b>A</b>,2 x 10-59,,0.467759,'-,0.0182759 unit increase,[0.016-0.021],SLC22A3,Sex hormone-binding globulin levels adjusted for BMI,sex hormone-binding globulin measurement,GCST90012106,6:160348391,Hormone
2800,SLC22A3*,SLC22A3*,Maternal,rs555754-<b>A</b>,2 x 10-36,,0.467759,'-,0.0164673 unit increase,[0.014-0.019],SLC22A3,Sex hormone-binding globulin levels,sex hormone-binding globulin measurement,GCST90012107,6:160348391,Hormone
2801,SLC22A3*,SLC22A3*,Maternal,rs668871-<b>T</b>,2 x 10-76,,0.469226,'-,0.0161164 unit increase,[0.014-0.018],SLC22A3,Sex hormone-binding globulin levels,sex hormone-binding globulin measurement,GCST90012111,6:160348779,Hormone
2802,SLC22A3*,SLC22A3*,Maternal,rs668871-<b>T</b>,1 x 10-111,,0.469226,'-,0.0176137 unit increase,[0.016-0.019],SLC22A3,Sex hormone-binding globulin levels adjusted for BMI,sex hormone-binding globulin measurement,GCST90012110,6:160348779,Hormone
2803,SLC22A3*,SLC22A3*,Maternal,rs501470-<b>G</b>,3 x 10-55,,0.475454,'-,0.0166798 unit increase,[0.014-0.019],SLC22A3,Sex hormone-binding globulin levels adjusted for BMI,sex hormone-binding globulin measurement,GCST90012108,6:160349886,Hormone
2804,SLC22A3*,SLC22A3*,Maternal,rs501470-<b>G</b>,7 x 10-40,,0.475454,'-,0.0152025 unit increase,[0.013-0.018],SLC22A3,Sex hormone-binding globulin levels,sex hormone-binding globulin measurement,GCST90012109,6:160349886,Hormone
6,ADTRP,ADTRP,Maternal,rs116168042-<b>?</b>,9 x 10-6,,NR,2.76,'-,[1.71-4.46],ADTRP,Simvastatin-induced myopathy,"response to simvastatin, myopathy",GCST008551,6:11754825,Immune
30,ANO1,ANO1,Maternal,rs3889875-<b>?</b>,6 x 10-6,,NR,'-,0.0608 unit increase,[0.035-0.087],ANO1,Childhood ear infection,susceptibility to childhood ear infection measurement,GCST005013,11:70095303,Immune
39,ATP10A,ATP10A,Maternal,rs6576443-<b>A</b>,6 x 10-9,(EA),'-,'-,'-,'-,"AC023449.1, ATP10A",Immune reponse to smallpox (secreted IFN-alpha),"response to vaccine, cytokine measurement",GCST001538,15:25649511,Immune
46,ATP10A,ATP10A,Maternal,rs6576456-<b>?</b>,8 x 10-6,"(endpoint 3, dominant)",'-,2.4390244,'-,[NR],ATP10A,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,15:25764093,Immune
56,CPA4,CPA4,Maternal,rs2306848-<b>G</b>,6 x 10-12,,0.948,'-,'-,'-,CPA4,Rheumatoid arthritis,rheumatoid arthritis,GCST007843,7:130322574,Immune
864,H19,H19,Maternal,rs4930144-<b>A</b>,7 x 10-6,,'-,'-,'-,'-,"IGF2, H19",Celiac disease,celiac disease,GCST002112,11:2027258,Immune
865,H19,H19,Maternal,rs78896587-<b>T</b>,1 x 10-9,,'-,'-,0.20937194 unit decrease,[0.14-0.28],"H19, IGF2",Type 1 diabetes,type I diabetes mellitus,GCST90000529,11:2055620,Immune
1877,KCNQ1,KCNQ1,Maternal,rs3852527-<b>?</b>,5 x 10-6,,NR,'-,0.3123 unit increase,[0.18-0.44],KCNQ1,Bacterial meningitis,susceptibility to bacterial meningitis measurement,GCST005010,11:2805373,Immune
2352,MEG3,MEG3,Maternal,rs941576-<b>A</b>,1 x 10-10,,0.57,1.11,'-,[1.06-1.16],"AL117190.2, AL117190.1, MEG3",Type 1 diabetes,type I diabetes mellitus,GCST000539,14:100839708,Immune
2353,MEG3,MEG3,Maternal,rs56994090-<b>T</b>,1 x 10-11,,0.59,1.1363636,'-,'-,"AL117190.2, MEG3, AL117190.1",Type 1 diabetes,type I diabetes mellitus,GCST005536,14:100840110,Immune
2376,NAA60,NAA60,Maternal,rs40363-<b>G</b>,3 x 10-6,,0.72,11.1111,'-,[NR],"AC004224.2, NAA60, AC025283.2",Tuberculosis,Tuberculosis,GCST002198,16:3459056,Immune
2411,NTM,NTM,Maternal,rs78430868-<b>A</b>,1 x 10-16,,0.068,'-,0.39 unit decrease,[0.3-0.48],"NTM-AS1, NTM",Pre-treatment viral load in HIV-1 infection,"HIV-1 infection, viral load",GCST008758,11:131630365,Immune
2412,NTM,NTM,Maternal,rs11222703-<b>C</b>,4 x 10-8,,0.587942,'-,0.0115924 unit decrease,[0.0075-0.0157],NTM,C-reactive protein levels,C-reactive protein measurement,GCST009777,11:131582053,Immune
2427,NTM,NTM,Maternal,rs112479596-<b>C</b>,1 x 10-6,,0.02604,1.4688601,'-,NR,NTM,Non-Hodgkin's lymphoma,non-Hodgkins lymphoma,GCST90011819,11:131936594,Immune
2449,NTM,NTM,Maternal,rs76140786-<b>?</b>,3 x 10-6,,0.14,1.75,'-,[1.38-2.23],"NTM, NTM-AS1",Interstitial lung diseases in rheumatoid arthritis,"rheumatoid arthritis, interstitial lung disease",GCST011319,11:131642123,Immune
2451,NTM,NTM,Maternal,rs4468361-<b>T</b>,8 x 10-6,(TNFA),0.32,'-,'-,'-,NTM,Chronic obstructive pulmonary disease-related biomarkers,"tumor necrosis factor-alpha measurement, chronic obstructive pulmonary disease",GCST001737,11:132140223,Immune
2458,NTM,NTM-AS1,Maternal,rs78430868-<b>A</b>,1 x 10-16,,0.068,'-,0.39 unit decrease,[0.3-0.48],"NTM-AS1, NTM",Pre-treatment viral load in HIV-1 infection,"HIV-1 infection, viral load",GCST008758,11:131630365,Immune
2459,NTM,NTM-AS1,Maternal,rs76140786-<b>?</b>,3 x 10-6,,0.14,1.75,'-,[1.38-2.23],"NTM, NTM-AS1",Interstitial lung diseases in rheumatoid arthritis,"rheumatoid arthritis, interstitial lung disease",GCST011319,11:131642123,Immune
2805,SLC22A3*,SLC22A3*,Maternal,rs402219-<b>G</b>,6 x 10-7,,0.3,'-,0.19 unit increase,[0.11-0.27],SLC22A3,Monocyte early outgrowth colony forming units,monocyte early outgrowth colony forming unit,GCST001048,6:160368264,Immune
2806,SLC22A3*,SLC22A3*,Maternal,rs189821701-<b>?</b>,5 x 10-7,,NR,'-,0.4656 unit increase,[0.28-0.65],SLC22A3,Childhood ear infection,susceptibility to childhood ear infection measurement,GCST005013,6:160441777,Immune
2824,SLC22A3*,SLC22A3*,Maternal,rs2504916-<b>T</b>,2 x 10-6,,NR,'-,0.306 ug/L increase,[0.18-0.43],SLC22A3,Response to hepatitis C treatment,chronic hepatitis C virus infection,GCST001325,6:160402996,Immune
2859,SMOC1,SMOC1,Maternal,rs77041705-<b>G</b>,4 x 10-6,,NR,'-,0.2534 SD units decrease,[0.15-0.36],SMOC1,Monokine induced by gamma interferon levels,monokine induced by gamma interferon measurement,GCST004435,14:69960258,Immune
2860,SMOC1,SMOC1,Maternal,rs17175227-<b>G</b>,9 x 10-9,,0.98,7.1429,'-,[NR],"SMOC1, SLC8A3",Tuberculosis,Tuberculosis,GCST002198,14:70035333,Immune
2864,SMOC1,SMOC1,Maternal,rs8012912-<b>?</b>,7 x 10-6,"(endpoint 5, East Asian, additive)",'-,1.62,'-,[NR],SMOC1,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,14:70007490,Immune
2865,SMOC1,SMOC1,Maternal,rs11158827-<b>?</b>,8 x 10-6,"(endpoint 5, East Asian, additive)",'-,1.62,'-,[NR],SMOC1,Peginterferon alfa-2a treatment response in chronic hepatitis B infection,"response to peginterferon alfa-2a, chronic hepatitis B virus infection",GCST008514,14:70012457,Immune
3018,TP73,TP73,Maternal,rs3765718-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,TP73,Joint damage in rheumatoid arthritis,"rheumatoid arthritis, joint damage measurement",GCST008992,1:3687131,Immune
3828,KCNQ1DN,KCNQ1DN,Maternal,rs140215710-<b>A</b>,4 x 10-8,,0.010339,'-,0.412643 unit increase,[0.27-0.56],"CDKN1C, KCNQ1DN",Type 1 diabetes,type I diabetes mellitus,GCST90014023,11:2881830,Immune
3846,CDKN1C,CDKN1C,Maternal,rs140215710-<b>A</b>,4 x 10-8,,0.010339,'-,0.412643 unit increase,[0.27-0.56],"CDKN1C, KCNQ1DN",Type 1 diabetes,type I diabetes mellitus,GCST90014023,11:2881830,Immune
866,H19,H19,Maternal,rs10840341-<b>?</b>,1 x 10-9,,NR,'-,0.02327 unit increase,[0.016-0.031],"IGF2, H19",Creatinine levels,creatinine measurement,GCST005985,11:2095263,Kidney
867,H19,H19,Maternal,rs10840341-<b>?</b>,5 x 10-8,,NR,'-,0.02131 unit decrease,[0.014-0.029],"IGF2, H19",Glomerular filtration rate,glomerular filtration rate,GCST005984,11:2095263,Kidney
868,H19,H19,Maternal,rs7482894-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"IGF2, H19",Estimated glomerular filtration rate,glomerular filtration rate,GCST007344,11:2100034,Kidney
869,H19,H19,Maternal,rs7482894-<b>T</b>,4 x 10-14,,0.65,'-,0.0147 unit increase,[0.011-0.019],"IGF2, H19",Urate levels,urate measurement,GCST011119,11:2100034,Kidney
1878,KCNQ1,KCNQ1,Maternal,rs143709408-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,KCNQ1,Estimated glomerular filtration rate,glomerular filtration rate,GCST007917,11:2527999,Kidney
1879,KCNQ1,KCNQ1,Maternal,rs143709408-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,KCNQ1,Chronic kidney disease,chronic kidney disease,GCST007920,11:2527999,Kidney
1880,KCNQ1,KCNQ1,Maternal,rs143709408-<b>?</b>,2 x 10-16,,9.66E-05,'-,'-,'-,KCNQ1,Creatinine levels,creatinine measurement,GCST007919,11:2527999,Kidney
1881,KCNQ1,KCNQ1,Maternal,rs84178-<b>A</b>,4 x 10-9,,NR,'-,0.0078 unit decrease,[0.0054-0.0102],KCNQ1,Glomerular filtration rate (creatinine),"creatinine measurement, glomerular filtration rate",GCST004292,11:2753144,Kidney
1882,KCNQ1,KCNQ1,Maternal,rs231889-<b>C</b>,2 x 10-10,,0.107,'-,0.416 ml/min/1.73m2 decrease,[0.15-0.68],KCNQ1,Estimated glomerular filtration rate,glomerular filtration rate,GCST007344,11:2755962,Kidney
1883,KCNQ1,KCNQ1,Maternal,rs63934-<b>A</b>,5 x 10-29,,0.8265,'-,0.0041 unit increase,[0.0033-0.0049],KCNQ1,Estimated glomerular filtration rate,glomerular filtration rate,GCST008058,11:2767832,Kidney
1884,KCNQ1,KCNQ1,Maternal,rs163160-<b>A</b>,2 x 10-9,,0.82,'-,0.0065 unit increase,[NR],KCNQ1,Glomerular filtration rate in non diabetics (creatinine),"creatinine measurement, glomerular filtration rate",GCST003401,11:2768725,Kidney
1885,KCNQ1,KCNQ1,Maternal,rs233438-<b>A</b>,8 x 10-27,,0.8122,'-,0.0043 unit increase,[0.0035-0.0051],KCNQ1,Estimated glomerular filtration rate,glomerular filtration rate,GCST008059,11:2773162,Kidney
1886,KCNQ1,KCNQ1,Maternal,rs81205-<b>A</b>,5 x 10-20,(EA),0.5352,'-,0.0034 unit increase,[0.0026-0.0042],KCNQ1,Estimated glomerular filtration rate,glomerular filtration rate,GCST008747,11:2777574,Kidney
1887,KCNQ1,KCNQ1,Maternal,rs81205-<b>A</b>,9 x 10-12,,0.49,'-,0.394 unit increase,[0.28-0.51],KCNQ1,Estimated glomerular filtration rate in non-diabetics,glomerular filtration rate,GCST008745,11:2777574,Kidney
1888,KCNQ1,KCNQ1,Maternal,rs81205-<b>A</b>,7 x 10-18,,0.513,'-,0.0033 unit increase,[0.0027-0.0039],KCNQ1,Estimated glomerular filtration rate,glomerular filtration rate,GCST008747,11:2777574,Kidney
1889,KCNQ1,KCNQ1,Maternal,rs143709408-<b>?</b>,4 x 10-15,,9.98E-05,'-,'-,'-,KCNQ1,Hyperuricemia,hyperuricemia,GCST007916,11:2527999,Kidney
1890,KCNQ1,KCNQ1,Maternal,rs147445322-<b>?</b>,4 x 10-11,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Hyperuricemia,hyperuricemia,GCST007916,11:2847803,Kidney
1891,KCNQ1,KCNQ1,Maternal,rs147445322-<b>?</b>,2 x 10-16,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Serum uric acid levels,uric acid measurement,GCST007918,11:2847803,Kidney
1894,KCNQ1,KCNQ1,Maternal,rs60808706-<b>A</b>,6 x 10-9,(East Asian),0.3902,'-,0.0345 mg/dL increase,[0.023-0.046],KCNQ1,Urate levels,urate measurement,GCST008972,11:2836003,Kidney
1910,KCNQ1,KCNQ1-AS1,Maternal,rs147445322-<b>?</b>,2 x 10-16,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Serum uric acid levels,uric acid measurement,GCST007918,11:2847803,Kidney
2610,RB1,RB1,Maternal,rs9535020-<b>G</b>,4 x 10-6,,0.13,1.69,'-,[1.35–2.10],RB1,Chronic kidney disease,chronic kidney disease,GCST003140,13:48349672,Kidney
2701,SLC22A2*,SLC22A2*,Maternal,rs28495851-<b>C</b>,5 x 10-9,,0.03,1.35,'-,[1.22-1.50],SLC22A2,Kidney stones,nephrolithiasis,GCST009599,6:160198886,Kidney
2702,SLC22A2*,SLC22A2*,Maternal,rs77648599-<b>G</b>,5 x 10-10,,0.03,1.3,'-,[1.20-1.42],SLC22A2,Kidney stones,nephrolithiasis,GCST009598,6:160203083,Kidney
2703,SLC22A2*,SLC22A2*,Maternal,rs12207180-<b>A</b>,1 x 10-10,,0.11,1.0877,'-,[1.0603-1.1158],SLC22A2,Chronic kidney disease,chronic kidney disease,GCST008064,6:160212075,Kidney
2704,SLC22A2*,SLC22A2*,Maternal,rs12207180-<b>A</b>,1 x 10-82,,0.119,'-,0.0085 unit decrease,[0.0075-0.0095],SLC22A2,Estimated glomerular filtration rate,glomerular filtration rate,GCST008059,6:160212075,Kidney
2705,SLC22A2*,SLC22A2*,Maternal,rs12207180-<b>A</b>,3 x 10-92,,0.113,'-,0.0085 unit decrease,[0.0075-0.0095],SLC22A2,Estimated glomerular filtration rate,glomerular filtration rate,GCST008058,6:160212075,Kidney
2706,SLC22A2*,SLC22A2*,Maternal,rs515140-<b>T</b>,4 x 10-22,,0.202,'-,0.518 ml/min/1.73m2 decrease,[0.33-0.71],SLC22A2,Estimated glomerular filtration rate,glomerular filtration rate,GCST007344,6:160227235,Kidney
2707,SLC22A2*,SLC22A2*,Maternal,rs145590578-<b>A</b>,5 x 10-12,,0.115,'-,0.944 unit decrease,[0.68-1.21],SLC22A2,Estimated glomerular filtration rate in diabetes,"glomerular filtration rate, diabetes mellitus",GCST008746,6:160236104,Kidney
2708,SLC22A2*,SLC22A2*,Maternal,rs3101823-<b>T</b>,6 x 10-39,(EA),0.8781,'-,0.0079 unit increase,[0.0067-0.0091],SLC22A2,Estimated glomerular filtration rate,glomerular filtration rate,GCST008747,6:160240136,Kidney
2709,SLC22A2*,SLC22A2*,Maternal,rs2279463-<b>A</b>,1 x 10-15,,NR,'-,0.0118 unit increase,[0.0091-0.0145],SLC22A2,Glomerular filtration rate (creatinine),"creatinine measurement, glomerular filtration rate",GCST004292,6:160247357,Kidney
2710,SLC22A2*,SLC22A2*,Maternal,rs2279463-<b>?</b>,8 x 10-7,,NR,'-,1.123259 unit decrease,[0.68-1.57],SLC22A2,Estimated glomerular filtration rate,glomerular filtration rate,GCST008030,6:160247357,Kidney
2711,SLC22A2*,SLC22A2*,Maternal,rs2279463-<b>G</b>,6 x 10-12,(eGFRcrea),0.12,'-,0.01 unit decrease,[0.009-0.017],SLC22A2,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,6:160247357,Kidney
2712,SLC22A2*,SLC22A2*,Maternal,rs2279463-<b>A</b>,7 x 10-18,,NR,'-,0.0119 unit increase,[0.0092-0.0146],SLC22A2,Glomerular filtration rate in non diabetics (creatinine),"creatinine measurement, glomerular filtration rate",GCST003401,6:160247357,Kidney
2713,SLC22A2*,SLC22A2*,Maternal,rs2279463-<b>A</b>,2 x 10-27,,0.857,'-,0.803 unit increase,[0.66-0.95],SLC22A2,Estimated glomerular filtration rate in non-diabetics,glomerular filtration rate,GCST008745,6:160247357,Kidney
2714,SLC22A2*,SLC22A2*,Maternal,rs2279463-<b>A</b>,2 x 10-48,,0.88,'-,0.0075 unit increase,[0.0065-0.0085],SLC22A2,Estimated glomerular filtration rate,glomerular filtration rate,GCST008747,6:160247357,Kidney
2715,SLC22A2*,SLC22A2*,Maternal,rs2279463-<b>G</b>,6 x 10-32,,0.1016,'-,11.759 z score decrease,NR,SLC22A2,Estimated glomerular filtration rate,glomerular filtration rate,GCST007876,6:160247357,Kidney
2716,SLC22A2*,SLC22A2*,Maternal,rs2279463-<b>G</b>,1 x 10-14,,0.124407,'-,0.071368 unit increase,[0.055-0.088],SLC22A2,Creatinine levels,creatinine measurement,GCST007877,6:160247357,Kidney
2717,SLC22A2*,SLC22A2*,Maternal,rs316020-<b>?</b>,1 x 10-11,,NR,'-,0.0553 unit increase,[0.039-0.071],SLC22A2,Creatinine levels,creatinine measurement,GCST005985,6:160248049,Kidney
2718,SLC22A2*,SLC22A2*,Maternal,rs316020-<b>?</b>,7 x 10-12,,NR,'-,0.05738 unit decrease,[0.041-0.074],SLC22A2,Glomerular filtration rate,glomerular filtration rate,GCST005984,6:160248049,Kidney
2719,SLC22A2*,SLC22A2*,Maternal,rs316020-<b>?</b>,3 x 10-25,,NR,'-,'-,'-,SLC22A2,Estimated glomerular filtration rate,glomerular filtration rate,GCST007344,6:160248049,Kidney
2720,SLC22A2*,SLC22A2*,Maternal,rs316009-<b>T</b>,4 x 10-19,(EA),0.1,'-,0.0131 unit increase,[0.01-0.016],SLC22A2,Glomerular filtration rate (creatinine),"creatinine measurement, glomerular filtration rate",GCST003372,6:160254732,Kidney
2721,SLC22A2*,SLC22A2*,Maternal,rs316009-<b>C</b>,1 x 10-9,,NR,'-,1.193 unit decrease,[0.82-1.57],SLC22A2,Glomerular filtration rate,glomerular filtration rate,GCST003790,6:160254732,Kidney
2722,SLC22A2*,SLC22A2*,Maternal,rs3127573-<b>G</b>,7 x 10-10,,0.13,'-,1.1 % increase,[0.8-1.4],SLC22A2,Creatinine levels,creatinine measurement,GCST000651,6:160260361,Kidney
2812,SLC22A3*,SLC22A3*,Maternal,rs505870-<b>A</b>,5 x 10-11,,0.48,'-,0.012 unit decrease,[0.0084-0.0156],SLC22A3,Urate levels,urate measurement,GCST011119,6:160350331,Kidney
1537,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,1 x 10-8,(RAC1),0.01045,'-,0.1381 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1538,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,2 x 10-9,(RSU1),0.01045,'-,0.05928 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1539,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,1 x 10-8,(ARHGDIB),0.01045,'-,0.0853 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1540,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,2 x 10-8,(KCTD12),0.01045,'-,0.03438 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1541,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,4 x 10-9,(MTPN),0.01045,'-,0.03722 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1542,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,6 x 10-9,(FKBP1A),0.01045,'-,0.03265 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1543,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,8 x 10-9,(RNH1),0.01045,'-,0.2098 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1544,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,7 x 10-9,(SEPT7),0.01045,'-,0.0741 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1545,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,2 x 10-8,(NUTF2),0.01045,'-,0.02923 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1546,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,3 x 10-10,(TAGLN2),0.01045,'-,0.4583 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1547,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,6 x 10-9,(PARVA),0.01045,'-,0.03069 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1548,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,2 x 10-8,(FLNA),0.01045,'-,1.16 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1549,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,7 x 10-9,(CAPN2),0.01045,'-,0.05833 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1550,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,4 x 10-10,(CFL1),0.01045,'-,1.089 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1551,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,9 x 10-9,(PFN1),0.01045,'-,1.429 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1552,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,3 x 10-12,(CNN2),0.01045,'-,0.02343 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1553,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,5 x 10-9,(ACTR2),0.01045,'-,0.09162 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1554,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,1 x 10-9,(CNN3),0.01045,'-,0.01974 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1555,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,5 x 10-10,(ACTR3),0.01045,'-,0.2062 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1556,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,1 x 10-8,(CTSC),0.01045,'-,0.02847 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1557,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,5 x 10-11,(LCP1),0.01045,'-,0.8332 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1558,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,1 x 10-10,(TYMP),0.01045,'-,0.6714 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1559,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,6 x 10-13,(CLIC1),0.01045,'-,0.245 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1560,KCNK9,KCNK9,Maternal,rs78209928-<b>T</b>,1 x 10-8,(RBP1),0.01045,'-,0.06815 unit increase,NR,KCNK9,Protein quantitative trait loci (liver),protein measurement,GCST011427,8:139695678,Liver
1889,KCNQ1,KCNQ1,Maternal,rs143709408-<b>?</b>,4 x 10-15,,9.98E-05,'-,'-,'-,KCNQ1,Hyperuricemia,hyperuricemia,GCST007916,11:2527999,Liver
1890,KCNQ1,KCNQ1,Maternal,rs147445322-<b>?</b>,4 x 10-11,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Hyperuricemia,hyperuricemia,GCST007916,11:2847803,Liver
1891,KCNQ1,KCNQ1,Maternal,rs147445322-<b>?</b>,2 x 10-16,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Serum uric acid levels,uric acid measurement,GCST007918,11:2847803,Liver
1910,KCNQ1,KCNQ1-AS1,Maternal,rs147445322-<b>?</b>,2 x 10-16,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Serum uric acid levels,uric acid measurement,GCST007918,11:2847803,Liver
2300,MAGI2,MAGI2,Maternal,rs10268856-<b>T</b>,2 x 10-9,(ITIH4),0.01916,'-,0.04438 unit increase,NR,MAGI2,Protein quantitative trait loci (liver),protein measurement,GCST011427,7:78970129,Liver
2413,NTM,NTM,Maternal,rs117275526-<b>A</b>,4 x 10-9,(CALD1),0.02613,'-,0.07231 unit increase,NR,NTM,Protein quantitative trait loci (liver),protein measurement,GCST011427,11:131865037,Liver
2414,NTM,NTM,Maternal,rs74863301-<b>C</b>,3 x 10-10,(ALDH16A1),0.01045,'-,0.03942 unit increase,NR,NTM,Protein quantitative trait loci (liver),protein measurement,GCST011427,11:132007525,Liver
2460,OSBPL5,OSBPL5,Maternal,rs11820744-<b>T</b>,2 x 10-7,,0.227188,'-,0.254587 unit increase,[0.16-0.35],OSBPL5,Aspartate aminotransferase levels in non-alcoholic fatty liver disease,"aspartate aminotransferase measurement, non-alcoholic fatty liver disease",GCST008467,11:3147308,Liver
2680,SLC22A18,SLC22A18,Maternal,rs16928809-<b>A</b>,1 x 10-7,,0.09,'-,0.06 umol/l increase,[0.04-0.08],SLC22A18,Bilirubin levels,bilirubin measurement,GCST000386,11:2915722,Liver
2681,SLC22A18,SLC22A18,Maternal,rs1661052-<b>?</b>,5 x 10-11,,NR,'-,0.05614 unit decrease,[0.039-0.073],SLC22A18,Total bilirubin levels,bilirubin measurement,GCST005980,11:2921363,Liver
2861,SMOC1,SMOC1,Maternal,rs227404-<b>G</b>,1 x 10-11,(ORM2),0.01045,'-,0.2076 unit increase,NR,SMOC1,Protein quantitative trait loci (liver),protein measurement,GCST011427,14:70024666,Liver
2886,SVOPL,SVOPL,Maternal,rs1659832-<b>A</b>,1 x 10-9,(RAC2),0.277,'-,0.003321 unit increase,NR,SVOPL,Protein quantitative trait loci (liver),protein measurement,GCST011427,7:138596610,Liver
1561,KCNK9,KCNK9,Maternal,rs969124-<b>A</b>,9 x 10-6,,NR,'-,0.01198 unit increase,[0.0067-0.0173],"AC090093.1, KCNK9",Parental longevity (father's age at death),parental longevity,GCST009447,8:139551949,Longevity
2723,SLC22A2*,SLC22A2*,Maternal,rs9456508-<b>T</b>,4 x 10-8,,0.978225,'-,0.0425855 unit decrease,[0.028-0.058],SLC22A2,"Parental longevity (combined parental attained age, Martingale residuals)",parental longevity,GCST006697,6:160177564,Longevity
2724,SLC22A2*,SLC22A2*,Maternal,rs9295128-<b>G</b>,2 x 10-11,,0.983087,'-,0.0594745 unit decrease,[0.042-0.077],"SLC22A3, SLC22A2","Parental longevity (combined parental attained age, Martingale residuals)",parental longevity,GCST006697,6:160330499,Longevity
2807,SLC22A3*,SLC22A3*,Maternal,rs9295128-<b>G</b>,2 x 10-11,,0.983087,'-,0.0594745 unit decrease,[0.042-0.077],"SLC22A3, SLC22A2","Parental longevity (combined parental attained age, Martingale residuals)",parental longevity,GCST006697,6:160330499,Longevity
2808,SLC22A3*,SLC22A3*,Maternal,rs9457925-<b>G</b>,2 x 10-6,,NR,'-,'-,'-,SLC22A3,Parental longevity (mother's age at death or mother's attained age),parental longevity,GCST009449,6:160427711,Longevity
2809,SLC22A3*,SLC22A3*,Maternal,rs9457925-<b>A</b>,4 x 10-12,,0.02,'-,0.06608 unit decrease,[0.047-0.085],SLC22A3,Parental longevity (father's age at death),parental longevity,GCST009447,6:160427711,Longevity
1225,HOXA4,HOXA4,Maternal,rs1801085-<b>G</b>,1 x 10-11,,0.091,1.45,'-,[NR],"HOXA4, HOXA-AS2, AC004080.6, HOXA3",Hypospadias,hypospadias,GCST002563,7:27128971,Male Reproductive System
2415,NTM,NTM,Maternal,rs433406-<b>G</b>,3 x 10-6,"(Birth rate, additive)",0.47,'-,'-,'-,NTM,Male fertility,"birth rate, male fertility",GCST001540,11:131501125,Male Reproductive System
2682,SLC22A18,SLC22A18,Maternal,rs440150-<b>G</b>,2 x 10-8,,0.0934089,'-,0.0256632 unit increase,[0.016-0.035],SLC22A18,Total testosterone levels,testosterone measurement,GCST90012112,11:2915427,Male Reproductive System
2725,SLC22A2*,SLC22A2*,Maternal,rs381194-<b>G</b>,5 x 10-8,,0.528176,'-,0.0127199 unit increase,[0.0078-0.0177],"SLC22A3, SLC22A2",Bioavailable testosterone levels,testosterone measurement,GCST90012102,6:160291162,Male Reproductive System
2726,SLC22A2*,SLC22A2*,Maternal,rs520829-<b>G</b>,2 x 10-16,,0.475492,'-,0.0100721 unit increase,[0.0075-0.0126],"SLC22A2, SLC22A3",Total testosterone levels,testosterone measurement,GCST90012114,6:160346873,Male Reproductive System
2810,SLC22A3*,SLC22A3*,Maternal,rs381194-<b>G</b>,5 x 10-8,,0.528176,'-,0.0127199 unit increase,[0.0078-0.0177],"SLC22A3, SLC22A2",Bioavailable testosterone levels,testosterone measurement,GCST90012102,6:160291162,Male Reproductive System
2811,SLC22A3*,SLC22A3*,Maternal,rs520829-<b>G</b>,2 x 10-16,,0.475492,'-,0.0100721 unit increase,[0.0075-0.0126],"SLC22A2, SLC22A3",Total testosterone levels,testosterone measurement,GCST90012114,6:160346873,Male Reproductive System
2814,SLC22A3*,SLC22A3*,Maternal,rs9364554-<b>T</b>,5 x 10-33,,0.28,1.11,'-,[1.09-1.13],SLC22A3,Prostate cancer,prostate carcinoma,GCST006085,6:160412632,Male Reproductive System
2815,SLC22A3*,SLC22A3*,Maternal,rs9364554-<b>T</b>,6 x 10-12,,0.279,1.14,'-,[1.10-1.18],SLC22A3,Prostate cancer,prostate carcinoma,GCST002944,6:160412632,Male Reproductive System
2816,SLC22A3*,SLC22A3*,Maternal,rs9364554-<b>T</b>,6 x 10-10,,0.29,1.17,'-,[1.08-1.26],SLC22A3,Prostate cancer,prostate carcinoma,GCST000152,6:160412632,Male Reproductive System
2818,SLC22A3*,SLC22A3*,Maternal,rs12194182-<b>C</b>,4 x 10-13,,NR,1.1188185,'-,NR,SLC22A3,Prostate cancer,prostate carcinoma,GCST90011808,6:160413483,Male Reproductive System
2820,SLC22A3*,SLC22A3*,Maternal,rs7758229-<b>T</b>,4 x 10-12,,0.31,1.15,'-,[1.10‐1.20],SLC22A3,Prostate cancer,prostate carcinoma,GCST002890,6:160419220,Male Reproductive System
2821,SLC22A3*,SLC22A3*,Maternal,rs3123636-<b>C</b>,3 x 10-9,,0.356,1.37,'-,[1.23-1.51],SLC22A3,Prostate cancer,prostate carcinoma,GCST003586,6:160421505,Male Reproductive System
2822,SLC22A3*,SLC22A3*,Maternal,rs9351730-<b>?</b> x rs9364554-<b>?</b>,5 x 10-6,,NR,1.25,'-,[1.13-1.37],AL606923.2 - AL606923.1 x SLC22A3,Prostate cancer (SNP x SNP interaction),prostate carcinoma,GCST001370,6:68584593|6:160412632,Male Reproductive System
1951,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,2 x 10-17,(EA),NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:130739885,Mental or Behavioural Disorder
1953,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,1 x 10-6,(Hispanic),NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:130739885,Mental or Behavioural Disorder
1954,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,6 x 10-25,,NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"triglyceride measurement, alcohol consumption measurement",GCST008074,7:130739885,Mental or Behavioural Disorder
1957,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,4 x 10-23,,NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"triglyceride measurement, alcohol drinking",GCST008083,7:130739885,Mental or Behavioural Disorder
1960,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,1 x 10-15,(EA),NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"triglyceride measurement, alcohol drinking",GCST008083,7:130739885,Mental or Behavioural Disorder
1961,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,2 x 10-6,(Hispanic),NR,'-,'-,'-,"AC016831.5, KLF14",Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"triglyceride measurement, alcohol drinking",GCST008083,7:130739885,Mental or Behavioural Disorder
2078,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,3 x 10-30,(EA),NR,'-,'-,'-,"AC016831.5, KLF14",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:130739885,Mental or Behavioural Disorder
2079,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,6 x 10-32,,NR,'-,'-,'-,"AC016831.5, KLF14",HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df),"alcohol consumption measurement, high density lipoprotein cholesterol measurement",GCST008075,7:130739885,Mental or Behavioural Disorder
2080,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,6 x 10-37,,NR,'-,'-,'-,"AC016831.5, KLF14",HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"alcohol drinking, high density lipoprotein cholesterol measurement",GCST008084,7:130739885,Mental or Behavioural Disorder
2081,KLF14,KLF14,Maternal,rs11762784-<b>A</b>,1 x 10-31,(EA),NR,'-,'-,'-,"AC016831.5, KLF14",HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df),"alcohol drinking, high density lipoprotein cholesterol measurement",GCST008084,7:130739885,Mental or Behavioural Disorder
8,ADTRP,ADTRP,Maternal,rs210918-<b>A</b>,5 x 10-6,,0.784,'-,0.018969879 unit decrease,[0.011-0.027],"AL022724.1, ADTRP",Neuroticism,neuroticism measurement,GCST003770,6:11711582,Mental or Behavioural Disorder
9,ADTRP,ADTRP,Maternal,rs210915-<b>T</b>,2 x 10-10,,0.805032828,'-,0.009374047 unit decrease,[0.0065-0.0123],ADTRP,Positive affect,wellbeing measurement,GCST007338,6:11712110,Mental or Behavioural Disorder
10,ADTRP,ADTRP,Maternal,rs210915-<b>T</b>,6 x 10-10,,0.805032828,'-,0.009881952 unit decrease,[0.0067-0.013],ADTRP,Life satisfaction,wellbeing measurement,GCST007337,6:11712110,Mental or Behavioural Disorder
11,ADTRP,ADTRP,Maternal,rs210915-<b>T</b>,1 x 10-10,,0.805032828,'-,0.012211247 unit decrease,[0.0085-0.0159],ADTRP,Neuroticism,neuroticism measurement,GCST007339,6:11712110,Mental or Behavioural Disorder
12,ADTRP,ADTRP,Maternal,rs210915-<b>T</b>,6 x 10-10,,0.805032828,'-,0.007673362 unit decrease,[0.0052-0.0101],ADTRP,Depressive symptoms,depressive symptom measurement,GCST007340,6:11712110,Mental or Behavioural Disorder
13,ADTRP,ADTRP,Maternal,rs210914-<b>C</b>,4 x 10-11,,0.806752311,'-,0.0076946197 unit decrease,[0.0054-0.01],ADTRP,Well-being spectrum (multivariate analysis),wellbeing measurement,GCST007341,6:11714917,Mental or Behavioural Disorder
14,ADTRP,ADTRP,Maternal,rs210899-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,"ADTRP, AL022724.3",Social science traits (pleiotropy) (HIPO component 1),"neuroticism measurement, wellbeing measurement, depressive symptom measurement",GCST006665,6:11727825,Mental or Behavioural Disorder
15,ADTRP,ADTRP,Maternal,rs210894-<b>T</b>,4 x 10-7,,0.548,1.068,'-,[NR],"AL022724.3, ADTRP",Autism spectrum disorder,autism spectrum disorder,GCST007556,6:11731766,Mental or Behavioural Disorder
16,ADTRP,ADTRP,Maternal,rs172404-<b>A</b>,2 x 10-9,,0.6073,'-,0.0113 unit increase,[0.0076-0.015],ADTRP,Subjective well-being (MTAG),wellbeing measurement,GCST005325,6:11734031,Mental or Behavioural Disorder
17,ADTRP,ADTRP,Maternal,rs10947543-<b>G</b>,3 x 10-8,,0.5876,'-,0.0128 unit decrease,[0.0083-0.0173],ADTRP,Subjective well-being,wellbeing measurement,GCST005328,6:11750897,Mental or Behavioural Disorder
48,ATP10A,ATP10A,Maternal,rs72699765-<b>A</b>,5 x 10-7,(Hispanic),0.11,'-,0.029 unit increase,[0.017-0.041],"AC023449.1, ATP10A",Obstructive sleep apnea trait (average respiratory event duration),"sleep apnea measurement, obstructive sleep apnea",GCST003675,15:25584050,Mental or Behavioural Disorder
277,DLX5,DLX5,Maternal,rs75290158-<b>A</b>,8 x 10-7,(between families),NR,'-,4.943 unit increase,'-,DLX5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:97023147,Mental or Behavioural Disorder
1906,KCNQ1,KCNQ1,Maternal,rs800336-<b>G</b>,4 x 10-6,,0.2504,'-,0.0558322 unit increase,NR,KCNQ1,Depressive symptoms x independent stressful life events interaction (1df test),"depressive symptom measurement, stressful life event measurement",GCST007412,11:2451901,Mental or Behavioural Disorder
1907,KCNQ1,KCNQ1,Maternal,rs116949162-<b>G</b>,1 x 10-6,,0.9857409,1.1350738,'-,[1.08-1.19],KCNQ1,Trauma exposure in major depressive disorder,"unipolar depression, response to trauma exposure",GCST009983,11:2495782,Mental or Behavioural Disorder
2318,MAGI2,MAGI2,Maternal,rs1034797-<b>G</b>,5 x 10-6,,0.08,3.84,'-,[3.27-4.41],"MAGI2-AS3, NUP35P2",Memory dysfunction in frontotemporal lobe dementia,"memory impairment, Frontotemporal dementia",GCST006151,7:79474577,Mental or Behavioural Disorder
2321,MAGI2,MAGI2,Maternal,rs17150687-<b>C</b>,3 x 10-6,"(Bupropion, Sexual side effects)",0.02,'-,'-,'-,"AC006043.1, MAGI2",Response to anti-depressant treatment in major depressive disorder,"antidepressant-induced sexual dysfunction, response to bupropion, response to antidepressant",GCST001308,7:78413974,Mental or Behavioural Disorder
2324,MAGI2,MAGI2,Maternal,rs7802996-<b>T</b>,9 x 10-10,,0.166,'-,0.00887691 unit decrease,[0.006-0.0117],MAGI2,Smoking initiation (ever regular vs never regular) (MTAG),smoking status measurement,GCST007468,7:78142666,Mental or Behavioural Disorder
2325,MAGI2,MAGI2,Maternal,rs7802996-<b>T</b>,1 x 10-9,,0.166,'-,0.020884689 unit decrease,[0.014-0.028],MAGI2,Smoking initiation (ever regular vs never regular),smoking status measurement,GCST007474,7:78142666,Mental or Behavioural Disorder
2326,MAGI2,MAGI2,Maternal,rs62468774-<b>A</b>,8 x 10-9,,0.869,'-,0.0101 unit decrease,[0.0066-0.0136],"MAGI2, AC006043.1",General risk tolerance (MTAG),risk-taking behaviour,GCST007325,7:78419425,Mental or Behavioural Disorder
2327,MAGI2,MAGI2,Maternal,rs1030015-<b>T</b>,6 x 10-8,,0.52,'-,0.00585017 unit increase,[0.0037-0.008],MAGI2,Smoking initiation (ever regular vs never regular) (MTAG),smoking status measurement,GCST007468,7:78510264,Mental or Behavioural Disorder
2328,MAGI2,MAGI2,Maternal,rs1030015-<b>T</b>,2 x 10-8,(Conditioned on chr7:77771983),0.519564,'-,0.014289635 unit increase,[0.0093-0.0193],MAGI2,Smoking initiation (ever regular vs never regular),smoking status measurement,GCST007474,7:78510264,Mental or Behavioural Disorder
2329,MAGI2,MAGI2,Maternal,rs323167-<b>C</b>,4 x 10-8,,NR,1.0570824,'-,[1.04-1.08],MAGI2,Schizophrenia,schizophrenia,GCST004946,7:78707361,Mental or Behavioural Disorder
2330,MAGI2,MAGI2,Maternal,rs323167-<b>C</b>,3 x 10-6,(East Asian),NR,1.103,'-,[1.06-1.14],MAGI2,Schizophrenia,schizophrenia,GCST007201,7:78707361,Mental or Behavioural Disorder
2331,MAGI2,MAGI2,Maternal,rs4727751-<b>T</b>,1 x 10-6,,NR,1.05,'-,[NR],MAGI2,Schizophrenia,schizophrenia,GCST003048,7:78707618,Mental or Behavioural Disorder
2332,MAGI2,MAGI2,Maternal,rs323169-<b>?</b>,3 x 10-8,,NR,1.054641,'-,[1.04-1.07],MAGI2,Schizophrenia,schizophrenia,GCST009337,7:78708384,Mental or Behavioural Disorder
2333,MAGI2,MAGI2,Maternal,rs73135595-<b>C</b>,1 x 10-8,,0.0439,'-,0.0150441 unit decrease,[0.0098-0.0202],MAGI2,Smoking initiation (ever regular vs never regular) (MTAG),smoking status measurement,GCST007468,7:78776093,Mental or Behavioural Disorder
2334,MAGI2,MAGI2,Maternal,rs535355-<b>G</b>,7 x 10-7,,0.377677,1.1547344,'-,[1.1-1.21],MAGI2,Major depressive disorder in trauma-unexposed individuals,unipolar depression,GCST009981,7:78841329,Mental or Behavioural Disorder
2347,MAGI2,MAGI2-AS3,Maternal,rs1034797-<b>G</b>,5 x 10-6,,0.08,3.84,'-,[3.27-4.41],"MAGI2-AS3, NUP35P2",Memory dysfunction in frontotemporal lobe dementia,"memory impairment, Frontotemporal dementia",GCST006151,7:79474577,Mental or Behavioural Disorder
2360,MEG8,MEG8,Maternal,rs2180386-<b>A</b>,7 x 10-6,,0.38,'-,0.21 unit decrease,[NR],"RTL1, MEG8, AL117190.1",Developmental language disorder (linguistic errors),"linguistic error measurement, specific language impairment",GCST003397,14:100898928,Mental or Behavioural Disorder
2401,NTM,NTM,Maternal,rs35974940-<b>T</b>,1 x 10-6,,'-,'-,3.2303 unit increase,[1.92-4.54],NTM,Aggressiveness in attention deficit hyperactivity disorder,"attention deficit hyperactivity disorder, aggressive behaviour measurement, childhood aggressive behaviour measurement",GCST003473,11:131375192,Mental or Behavioural Disorder
2406,NTM,NTM,Maternal,rs1550972-<b>?</b>,1 x 10-8,,NR,'-,0.0118359495 unit decrease,[0.0078-0.0159],NTM,"Cognitive ability, years of educational attainment or schizophrenia (pleiotropy)","schizophrenia, intelligence, self reported educational attainment",GCST008595,11:131421915,Mental or Behavioural Disorder
2429,NTM,NTM,Maternal,rs10791143-<b>G</b>,2 x 10-11,,0.62,'-,0.0074861 unit increase,[0.0053-0.0097],NTM,Mental health study participation (completed survey),health study participation,GCST008550,11:131408781,Mental or Behavioural Disorder
2430,NTM,NTM,Maternal,rs1448355-<b>?</b>,1 x 10-10,,'-,'-,0.0146118 unit decrease,[0.01-0.019],NTM,Leisure sedentary behaviour (computer use),lifestyle measurement,GCST010085,11:131416791,Mental or Behavioural Disorder
2431,NTM,NTM,Maternal,rs7108020-<b>C</b>,9 x 10-12,,0.36,0.97,'-,"[0.96, 0.98]",NTM,Acceptance of an invitation to participate in a mental health questionnaire,health study participation,GCST90012792,11:131419926,Mental or Behavioural Disorder
2432,NTM,NTM,Maternal,rs1448354-<b>G</b>,5 x 10-8,,NR,'-,0.0069314 unit increase,[0.0044-0.0094],NTM,Mental health study participation (completed survey),health study participation,GCST008550,11:131426671,Mental or Behavioural Disorder
2433,NTM,NTM,Maternal,rs35659386-<b>A</b>,9 x 10-6,,NR,1.07,'-,[NR],NTM,Schizophrenia,schizophrenia,GCST003048,11:131430474,Mental or Behavioural Disorder
2434,NTM,NTM,Maternal,rs1550976-<b>?</b>,2 x 10-6,,0.33,'-,'-,'-,NTM,Asperger disorder,Asperger syndrome,GCST000904,11:131450176,Mental or Behavioural Disorder
2435,NTM,NTM,Maternal,rs992564-<b>?</b>,4 x 10-6,,NR,1.6221,'-,[NR],NTM,Bipolar disorder and schizophrenia,mental or behavioural disorder,GCST000821,11:131466180,Mental or Behavioural Disorder
2436,NTM,NTM,Maternal,rs10750486-<b>A</b>,3 x 10-8,,0.498564,'-,5.546 unit increase,'-,NTM,Feeling worry,worry measurement,GCST006950,11:131594022,Mental or Behavioural Disorder
2437,NTM,NTM,Maternal,rs75038630-<b>A</b>,1 x 10-7,"(mYscore, binary)",0.06,2.09,'-,'-,"NTM, AP000844.2",Food addiction,"eating behaviour, food addiction measurement",GCST003489,11:131888434,Mental or Behavioural Disorder
2438,NTM,NTM,Maternal,rs75038630-<b>A</b>,5 x 10-6,"(mYscore, continuous, adjusted for BMI)",0.06,'-,0.19 unit increase,[0.11-0.27],"NTM, AP000844.2",Food addiction,"eating behaviour, food addiction measurement",GCST003489,11:131888434,Mental or Behavioural Disorder
2439,NTM,NTM,Maternal,rs1106363-<b>T</b>,2 x 10-8,,0.343,'-,0.00861905 unit decrease,[0.0056-0.0116],NTM,Age of smoking initiation (MTAG),smoking initiation,GCST007462,11:132096370,Mental or Behavioural Disorder
2440,NTM,NTM,Maternal,rs1106363-<b>T</b>,9 x 10-11,(Conditioned on chr11:132098205),0.344579,'-,0.017374555 unit increase,[0.012-0.023],NTM,Smoking initiation (ever regular vs never regular),smoking status measurement,GCST007474,11:132096370,Mental or Behavioural Disorder
2441,NTM,NTM,Maternal,rs1106363-<b>T</b>,3 x 10-12,,0.345,'-,0.00793514 unit increase,[0.0057-0.0102],NTM,Smoking initiation (ever regular vs never regular) (MTAG),smoking status measurement,GCST007468,11:132096370,Mental or Behavioural Disorder
2442,NTM,NTM,Maternal,rs74802478-<b>?</b>,4 x 10-9,,'-,'-,0.0166419 unit increase,[0.011-0.022],NTM,Leisure sedentary behaviour (television watching),lifestyle measurement,GCST010084,11:132097013,Mental or Behavioural Disorder
2443,NTM,NTM,Maternal,rs1449435-<b>A</b>,2 x 10-8,,0.4232,'-,0.012346945 unit increase,[0.008-0.0167],NTM,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:132219023,Mental or Behavioural Disorder
2444,NTM,NTM,Maternal,rs2010921-<b>A</b>,2 x 10-10,,0.311,'-,0.017429141 unit increase,[0.012-0.023],NTM,Smoking initiation (ever regular vs never regular),smoking status measurement,GCST007474,11:132228311,Mental or Behavioural Disorder
2445,NTM,NTM,Maternal,rs2010921-<b>?</b>,1 x 10-10,,NR,'-,'-,'-,NTM,Smoking status,smoking status measurement,GCST007085,11:132228311,Mental or Behavioural Disorder
2446,NTM,NTM,Maternal,rs2010921-<b>A</b>,1 x 10-13,,0.311,'-,0.0086703 unit increase,[0.0064-0.011],NTM,Smoking initiation (ever regular vs never regular) (MTAG),smoking status measurement,GCST007468,11:132228311,Mental or Behavioural Disorder
2447,NTM,NTM,Maternal,rs3099769-<b>A</b>,2 x 10-12,,0.4091,'-,0.014361975 unit increase,[0.01-0.018],NTM,Smoking status (ever vs never smokers),smoking behavior,GCST007327,11:132318528,Mental or Behavioural Disorder
2448,NTM,NTM,Maternal,rs662024-<b>G</b>,2 x 10-9,,'-,'-,0.0111769 unit decrease,[0.0075-0.0148],"NTM, AP000843.1",Biological sex,sex,GCST90013473,11:132343078,Mental or Behavioural Disorder
2567,PPP1R9A,PPP1R9A,Maternal,rs777583985-<b>?</b>,2 x 10-6,,NR,'-,0.0077314 unit increase,[0.0045-0.0109],"ARF1P1, PPP1R9A",Reaction time,reaction time measurement,GCST006268,7:94873152,Mental or Behavioural Disorder
2620,RB1,RB1,Maternal,rs544475121-<b>AT</b>,5 x 10-6,(AA),NR,'-,0.561 unit increase,'-,"LPAR6, RB1",Major depression and alcohol dependence,"unipolar depression, alcohol dependence",GCST005022,13:48442207,Mental or Behavioural Disorder
2621,RB1,RB1,Maternal,rs4151636-<b>G</b>,4 x 10-6,,0.0438058,1.136,'-,[1.08-1.19],RB1,Trauma exposure in major depressive disorder,"unipolar depression, response to trauma exposure",GCST009983,13:48482598,Mental or Behavioural Disorder
2631,RB1,RB1CC1,Maternal,rs35551581-<b>?</b>,4 x 10-6,,NR,1.600512,'-,NR,"NPBWR1, RB1CC1",Response to antidepressants (symptom remission),response to antidepressant,GCST007061,8:52844839,Mental or Behavioural Disorder
2733,SLC22A2*,SLC22A2*,Maternal,rs117901488-<b>T</b>,6 x 10-6,,NR,'-,0.2 unit increase,[0.12-0.28],SLC22A2,Recurrent major depressive disorder,unipolar depression,GCST005230,6:160182100,Mental or Behavioural Disorder
140,DIO3OS,DIO3OS,Maternal,rs11626434-<b>C</b>,2 x 10-16,,0.36,'-,0.053 unit increase,[0.039-0.067],"LINC02314, DIO3OS",Free thyroxine concentration,thyroxine measurement,GCST006896,14:101532106,Metabolism
869,H19,H19,Maternal,rs7482894-<b>T</b>,4 x 10-14,,0.65,'-,0.0147 unit increase,[0.011-0.019],"IGF2, H19",Urate levels,urate measurement,GCST011119,11:2100034,Metabolism
1892,KCNQ1,KCNQ1,Maternal,rs7130232-<b>?</b>,5 x 10-6,(anthranilic acid),NR,'-,1.1864697 unit increase,[0.68-1.69],KCNQ1,Metabolite levels,anthranilic acid measurement,GCST009391,11:2605561,Metabolism
1893,KCNQ1,KCNQ1,Maternal,rs2237878-<b>?</b>,1 x 10-6,(Lactic dehydrogenase),0.07,'-,'-,'-,KCNQ1,Protein quantitative trait loci,L lactate dehydrogenase measurement,GCST000189,11:2745052,Metabolism
1894,KCNQ1,KCNQ1,Maternal,rs60808706-<b>A</b>,6 x 10-9,(East Asian),0.3902,'-,0.0345 mg/dL increase,[0.023-0.046],KCNQ1,Urate levels,urate measurement,GCST008972,11:2836003,Metabolism
2070,KLF14,KLF14,Maternal,rs10260148-<b>T</b>,7 x 10-13,,0.27901,'-,0.0521287 unit increase,[0.038-0.066],"KLF14, AC016831.5",Metabolic syndrome,metabolic syndrome,GCST009602,7:130746210,Metabolism
2071,KLF14,KLF14,Maternal,rs13230111-<b>A</b>,6 x 10-11,,0.507651,'-,0.0136169 unit increase,[0.0095-0.0177],"AC016831.5, KLF14",Apolipoprotein B levels,apolipoprotein B measurement,GCST010243,7:130752365,Metabolism
2072,KLF14,KLF14,Maternal,rs1364422-<b>C</b>,5 x 10-35,,0.719852,'-,0.0270358 unit increase,[0.023-0.031],"AC016831.5, KLF14",Apolipoprotein A1 levels,apolipoprotein A 1 measurement,GCST010241,7:130761222,Metabolism
2301,MAGI2,MAGI2,Maternal,rs3807766-<b>?</b>,4 x 10-6,(EA),NR,'-,0.2122 unit decrease,[0.12-0.3],MAGI2,3-hydroxypropylmercapturic acid levels in smokers,"smoking behavior, 3-hydroxypropylmercapturic acid measurement",GCST002956,7:78053573,Metabolism
2302,MAGI2,MAGI2,Maternal,rs13240161-<b>?</b>,8 x 10-6,(allantoin),NR,'-,0.18936239 unit decrease,[0.11-0.27],MAGI2,Metabolite levels,allantoin measurement,GCST009391,7:78175529,Metabolism
2398,NTM,NTM,Maternal,rs2658882-<b>?</b>,9 x 10-6,(total PUFA),NR,'-,'-,'-,"NTM-AS1, NTM",Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome,polyunsaturated fatty acid measurement,GCST010313,11:131645762,Metabolism
2399,NTM,NTM,Maternal,rs11827555-<b>?</b>,4 x 10-6,(AA),NR,4.84,'-,[3.74-5.94],NTM,Peripheral arterial disease (traffic-related air pollution interaction),"peripheral arterial disease, traffic air pollution measurement",GCST004482,11:131855008,Metabolism
2416,NTM,NTM,Maternal,rs11222660-<b>?</b>,1 x 10-7,(isoleucine),NR,'-,0.26215872 unit decrease,[0.16-0.36],NTM,Metabolite levels,isoleucine measurement,GCST009391,11:131473384,Metabolism
2417,NTM,NTM,Maternal,rs11222660-<b>?</b>,3 x 10-6,(leucine),NR,'-,0.23220143 unit decrease,[0.13-0.33],NTM,Metabolite levels,leucine measurement,GCST009391,11:131473384,Metabolism
2457,NTM,NTM-AS1,Maternal,rs2658882-<b>?</b>,9 x 10-6,(total PUFA),NR,'-,'-,'-,"NTM-AS1, NTM",Serum polyunsaturated fatty acid concentration x sex interaction in metabolic syndrome,polyunsaturated fatty acid measurement,GCST010313,11:131645762,Metabolism
2683,SLC22A18,SLC22A18,Maternal,rs450244-<b>T</b>,2 x 10-18,,0.0892726,'-,0.0302382 unit decrease,[0.023-0.037],SLC22A18,Apolipoprotein A1 levels,apolipoprotein A 1 measurement,GCST010241,11:2919262,Metabolism
2727,SLC22A2*,SLC22A2*,Maternal,rs316020-<b>?</b>,2 x 10-72,(X-12798),NR,'-,0.1748 unit decrease,[NR],SLC22A2,Serum metabolite levels,serum metabolite measurement,GCST006249,6:160248049,Metabolism
2728,SLC22A2*,SLC22A2*,Maternal,rs316020-<b>A</b>,3 x 10-286,(X-12798/phenylalanine),0.09,'-,0.183 unit decrease,[0.17-0.19],SLC22A2,Blood metabolite ratios,blood metabolite measurement,GCST002442,6:160248049,Metabolism
2729,SLC22A2*,SLC22A2*,Maternal,rs316019-<b>A</b>,2 x 10-259,(X-12798),0.09,'-,0.181 unit decrease,[0.17-0.19],SLC22A2,Blood metabolite levels,blood metabolite measurement,GCST002443,6:160249250,Metabolism
2711,SLC22A2*,SLC22A2*,Maternal,rs2279463-<b>G</b>,6 x 10-12,(eGFRcrea),0.12,'-,0.01 unit decrease,[0.009-0.017],SLC22A2,Chronic kidney disease,"creatinine measurement, chronic kidney disease",GCST000649,6:160247357,Metabolism
2812,SLC22A3*,SLC22A3*,Maternal,rs505870-<b>A</b>,5 x 10-11,,0.48,'-,0.012 unit decrease,[0.0084-0.0156],SLC22A3,Urate levels,urate measurement,GCST011119,6:160350331,Metabolism
2862,SMOC1,SMOC1,Maternal,rs12433177-<b>?</b>,6 x 10-6,(fructose; glucose; galactose),NR,'-,0.17460604 unit decrease,[0.099-0.25],SMOC1,Metabolite levels,"fructose measurement, glucose measurement, galactose measurement",GCST009391,14:69995644,Metabolism
2863,SMOC1,SMOC1,Maternal,rs7159934-<b>?</b>,6 x 10-7,(taurocholate),NR,'-,0.26817906 unit increase,[0.16-0.37],SMOC1,Metabolite levels,taurocholate measurement,GCST009391,14:70024736,Metabolism
40,ATP10A,ATP10A,Maternal,rs2291354-<b>A</b>,1 x 10-6,(EA),0.48,'-,'-,'-,ATP10A,Neuropathologic traits (pleiotropy),"brain infarction, neuritic plaque measurement, Lewy body dementia, cerebral amyloid angiopathy, neurofibrillary tangles measurement",GCST90012832,15:25707742,Nervous System
277,DLX5,DLX5,Maternal,rs75290158-<b>A</b>,8 x 10-7,(between families),NR,'-,4.943 unit increase,'-,DLX5,Alzheimer disease and age of onset,"Alzheimer's disease, age at onset",GCST003427,7:97023147,Nervous System
278,DLX5,DLX5,Maternal,rs62497458-<b>?</b>,7 x 10-6,,'-,'-,'-,'-,"SDHAF3, DLX5",Postcentral gyrus volume,postcentral gyrus volume measurement,GCST009215,7:97089777,Nervous System
872,H19,H19,Maternal,rs4529869-<b>A</b>,3 x 10-6,,0.5051,'-,0.0293 unit decrease,[0.017-0.042],"H19, IGF2",Periventricular white matter hyperintensities,white matter hyperintensity measurement,GCST010726,11:2123215,Nervous System
1899,KCNQ1,KCNQ1,Maternal,rs3819506-<b>?</b> x rs2002258-<b>?</b>,1 x 10-8,,NR,'-,'-,'-,KCNQ1 x RPPH1-3P - AC079403.1,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,11:2507094|4:157034536,Nervous System
1900,KCNQ1,KCNQ1,Maternal,rs2237866-<b>?</b> x rs12472513-<b>?</b>,2 x 10-13,,NR,'-,'-,'-,KCNQ1 x LYPD6B,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,11:2508932|2:149203960,Nervous System
1901,KCNQ1,KCNQ1,Maternal,rs108961-<b>T</b>,9 x 10-6,,0.474,'-,0.09 unit increase,[0.051-0.129],KCNQ1,Plasma amyloid beta peptide concentrations (ABx-40),plasma beta-amyloid 1-40 measurement,GCST002360,11:2736755,Nervous System
2040,KLF14,KLF14,Maternal,rs3996352-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"AC016831.5, KLF14",Circulating leptin levels or type 2 diabetes,"leptin measurement, type II diabetes mellitus",GCST010272,7:130760175,Nervous System
2053,KLF14,KLF14,Maternal,rs972283-<b>G</b>,7 x 10-8,,0.555,'-,0.043 unit decrease,[0.027-0.059],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007309,7:130782095,Nervous System
2054,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-10,,0.521,'-,0.041 unit decrease,[0.029-0.053],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007310,7:130782095,Nervous System
2055,KLF14,KLF14,Maternal,rs972283-<b>G</b>,2 x 10-8,,0.521,'-,0.048 unit decrease,[0.03-0.066],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007312,7:130782095,Nervous System
2056,KLF14,KLF14,Maternal,rs972283-<b>G</b>,3 x 10-7,,0.551,'-,0.049 unit decrease,[0.031-0.067],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007313,7:130782095,Nervous System
2057,KLF14,KLF14,Maternal,rs972283-<b>G</b>,9 x 10-6,,0.555,'-,0.055 unit decrease,[0.031-0.079],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007315,7:130782095,Nervous System
2058,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-7,,0.521,'-,0.054 unit decrease,[0.034-0.074],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007316,7:130782095,Nervous System
2059,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-6,,0.521,'-,0.062 unit decrease,[0.035-0.089],"AC016831.5, KLF14",circulating leptin levels,leptin measurement,GCST90007318,7:130782095,Nervous System
2060,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-18,,0.55,'-,0.053 unit decrease,[0.041-0.065],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007319,7:130782095,Nervous System
2061,KLF14,KLF14,Maternal,rs972283-<b>G</b>,2 x 10-6,,0.544,'-,0.045 unit decrease,[0.027-0.063],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007320,7:130782095,Nervous System
2062,KLF14,KLF14,Maternal,rs972283-<b>G</b>,4 x 10-15,,0.555,'-,0.063 unit decrease,[0.047-0.079],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007321,7:130782095,Nervous System
2062,KLF14,KLF14,Maternal,rs972283-<b>G</b>,4 x 10-15,,0.555,'-,0.063 unit decrease,[0.047-0.079],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007321,7:130782095,Nervous System
2064,KLF14,KLF14,Maternal,rs972283-<b>G</b>,5 x 10-7,,0.522,'-,0.048 unit decrease,[0.028-0.068],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007323,7:130782095,Nervous System
2065,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-14,,0.521,'-,0.066 unit decrease,[0.048-0.084],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007324,7:130782095,Nervous System
2066,KLF14,KLF14,Maternal,rs972283-<b>G</b>,6 x 10-14,,0.55,'-,0.071 unit decrease,[0.053-0.089],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007325,7:130782095,Nervous System
2067,KLF14,KLF14,Maternal,rs972283-<b>G</b>,3 x 10-12,,0.555,'-,0.086 unit decrease,[0.062-0.11],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007327,7:130782095,Nervous System
2068,KLF14,KLF14,Maternal,rs972283-<b>G</b>,8 x 10-18,,0.521,'-,0.079 unit decrease,[0.059-0.099],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007328,7:130782095,Nervous System
2069,KLF14,KLF14,Maternal,rs972283-<b>G</b>,1 x 10-12,,0.521,'-,0.096 unit decrease,[0.069-0.123],"AC016831.5, KLF14",circulating leptin levels adjusted for BMI,BMI-adjusted leptin measurement,GCST90007330,7:130782095,Nervous System
2303,MAGI2,MAGI2,Maternal,rs7512474-<b>?</b> x rs12668317-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,ERICH3 - AC135803.1 x MAGI2,Neurofibrillary tangles (SNP x SNP interaction),neurofibrillary tangles measurement,GCST010343,1:74679187|7:78305285,Nervous System
2304,MAGI2,MAGI2,Maternal,rs687813-<b>?</b> x rs3807775-<b>?</b>,3 x 10-9,,NR,'-,'-,'-,ROBO2 x MAGI2,Diffuse plaques (SNP x SNP interaction),diffuse plaque measurement,GCST010341,3:76019242|7:78044415,Nervous System
2305,MAGI2,MAGI2,Maternal,rs6838861-<b>?</b> x rs322007-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,C4orf50 x MAGI2,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,4:6017139|7:78649816,Nervous System
2306,MAGI2,MAGI2,Maternal,rs200638911-<b>?</b>,9 x 10-6,,NR,'-,652.5593 unit decrease,NR,"AC004990.1, MAGI2",Cerebrospinal fluid sTREM-2 levels,soluble triggering receptor expressed on myeloid cells 2 measurement,GCST009246,7:77996667,Nervous System
2307,MAGI2,MAGI2,Maternal,rs12668317-<b>?</b> x rs4782271-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,MAGI2 x GRIN2A,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,7:78305285|16:10125560,Nervous System
2308,MAGI2,MAGI2,Maternal,rs17150684-<b>?</b> x rs34729156-<b>?</b>,1 x 10-11,,NR,'-,'-,'-,"MAGI2, AC006043.1 x RYR2",Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,7:78399081|1:237571716,Nervous System
2309,MAGI2,MAGI2,Maternal,rs17150684-<b>?</b> x rs34729156-<b>?</b>,1 x 10-7,,NR,'-,'-,'-,"MAGI2, AC006043.1 x RYR2",Neurofibrillary tangles (SNP x SNP interaction),neurofibrillary tangles measurement,GCST010343,7:78399081|1:237571716,Nervous System
2310,MAGI2,MAGI2,Maternal,rs17150684-<b>?</b> x rs437858-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,"MAGI2, AC006043.1 x AL162291.1 - AL354984.1",Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,7:78399081|20:57957124,Nervous System
2311,MAGI2,MAGI2,Maternal,rs2362598-<b>?</b> x rs1869500-<b>?</b>,9 x 10-16,,NR,'-,'-,'-,"MAGI2, AC006043.1 x CNTNAP5",Neurofibrillary tangles (SNP x SNP interaction),neurofibrillary tangles measurement,GCST010343,7:78443385|2:124679493,Nervous System
2312,MAGI2,MAGI2,Maternal,rs2362598-<b>?</b> x rs6925200-<b>?</b>,1 x 10-12,,NR,'-,'-,'-,"MAGI2, AC006043.1 x AL096854.1",Neurofibrillary tangles (SNP x SNP interaction),neurofibrillary tangles measurement,GCST010343,7:78443385|6:120548044,Nervous System
2313,MAGI2,MAGI2,Maternal,rs7802215-<b>?</b> x rs3772284-<b>?</b>,7 x 10-9,,NR,'-,'-,'-,"MAGI2, AC006043.1 x CNTN6",Neurofibrillary tangles (SNP x SNP interaction),neurofibrillary tangles measurement,GCST010343,7:78443653|3:1355730,Nervous System
2314,MAGI2,MAGI2,Maternal,rs11525066-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,MAGI2,Hippocampal atrophy,hippocampal atrophy,GCST000461,7:78546660,Nervous System
2315,MAGI2,MAGI2,Maternal,rs2159017-<b>?</b> x rs12564769-<b>?</b>,3 x 10-10,,NR,'-,'-,'-,MAGI2 x HIVEP3,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,7:78686608|1:41579346,Nervous System
2316,MAGI2,MAGI2,Maternal,rs2159017-<b>?</b> x rs12731266-<b>?</b>,7 x 10-13,,NR,'-,'-,'-,"MAGI2 x AC119676.1, HIVEP3",Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,7:78686608|1:41596413,Nervous System
2317,MAGI2,MAGI2,Maternal,rs74388387-<b>C</b>,2 x 10-22,,0.19,1.61,'-,[NR],MAGI2,Moyamoya disease,Moyamoya disease,GCST005575,7:79037327,Nervous System
2322,MAGI2,MAGI2,Maternal,rs78723182-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,MAGI2,Response to lamotrigine and valproic acid in genetic generalized epilepsy,"generalised epilepsy, response to anticonvulsant",GCST010292,7:78891976,Nervous System
2363,MEG8,MEG8,Maternal,rs10145110-<b>?</b>,1 x 10-7,,'-,'-,'-,'-,MEG8,Amyotrophic lateral sclerosis (sporadic),sporadic amyotrophic lateral sclerosis,GCST002337,14:101008533,Nervous System
2377,NAA60,NAA60,Maternal,rs28810-<b>A</b>,5 x 10-7,,0.11,'-,0.0624 unit increase,[NR],"NAA60, AC025283.2",Cerebral amyloid deposition (PET imaging),cerebral amyloid deposition measurement,GCST003073,16:3450515,Nervous System
2378,NAA60,NAA60,Maternal,rs28810-<b>A</b>,6 x 10-7,(correcting APOE e4),0.12,'-,0.0577 unit increase,[NR],"NAA60, AC025283.2",Cerebral amyloid deposition (PET imaging),cerebral amyloid deposition measurement,GCST003073,16:3450515,Nervous System
2418,NTM,NTM,Maternal,rs2458778-<b>C</b>,4 x 10-6,(men),NR,'-,0.2460361 unit decrease,[0.14-0.35],NTM,Plasma anti-thyroglobulin levels,anti-thyroglobulin antibody measurement,GCST008369,11:131597486,Nervous System
2419,NTM,NTM,Maternal,rs1086216-<b>?</b> x rs962993-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,NTM x AC044784.1 - LINC00709,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,11:131665529|10:9011169,Nervous System
2420,NTM,NTM,Maternal,rs73035809-<b>G</b>,8 x 10-6,(EA),0.97,'-,0.39 unit decrease,[0.22-0.56],NTM,Neurofibrillary tanglesn,neurofibrillary tangles measurement,GCST90012826,11:131737090,Nervous System
2421,NTM,NTM,Maternal,rs17767642-<b>?</b> x rs4468361-<b>?</b>,7 x 10-10,,NR,'-,'-,'-,AC064856.1 - AC009312.1 x NTM,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,2:117603260|11:132140223,Nervous System
2422,NTM,NTM,Maternal,rs11695562-<b>?</b> x rs2658833-<b>?</b>,3 x 10-11,,NR,'-,'-,'-,CATIP - SLC11A1 x NTM,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,2:218369982|11:131678632,Nervous System
2423,NTM,NTM,Maternal,rs504534-<b>?</b> x rs1547895-<b>?</b>,4 x 10-11,,NR,'-,'-,'-,H3P15 - AC097528.1 x NTM,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,4:126142693|11:132077086,Nervous System
2424,NTM,NTM,Maternal,rs17544050-<b>?</b> x rs2027782-<b>?</b>,4 x 10-8,,NR,'-,'-,'-,LINC02473 - AC006390.1 x NTM,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,4:24740773|11:132012122,Nervous System
2425,NTM,NTM,Maternal,rs10259803-<b>?</b> x rs667007-<b>?</b>,6 x 10-9,,NR,'-,'-,'-,LRRC72 x NTM,Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,7:16531403|11:131933540,Nervous System
2615,RB1,RB1,Maternal,rs3945837-<b>A</b>,8 x 10-6,(adjusted for severity),0.57,1.25,'-,[1.15-1.35],"CYSLTR2, RB1",3-month functional outcome in ischaemic stroke (modified Rankin score),"Ischemic stroke, stroke outcome severity measurement",GCST007676,13:48619791,Nervous System
2790,SLC22A3*,SLC22A3*,Maternal,rs543159-<b>A</b>,4 x 10-10,,0.482,'-,0.035 unit increase,[0.023-0.047],SLC22A3,Glycine levels,glycine measurement,GCST007638,6:160354985,Nervous System
3015,TP73,TP73,Maternal,rs2230912-<b>?</b> x rs17379833-<b>?</b>,2 x 10-10,,NR,'-,'-,'-,"P2RX7, AC069209.2 x TP73",Total PHF-tau (SNP x SNP interaction),PHF-tau measurement,GCST010340,12:121184393|1:3703616,Nervous System
41,ATP10A,ATP10A,Maternal,"rs2930590-<b>C</b>, rs2925253-<b>A</b>, rs2086907-<b>A</b>, rs2925256-<b>C</b>, rs8025092-<b>C</b>, rs11858433-<b>A</b>, rs2930593-<b>G</b>, rs952121-<b>C</b>, rs7176242-<b>A</b>",5 x 10-17,,0.003,'-,'-,'-,AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,15:25633329|15:25630857|15:25628262|15:25627862|15:25630114|15:25636283|15:25632668|15:25630251|15:25632574,Orthopaedic
42,ATP10A,ATP10A,Maternal,"rs2930590-<b>C</b>, rs2925253-<b>A</b>, rs2086907-<b>A</b>, rs2925256-<b>C</b>, rs8025092-<b>T</b>, rs11858433-<b>A</b>, rs2930593-<b>G</b>, rs952121-<b>C</b>, rs7176242-<b>A</b>",2 x 10-9,,0.218,'-,'-,'-,AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A; AC023449.1 - ATP10A,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,15:25633329|15:25630857|15:25628262|15:25627862|15:25630114|15:25636283|15:25632668|15:25630251|15:25632574,Orthopaedic
141,DIO3OS,DIO3OS,Maternal,"rs10142332-<b>G</b>, rs12435279-<b>C</b>, rs12586651-<b>T</b>",3 x 10-7,,0.155,'-,'-,'-,LINC02314 - DIO3OS; No mapped genes; No mapped genes,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,14:101519289,Orthopaedic
1902,KCNQ1,KCNQ1,Maternal,"rs10832134-<b>C</b>, rs12576156-<b>A</b>, rs11523905-<b>A</b>",3 x 10-15,,0.021,'-,'-,'-,KCNQ1; KCNQ1; KCNQ1,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,11:2481256|11:2477588|11:2477029,Orthopaedic
1903,KCNQ1,KCNQ1,Maternal,"rs10832134-<b>C</b>, rs12576156-<b>A</b>, rs11523905-<b>G</b>",4 x 10-13,,0.241,'-,'-,'-,KCNQ1; KCNQ1; KCNQ1,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,11:2481256|11:2477588|11:2477029,Orthopaedic
2426,NTM,NTM,Maternal,"rs4937627-<b>C</b>, rs12419920-<b>T</b>, rs12575010-<b>A</b>, rs992564-<b>G</b>, rs11222647-<b>G</b>, rs12278021-<b>G</b>, rs11222652-<b>C</b>, rs7107326-<b>C</b>, rs11222631-<b>A</b>, rs11222653-<b>A</b>",2 x 10-14,,0.273,'-,'-,'-,NTM; NTM; NTM; NTM; NTM; NTM; NTM; NTM; NTM; NTM,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,11:131481990|11:131466286|11:131474218|11:131466180|11:131461593|11:131462231|11:131463268|11:131462673|11:131456474|11:131463704,Orthopaedic
2888,SVOPL,SVOPL,Maternal,"rs11769043-<b>A</b>, rs17160472-<b>G</b>, rs7798990-<b>C</b>, rs296917-<b>T</b>, rs11769011-<b>G</b>, rs17160478-<b>T</b>",9 x 10-6,,0.061,'-,'-,'-,SVOPL; SVOPL; SVOPL; SVOPL; SVOPL; SVOPL,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,7:138694160|7:138694681|7:138687094|7:138693060|7:138694200|7:138698792,Orthopaedic
3016,TP73,TP73,Maternal,"rs3765753-<b>G</b>, rs17379833-<b>A</b>",5 x 10-13,,0.334,'-,'-,'-,TP73; TP73,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,1:3705742|1:3703616,Orthopaedic
3017,TP73,TP73,Maternal,"rs3765753-<b>T</b>, rs17379833-<b>A</b>",5 x 10-13,,0.28,'-,'-,'-,TP73; TP73,Core binding factor acute myeloid leukemia,acute myeloid leukemia,GCST008413,1:3705742|1:3703616,Orthopaedic
2320,MAGI2,MAGI2,Maternal,rs1496766-<b>C</b>,5 x 10-6,,0.014,2.84,'-,[1.81-4.44],MAGI2,Acute lymphoblastic leukemia (childhood),acute lymphoblastic leukemia,GCST001693,7:78702149,Orthopaedic
56,CPA4,CPA4,Maternal,rs2306848-<b>G</b>,6 x 10-12,,0.948,'-,'-,'-,CPA4,Rheumatoid arthritis,rheumatoid arthritis,GCST007843,7:130322574,Orthopaedic
1870,KCNQ1,KCNQ1,Maternal,rs179785-<b>?</b>,1 x 10-8,,0.489,1.22,'-,[NR],KCNQ1,Gout,gout,GCST002909,11:2760289,Orthopaedic
1889,KCNQ1,KCNQ1,Maternal,rs143709408-<b>?</b>,4 x 10-15,,9.98E-05,'-,'-,'-,KCNQ1,Hyperuricemia,hyperuricemia,GCST007916,11:2527999,Orthopaedic
1890,KCNQ1,KCNQ1,Maternal,rs147445322-<b>?</b>,4 x 10-11,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Hyperuricemia,hyperuricemia,GCST007916,11:2847803,Orthopaedic
1891,KCNQ1,KCNQ1,Maternal,rs147445322-<b>?</b>,2 x 10-16,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Serum uric acid levels,uric acid measurement,GCST007918,11:2847803,Orthopaedic
1910,KCNQ1,KCNQ1-AS1,Maternal,rs147445322-<b>?</b>,2 x 10-16,,2.00E-04,'-,'-,'-,"KCNQ1, KCNQ1-AS1",Serum uric acid levels,uric acid measurement,GCST007918,11:2847803,Orthopaedic
2073,KLF14,KLF14,Maternal,rs74446409-<b>?</b>,4 x 10-6,,NR,'-,'-,'-,"KLF14, TSGA13",Glucocorticoid-induced osteonecrosis (age 10 years and older),"response to glucocorticoid, osteonecrosis",GCST003081,7:130711940,Orthopaedic
2449,NTM,NTM,Maternal,rs76140786-<b>?</b>,3 x 10-6,,0.14,1.75,'-,[1.38-2.23],"NTM, NTM-AS1",Interstitial lung diseases in rheumatoid arthritis,"rheumatoid arthritis, interstitial lung disease",GCST011319,11:131642123,Orthopaedic
2459,NTM,NTM-AS1,Maternal,rs76140786-<b>?</b>,3 x 10-6,,0.14,1.75,'-,[1.38-2.23],"NTM, NTM-AS1",Interstitial lung diseases in rheumatoid arthritis,"rheumatoid arthritis, interstitial lung disease",GCST011319,11:131642123,Orthopaedic
2571,PPP1R9A,PPP1R9A,Maternal,rs192462116-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"PPP1R9A, PPP1R9A-AS1",Glucocorticoid-induced osteonecrosis (age 10 years and older),"response to glucocorticoid, osteonecrosis",GCST003081,7:95138094,Orthopaedic
2575,PPP1R9A,PPP1R9A-AS1,Maternal,rs192462116-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"PPP1R9A, PPP1R9A-AS1",Glucocorticoid-induced osteonecrosis (age 10 years and older),"response to glucocorticoid, osteonecrosis",GCST003081,7:95138094,Orthopaedic
2630,RB1,RB1CC1,Maternal,rs11997538-<b>?</b>,1 x 10-13,,NR,'-,'-,'-,"RB1CC1, NPBWR1",Adolescent idiopathic scoliosis,adolescent idiopathic scoliosis,GCST006287,8:52920103,Orthopaedic
2732,SLC22A2*,SLC22A2*,Maternal,rs3125055-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"SLC22A2, SLC22A3",Adolescent idiopathic scoliosis,adolescent idiopathic scoliosis,GCST006287,6:160315755,Orthopaedic
2823,SLC22A3*,SLC22A3*,Maternal,rs3125055-<b>?</b>,3 x 10-6,,NR,'-,'-,'-,"SLC22A2, SLC22A3",Adolescent idiopathic scoliosis,adolescent idiopathic scoliosis,GCST006287,6:160315755,Orthopaedic
3018,TP73,TP73,Maternal,rs3765718-<b>?</b>,2 x 10-6,,NR,'-,'-,'-,TP73,Joint damage in rheumatoid arthritis,"rheumatoid arthritis, joint damage measurement",GCST008992,1:3687131,Orthopaedic
7,ADTRP,ADTRP,Maternal,rs185569610-<b>C</b>,3 x 10-6,(AA),0.999,'-,0.359 unit increase,'-,ADTRP,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,6:11785127,Respiratory
34,ANO1,ANO1,Maternal,rs78460763-<b>?</b>,5 x 10-15,,NR,'-,'-,'-,"FADD, ANO1",Lung function (FEV1/FVC),FEV/FEC ratio,GCST007080,11:70198345,Respiratory
874,H19,H19,Maternal,rs78276179-<b>C</b>,5 x 10-6,,0.089914211,1.1871005,'-,[1.102555221-1.278128967],H19,Squamous cell lung carcinoma,squamous cell lung carcinoma,GCST004750,11:2000263,Respiratory
2335,MAGI2,MAGI2,Maternal,rs10251504-<b>?</b>,6 x 10-7,,NR,'-,0.035 unit increase,[NR],MAGI2,Airway wall thickness,airway wall thickness measurement,GCST002794,7:78060571,Respiratory
2336,MAGI2,MAGI2,Maternal,rs10251504-<b>?</b>,1 x 10-6,(Males only),NR,'-,0.036 unit increase,[NR],MAGI2,Airway wall thickness,airway wall thickness measurement,GCST002794,7:78060571,Respiratory
2337,MAGI2,MAGI2,Maternal,rs10251504-<b>?</b>,2 x 10-6,(FEV1/FVC < 80%),NR,'-,0.036 unit increase,[NR],MAGI2,Airway wall thickness,airway wall thickness measurement,GCST002794,7:78060571,Respiratory
2338,MAGI2,MAGI2,Maternal,rs118028745-<b>?</b>,2 x 10-9,(CCL24),NR,'-,0.671637 unit decrease,[0.45-0.89],MAGI2,Blood protein levels,CCL24 measurement,GCST009696,7:78303714,Respiratory
2339,MAGI2,MAGI2,Maternal,rs62468577-<b>G</b>,6 x 10-6,(Dominant model),0.82,1.5385,'-,[NR],MAGI2,Bronchopulmonary dysplasia,Bronchopulmonary dysplasia,GCST002104,7:78523355,Respiratory
2340,MAGI2,MAGI2,Maternal,rs9649366-<b>?</b>,2 x 10-9,(CCL24),NR,'-,1.05366 unit increase,[0.71-1.4],MAGI2,Blood protein levels,CCL24 measurement,GCST009696,7:79023530,Respiratory
2357,MEG3,MEG3,Maternal,rs12587062-<b>G</b>,8 x 10-6,,NR,'-,0.102 unit decrease,[0.057-0.147],"MEG3, AL117190.1, AL117190.2",Emphysema annual change measurement in smokers (adjusted lung density),"emphysema imaging measurement, smoking status measurement",GCST008477,14:100844542,Respiratory
2358,MEG3,MEG3,Maternal,rs12587062-<b>G</b>,6 x 10-6,(EA),0.763,'-,0.11 unit decrease,[0.063-0.157],"MEG3, AL117190.1, AL117190.2",Emphysema annual change measurement in smokers (adjusted lung density),"emphysema imaging measurement, smoking status measurement",GCST008477,14:100844542,Respiratory
2428,NTM,NTM,Maternal,rs145397878-<b>C</b>,2 x 10-6,,0.005,5.81,'-,[2.80-12.09],NTM,Familial lung adenocarcinoma,"lung adenocarcinoma, family history of lung cancer",GCST006087,11:132170004,Respiratory
2450,NTM,NTM,Maternal,rs4491239-<b>?</b>,7 x 10-28,,NR,'-,'-,'-,NTM,Lung function (FEV1/FVC),FEV/FEC ratio,GCST007080,11:132102628,Respiratory
2449,NTM,NTM,Maternal,rs76140786-<b>?</b>,3 x 10-6,,0.14,1.75,'-,[1.38-2.23],"NTM, NTM-AS1",Interstitial lung diseases in rheumatoid arthritis,"rheumatoid arthritis, interstitial lung disease",GCST011319,11:131642123,Respiratory
2451,NTM,NTM,Maternal,rs4468361-<b>T</b>,8 x 10-6,(TNFA),0.32,'-,'-,'-,NTM,Chronic obstructive pulmonary disease-related biomarkers,"tumor necrosis factor-alpha measurement, chronic obstructive pulmonary disease",GCST001737,11:132140223,Respiratory
2459,NTM,NTM-AS1,Maternal,rs76140786-<b>?</b>,3 x 10-6,,0.14,1.75,'-,[1.38-2.23],"NTM, NTM-AS1",Interstitial lung diseases in rheumatoid arthritis,"rheumatoid arthritis, interstitial lung disease",GCST011319,11:131642123,Respiratory
2616,RB1,RB1,Maternal,rs183816717-<b>A</b>,2 x 10-6,(AA),0.999,'-,0.465 unit increase,'-,RB1,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,13:48445893,Respiratory
2617,RB1,RB1,Maternal,rs185837131-<b>T</b>,2 x 10-6,(AA),0.999,'-,0.453 unit increase,'-,RB1,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,13:48455468,Respiratory
2618,RB1,RB1,Maternal,rs187785117-<b>T</b>,2 x 10-6,(AA),0.999,'-,0.405 unit increase,'-,RB1,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,13:48575735,Respiratory
2619,RB1,RB1,Maternal,rs193251247-<b>A</b>,2 x 10-6,(AA),0.999,'-,0.4 unit increase,'-,RB1,Post bronchodilator FEV1/FVC ratio,"response to bronchodilator, FEV/FEC ratio",GCST003264,13:48589044,Respiratory
2731,SLC22A2*,SLC22A2*,Maternal,rs3908804-<b>A</b>,2 x 10-6,,0.042,2.11,'-,[1.55-2.88],"SLC22A2, SLC22A3",Familial squamous cell lung carcinoma,"squamous cell lung carcinoma, family history of lung cancer",GCST006088,6:160282296,Respiratory
2813,SLC22A3*,SLC22A3*,Maternal,rs3908804-<b>A</b>,2 x 10-6,,0.042,2.11,'-,[1.55-2.88],"SLC22A2, SLC22A3",Familial squamous cell lung carcinoma,"squamous cell lung carcinoma, family history of lung cancer",GCST006088,6:160282296,Respiratory
2887,SVOPL,SVOPL,Maternal,rs28625106-<b>A</b>,5 x 10-6,,0.041,2.46,'-,[1.67-3.63],SVOPL,Familial squamous cell lung carcinoma,"squamous cell lung carcinoma, family history of lung cancer",GCST006088,7:138667056,Respiratory
18,ADTRP,ADTRP,Maternal,rs115504329-<b>?</b>,3 x 10-8,,'-,'-,'-,'-,ADTRP,Refractive error,Abnormality of refraction,GCST010002,6:11719245,Sensory System
875,H19,H19,Maternal,rs12575480-<b>A</b>,2 x 10-6,(African),0.06211,'-,'-,'-,"H19, IGF2",Pursuit maintenance gain,pursuit maintenance gain measurement,GCST005024,11:2086425,Sensory System
2341,MAGI2,MAGI2,Maternal,rs987493-<b>C</b>,1 x 10-6,,0.1186,'-,'-,'-,MAGI2,Pursuit maintenance gain,pursuit maintenance gain measurement,GCST005024,7:78137203,Sensory System
2342,MAGI2,MAGI2,Maternal,rs2216076-<b>A</b>,6 x 10-7,,0.1219,'-,0.0124 unit increase,[0.0075-0.0173],"MAGI2, AC006043.1",Bitter beverage consumption,bitter beverage consumption measurement,GCST008521,7:78441311,Sensory System
2343,MAGI2,MAGI2,Maternal,rs10260177-<b>?</b>,3 x 10-17,,'-,'-,'-,'-,"AC006043.1, MAGI2",Refractive error,Abnormality of refraction,GCST010002,7:78446317,Sensory System
2359,MEG3,MEG3,Maternal,rs1884537-<b>C</b>,2 x 10-6,,NR,'-,0.134 unit increase,[0.052-0.216],MEG3,Optic nerve measurement (disc area),optic disc size measurement,GCST000657,14:100785652,Sensory System
2452,NTM,NTM,Maternal,rs1790165-<b>?</b>,7 x 10-29,,'-,'-,'-,'-,NTM,Refractive error,Abnormality of refraction,GCST010002,11:132059077,Sensory System
2453,NTM,NTM,Maternal,rs1790165-<b>A</b>,2 x 10-12,,0.423,'-,0.0504 unit increase,[0.036-0.065],NTM,Myopia (age of diagnosis),"age at onset, Myopia",GCST006290,11:132059077,Sensory System
2454,NTM,NTM,Maternal,rs1790165-<b>A</b>,7 x 10-12,,0.4113,'-,6.854 z score increase,[NR],NTM,Spherical equivalent or myopia (age of diagnosis),"age at onset, Myopia, refractive error measurement",GCST006291,11:132059077,Sensory System
2455,NTM,NTM,Maternal,rs1793639-<b>?</b>,1 x 10-15,,NR,1.061,'-,[1.046-1.076],NTM,Myopia,Myopia,GCST003997,11:132061637,Sensory System
2456,NTM,NTM,Maternal,rs1015053-<b>T</b>,1 x 10-9,,'-,'-,0.07 unit increase,[0.05-0.09],NTM,Spherical equivalent,refractive error measurement,GCST010378,11:132063617,Sensory System
2526,PARD6G,PARD6G,Maternal,rs2197609-<b>?</b> x rs1547553-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"LINC00333 - AL445588.1 x PARD6G-AS1, PARD6G",Age-related hearing impairment (SNP x SNP interaction),age-related hearing impairment,GCST002487,13:84603753|18:80168314,Sensory System
2527,PARD6G,PARD6G,Maternal,rs4424809-<b>?</b> x rs1547553-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"LINC00333 - AL445588.1 x PARD6G-AS1, PARD6G",Age-related hearing impairment (SNP x SNP interaction),age-related hearing impairment,GCST002487,13:84774112|18:80168314,Sensory System
2528,PARD6G,PARD6G-AS1,Maternal,rs2197609-<b>?</b> x rs1547553-<b>?</b>,2 x 10-9,,NR,'-,'-,'-,"LINC00333 - AL445588.1 x PARD6G-AS1, PARD6G",Age-related hearing impairment (SNP x SNP interaction),age-related hearing impairment,GCST002487,13:84603753|18:80168314,Sensory System
2529,PARD6G,PARD6G-AS1,Maternal,rs4424809-<b>?</b> x rs1547553-<b>?</b>,1 x 10-9,,NR,'-,'-,'-,"LINC00333 - AL445588.1 x PARD6G-AS1, PARD6G",Age-related hearing impairment (SNP x SNP interaction),age-related hearing impairment,GCST002487,13:84774112|18:80168314,Sensory System
2408,NTM,NTM,Maternal,rs12421680-<b>A</b>,6 x 10-6,,NR,'-,0.41 unit increase,[0.23-0.59],NTM,Sunburns,sunburn,GCST001933,11:131481074,Skin
2032,KLF14,KLF14,Maternal,rs11762784-<b>?</b>,1 x 10-16,,NR,'-,0.007549 unit increase,[0.0056-0.0095],"AC016831.5, KLF14",HDL cholesterol levels x long total sleep time interaction (2df test),"sleep duration, high density lipoprotein cholesterol measurement",GCST009368,7:130739885,Sleep
2033,KLF14,KLF14,Maternal,rs13234407-<b>?</b>,3 x 10-17,,NR,'-,0.007863 unit increase,[0.006-0.0097],"KLF14, AC016831.5",HDL cholesterol levels x short total sleep time interaction (2df test),"sleep duration, high density lipoprotein cholesterol measurement",GCST009367,7:130753455,Sleep
2286,MAGI2,MAGI2,Maternal,rs10236696-<b>G</b>,8 x 10-6,"(sleep offset, weekdays)",NR,'-,0.2551 unit increase,[0.14-0.37],MAGI2,Night sleep phenotypes,sleep duration,GCST003542,7:78052062,Sleep
2287,MAGI2,MAGI2,Maternal,rs3807651-<b>A</b>,9 x 10-9,,0.4938,1.0249051,'-,'-,MAGI2,Chronotype,chronotype measurement,GCST007576,7:78194454,Sleep
2288,MAGI2,MAGI2,Maternal,rs6466171-<b>?</b>,3 x 10-11,(EA),NR,'-,0.8267 unit increase,[0.4-1.26],MAGI2,LDL cholesterol levels x short total sleep time interaction (2df test),"sleep duration, low density lipoprotein cholesterol measurement",GCST009365,7:78364977,Sleep
2289,MAGI2,MAGI2,Maternal,rs6466171-<b>?</b>,2 x 10-6,(EA),NR,'-,2.674 unit increase,[1.58-3.77],MAGI2,LDL cholesterol levels x short total sleep time interaction (1df test),"sleep duration, low density lipoprotein cholesterol measurement",GCST009359,7:78364977,Sleep
2290,MAGI2,MAGI2,Maternal,rs10244093-<b>?</b>,3 x 10-9,,NR,'-,0.6898 unit decrease,[0.32-1.06],MAGI2,LDL cholesterol levels x short total sleep time interaction (2df test),"sleep duration, low density lipoprotein cholesterol measurement",GCST009365,7:78371701,Sleep
2837,SMOC1,SMOC1,Maternal,rs75987388-<b>T</b>,2 x 10-6,"(daytime resting duration, weekdays)",NR,'-,0.2994 unit increase,[0.18-0.42],SMOC1,Daytime sleep phenotypes,daytime rest measurement,GCST003518,14:69918990,Sleep
2344,MAGI2,MAGI2,Maternal,rs3779306-<b>?</b>,9 x 10-6,,NR,'-,'-,'-,MAGI2,Serum folate levels,folic acid measurement,GCST006137,7:78094909,Vitamin
